CCC Intelligent Solutions (CCCS) 10-K 28 Feb 24 2023 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Feb. 21, 2024	Jun. 30, 2023
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2023
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity Registrant Name	CCC Intelligent Solutions Holdings Inc.
Entity Central Index Key	0001818201
Entity File Number	001-03551
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Document Annual Report	true
Document Transition Report	false
Entity Tax Identification Number	98-1546280
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	167 N. Green Street
Entity Address, Address Line Two	9th Floor
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60607
City Area Code	800
Local Phone Number	621-8070
Entity Common Stock, Shares Outstanding		604,651,284
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	CCCS
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Public Float			$ 1,847
ICFR Auditor Attestation Flag	true
Auditor Name	Deloitte & Touche LLP
Auditor Firm ID	34
Auditor Location	Chicago, IL
Document Financial Statement Error Correction [Flag]	false
Documents Incorporated by Reference [Text Block]	Our definitive proxy statement relating to our 2024 annual meeting of shareholders will be filed with the Securities and Exchange Commission within 120 days after the close of our fiscal year ended December 31, 2023 and is incorporated by reference in Part III to the extent described therein.

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 195,572	$ 323,788
Accounts receivable - Net of allowances of $5,574 and $5,339 as of December 31, 2023 and 2022,respectively	102,365	98,353
Income taxes receivable	1,798	4,015
Deferred contract costs	17,900	16,556
Other current assets	32,364	36,358
Total current assets	349,999	479,070
SOFTWARE, EQUIPMENT, AND PROPERTY—Net	160,416	146,443
OPERATING LEASE ASSETS	30,456	32,874
INTANGIBLE ASSETS—Net	1,015,046	1,118,819
Goodwill	1,417,724	1,495,129
DEFERRED FINANCING FEES, REVOLVER—Net	1,672	2,286
DEFERRED CONTRACT COSTS	22,302	20,161
EQUITY METHOD INVESTMENT	10,228	10,228
OTHER ASSETS	43,197	45,911
TOTAL	3,051,040	3,350,921
CURRENT LIABILITIES:
Accounts payable	16,324	27,599
Accrued expenses	71,478	71,445
Income taxes payable	3,689	922
Current portion of long-term debt	8,000	8,000
Current portion of long-term licensing agreement—Net	3,061	2,876
Operating lease liabilities	6,788	5,484
Deferred revenues	43,567	35,239
Total current liabilities	152,907	151,565
LONG-TERM DEBT - Net	767,504	774,132
DEFERRED INCOME TAXES—Net	195,365	241,698
LONG-TERM LICENSING AGREEMENT—Net	27,692	30,752
OPERATING LEASE LIABILITIES	50,796	54,245
WARRANT LIABILITIES	51,501	36,405
OTHER LIABILITIES	6,414	2,658
Total liabilities	1,252,179	1,291,455
COMMITMENTS AND CONTINGENCIES (Notes 23 and 24)
MEZZANINE EQUITY:
Redeemable non-controlling interest	16,584	14,179
STOCKHOLDERS' EQUITY:
Preferred stock, $0.0001 par; 100,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock - $0.0001 par; 5,000,000,000 shares authorized; 603,128,781 and 622,072,905 shares issued and outstanding at December 31, 2023 and 2022, respectively	60	62
Additional paid-in capital	2,909,757	2,754,055
Accumulated deficit	(1,126,467)	(707,946)
Accumulated other comprehensive loss	(1,073)	(884)
Total stockholders' equity	1,782,277	2,045,287
TOTAL	$ 3,051,040	$ 3,350,921

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Allowances for doubtful accounts receivable current	$ 5,574	$ 5,339
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	100,000,000	100,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	5,000,000,000	5,000,000,000
Common Stock, Shares, Issued	603,128,781	622,072,905
Common Stock, Shares, Outstanding	603,128,781	622,072,905

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive (Loss) Income - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Comprehensive Income
REVENUES	$ 866,378,000	$ 782,448,000	$ 688,288,000
COST OF REVENUES
Cost of revenues, exclusive of amortization and impairment of acquired technologies	203,324,000	187,001,000	169,335,000
Amortization of acquired technologies	26,464,000	26,938,000	26,320,000
Impairment of acquired technologies	431,000	0	0
Total cost of revenues	230,219,000	213,939,000	195,655,000
GROSS PROFIT	636,159,000	568,509,000	492,633,000
OPERATING EXPENSES:
Research and development	173,106,000	156,957,000	165,991,000
Selling and marketing	140,851,000	119,594,000	148,861,000
General and administrative	191,844,000	167,758,000	250,098,000
Amortization of intangible assets	71,972,000	72,278,000	72,358,000
Impairment of goodwill	77,405,000	0	0
Impairment of intangible assets	4,906,000	0	0
Total operating expenses	660,084,000	516,587,000	637,308,000
OPERATING (LOSS) INCOME	(23,925,000)	51,922,000	(144,675,000)
INTEREST EXPENSE	(63,577,000)	(38,990,000)	(58,990,000)
INTEREST INCOME	16,252,000	908,000	0
CHANGE IN FAIR VALUE OF WARRANT LIABILITIES	(15,096,000)	26,073,000	(64,501,000)
CHANGE IN FAIR VALUE OF INTEREST RATE SWAP AGREEMENTS	0	0	8,373,000
GAIN ON SALE OF COST METHOD INVESTMENT	0	3,587,000	0
LOSS ON EARLY EXTINGUISHMENT OF DEBT	0	0	(15,240,000)
OTHER INCOME — Net	1,799,000	6,362,000	114,000
PRETAX (LOSS) INCOME	(84,547,000)	49,862,000	(274,919,000)
INCOME TAX (PROVISION) BENEFIT	(5,524,000)	(11,456,000)	26,000,000
NET (LOSS) INCOME INCLUDING NON-CONTROLLING INTEREST	(90,071,000)	38,406,000	(248,919,000)
LESS: ACCRETION OF REDEEMABLE NON-CONTROLLING INTEREST	(2,405,000)	0	0
NET (LOSS) INCOME ATTRIBUTABLE TO CCC INTELLIGENT SOLUTIONS HOLDINGS INC.'s COMMON STOCKHOLDERS	$ (92,476,000)	$ 38,406,000	$ (248,919,000)
Net (loss) income per share attributable to common stockholders:
Basic	$ (0.15)	$ 0.06	$ (0.46)
Diluted	$ (0.15)	$ 0.06	$ (0.46)
Weighted-average shares used in computing net (loss) income per share attributable to common stockholders:
Basic	617,889,384	607,760,886	543,558,222
Diluted	617,889,384	642,841,596	543,558,222
COMPREHENSIVE (LOSS) INCOME:
Net income (loss) including non-controlling interest	$ (90,071,000)	$ 38,406,000	$ (248,919,000)
Other comprehensive (loss) income—Foreign currency translation adjustment	(189,000)	(569,000)	(44,000)
COMPREHENSIVE (LOSS) INCOME INCLUDING NON-CONTROLLING INTEREST	(90,260,000)	37,837,000	(248,963,000)
Less: accretion of redeemable non-controlling interest	(2,405,000)	0	0
COMPREHENSIVE (LOSS) INCOME INCLUDING NON-CONTROLLING INTEREST	$ (92,665,000)	$ 37,837,000	$ (248,963,000)

Consolidated Statements of Mezz

Consolidated Statements of Mezzanine Equity and Stockholders' Equity - USD ($) $ in Thousands	Total	Redeemable Non-Controlling Interest [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2020	$ 14,179	$ 14,179
Beginning balance at Dec. 31, 2020	1,371,615		$ 0	$ 50	$ 1,501,206	$ (129,370)	$ (271)
Beginning balance, Shares at Dec. 31, 2020			0	504,274,890
Issuance of common stock	1,007				1,007
Issuance of common stock, Shares				110,679
Stock-based compensation expense	254,965				254,965
Stock-based compensation expense, Shares				883,729
Net equity infusion from the Business Combination	704,841			$ 10	704,831
Net equity infusion from the Business Combination, Shares				97,740,002
Exercise of stock options—net of tax	5,180				5,180
Exercise of stock options—net of tax , Shares				1,922,019
Exercise of warrants-Net	60,462			$ 1	60,461
Exercise of warrants-Net, Shares				4,836,977
Accretion of redeemable non-controlling interest	0
LESS: ACCRETION OF REDEEMABLE NON-CONTROLLING INTEREST	0
Dividends to CCCIS stockholders	(269,178)					(269,178)
Deemed distribution to CCCIS option holders	(9,006)				(9,006)
Company Vesting Shares granted to CCCIS stockholders					98,885	(98,885)
Foreign currency translation adjustment	(44)						(44)
Net (loss) income	(248,919)					(248,919)
Redeemable Non-Controlling Interest, Ending balance at Dec. 31, 2021	14,179	14,179
Ending balance at Dec. 31, 2021	1,872,318		$ 0	$ 61	2,618,924	(746,352)	(315)
Ending balance, Shares at Dec. 31, 2021			0	609,768,296
Tax effect of Business Combination transaction costs	1,395				1,395
Stock-based compensation expense	109,387				109,387
Exercise of stock options—net of tax	27,563			$ 1	27,562
Exercise of stock options—net of tax , Shares				10,074,354
Exercise of warrants-Net, Shares				1,246
Issuance of common stock under employee stock purchase plan	3,197				3,197
Issuance of common stock under employee stock purchase plan, Shares				408,879
Issuance of common stock upon vesting of RSUs-net of tax	(5,015)				(5,015)
Issuance of common stock upon vesting of RSUs-net of tax, Shares				1,820,130
Accretion of redeemable non-controlling interest	0
LESS: ACCRETION OF REDEEMABLE NON-CONTROLLING INTEREST	0
Foreign currency translation adjustment	(569)						(569)
Net (loss) income	38,406					38,406
Redeemable Non-Controlling Interest, Ending balance at Dec. 31, 2022	14,179	14,179
Ending balance at Dec. 31, 2022	2,045,287		$ 0	$ 62	2,754,055	(707,946)	(884)
Ending balance, Shares at Dec. 31, 2022			0	622,072,905
Stock-based compensation expense	144,628				144,628
Exercise of stock options—net of tax	25,434			$ 1	25,433
Exercise of stock options—net of tax , Shares				8,923,718
Issuance of common stock under employee stock purchase plan	4,761				4,761
Issuance of common stock under employee stock purchase plan, Shares				641,691
Issuance of common stock upon vesting of RSUs-net of tax	(16,715)				(16,715)
Issuance of common stock upon vesting of RSUs-net of tax, Shares				3,990,467
Repurchase and retirement of common stock	(328,453)			$ (3)		(328,450)
Repurchase and retirement of common stock, Shares				(32,500,000)
Accretion of redeemable non-controlling interest	2,405	2,405
LESS: ACCRETION OF REDEEMABLE NON-CONTROLLING INTEREST	(2,405)				(2,405)
Foreign currency translation adjustment	(189)						(189)
Net (loss) income	(90,071)					(90,071)
Redeemable Non-Controlling Interest, Ending balance at Dec. 31, 2023	16,584	$ 16,584
Ending balance at Dec. 31, 2023	$ 1,782,277			$ 60	$ 2,909,757	$ (1,126,467)	$ (1,073)
Ending balance, Shares at Dec. 31, 2023				603,128,781

Condensed Consolidated Statemen

Condensed Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income	$ (90,071,000)	$ 38,406,000	$ (248,919,000)
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization of software, equipment, and property	36,902,000	27,933,000	24,451,000
Amortization of intangible assets	98,436,000	99,216,000	98,678,000
Impairment of goodwill and intangible assets	82,742,000	0	0
Deferred income taxes	(46,333,000)	(34,401,000)	(46,883,000)
Stock-based compensation	144,518,000	109,497,000	261,995,000
Amortization of deferred financing fees	1,753,000	1,878,000	3,682,000
Amortization of discount on debt	233,000	257,000	604,000
Change in fair value of derivative instruments	5,743,000	(5,663,000)	0
Change in fair value of interest rate swap agreements	0	0	(8,373,000)
Change in fair value of warrant liabilities	15,096,000	(26,073,000)	64,501,000
Change in fair value of estimated contingent consideration	0	(100,000)	0
Loss on early extinguishment of debt	0	0	15,240,000
Non-cash lease expense	1,232,000	3,697,000	6,279,000
Gain on divestitures	0	0	(600,000)
Gain on sale of cost method investment	0	(3,587,000)	0
Loss on disposal of software, equipment and property	79,000	2,651,000	0
Other	620,000	104,000	541,000
Changes in:
Accounts receivable—Net	(4,001,000)	(19,844,000)	(4,725,000)
Deferred contract costs	(1,344,000)	(1,487,000)	(3,152,000)
Other current assets	4,046,000	9,792,000	(12,273,000)
Deferred contract costs—Non-current	(2,141,000)	1,956,000	(7,728,000)
Other assets	(3,649,000)	(14,501,000)	(7,838,000)
Operating lease assets	1,186,000	3,448,000	6,354,000
Income taxes	4,984,000	(10,018,000)	3,833,000
Accounts payable	(11,270,000)	15,516,000	(1,052,000)
Accrued expenses	1,041,000	4,592,000	8,347,000
Operating lease liabilities	(2,145,000)	(7,241,000)	(8,398,000)
Deferred revenues	8,321,000	4,196,000	4,513,000
Extinguishment of interest rate swap liability	0	0	(9,987,000)
Other liabilities	4,055,000	(317,000)	(11,755,000)
Net cash provided by operating activities	250,033,000	199,907,000	127,335,000
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of software, equipment, and property	(55,032,000)	(47,951,000)	(38,321,000)
Proceeds from sale of cost method investment	0	3,901,000	0
Acquisition of Safekeep, Inc., net of cash	0	(32,242,000)	0
Purchase of equity method investment	0	0	(10,228,000)
Purchase of intangible asset	0	0	(49,000)
Net cash used in investing activities	(55,032,000)	(76,292,000)	(48,598,000)
CASH FLOWS (USED IN) PROVIDED BY FINANCING ACTIVITIES:
Proceeds from exercise of stock options	25,381,000	27,693,000	5,085,000
Proceeds from employee stock purchase plan	4,761,000	3,197,000	0
Principal payments on long-term debt	(8,000,000)	(8,000,000)	(1,336,153,000)
Payments for employee taxes withheld upon vesting of equity awards	(16,715,000)	(5,015,000)	0
Repurchase of common stock	(328,453,000)	0	0
Proceeds from issuance of long-term debt, net of fees paid to lender	0	0	789,927,000
Net proceeds from equity infusion from the Business Combination	0	0	763,300,000
Payment of fees associated with early extinguishment of long-term debt	0	0	(4,821,000)
Dividends to CCCIS stockholders	0	0	(269,174,000)
Deemed distribution to CCCIS option holders	0	0	(9,006,000)
Proceeds from issuance of common stock	0	0	1,007,000
Tax effect of Business Combination transaction costs	0	0	1,395,000
Net cash (used in) provided by financing activities	(323,026,000)	17,875,000	(58,440,000)
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(191,000)	(246,000)	129,000
NET CHANGE IN CASH AND CASH EQUIVALENTS	(128,216,000)	141,244,000	20,426,000
Beginning of period	323,788,000	182,544,000	162,118,000
End of period	195,572,000	323,788,000	182,544,000
NONCASH INVESTING AND FINANCING ACTIVITIES:
Noncash purchases of software, equipment, and property	2,044,000	100,000	8,035,000
Leasehold improvements acquired by tenant improvement allowance	0	0	16,924,000
Fair value of assumed Public Warrants exercised	0	0	60,481,000
Contingent consideration related to business acquisition	0	200,000	0
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest	61,367,000	36,636,000	54,980,000
Cash paid for income taxes-Net	$ 42,948,000	$ 55,697,000	$ 15,233,000

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Pay vs Performance Disclosure
Net Income (Loss)	$ (90,071)	$ 38,406	$ (248,919)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 31, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	During the three months ended December 31, 2023, each of Githesh Ramamurthy , Chairman of the Board and Chief Executive Officer of the Company ; Brian Herb , Executive Vice President, Chief Financial and Administrative Officer of the Company ; Mary Jo Prigge , Executive Vice President, Chief Service Delivery Officer of the Company ; Marc Fredman , Senior Vice President, Chief Strategy Officer of the Company ; and Rodney Christo , Senior Vice President, Finance and Chief Accounting Officer of the Company , adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5–1(c). The 10b-5-1 trading arrangement was adopted by Mr. Ramamurthy on December 20, 2023 and provides for the sale of up to 6,000,000 shares of the Common Stock of the Company in the period commencing on March 20, 2024 and ending on the earlier of December 2, 2024 or the execution of all trades contemplated by the plan. The 10b-5-1 trading arrangement was adopted by Mr. Herb on November 29, 2023 and provides for the sale of up to 265,173 shares of the Common Stock of the Company in the period commencing on March 7, 2024 and ending on the earlier of November 15, 2024 or the execution of all trades contemplated by the plan. The 10b-5-1 trading arrangement was adopted by Ms. Prigge on November 10, 2023 and provides for the sale of up to 100,000 shares of the Common Stock of the Company in the period commencing on March 11, 2024 and ending on the earlier of November 8, 2024 or the execution of all trades contemplated by the plan. The 10b-5-1 trading arrangement was adopted by Mr. Fredman on November 17, 2023 and provides for the sale of up to 1,124,008 shares of the Common Stock of the Company in the period commencing on March 14, 2024 and ending on the earlier of November 15, 2024 or the execution of all trades contemplated by the plan. The 10b-5-1 trading arrangement was adopted by Mr. Christo on November 30, 2023 and provides for the sale of up to 205,624 shares of the Common Stock of the Company in the period commencing on March 4, 2024 and ending on the earlier of November 29, 2024 or the execution of all trades contemplated by the plan. The number of shares to be sold under each of Mr. Herb's, Mr. Fredman's and Mr. Christo's plan assumes the vesting of the maximum number of shares under performance-based RSUs, the actual number of shares to be sold under each plan will depend on the achievement of the applicable performance conditions under the performance-based RSUs and the number of shares withheld to satisfy tax obligations upon the vesting of the applicable awards.
Githesh Ramamurthy [Member]
Trading Arrangements, by Individual
Name	Githesh Ramamurthy
Title	Chairman of the Board and Chief Executive Officer of the Company
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 20, 2023
Arrangement Duration	257 days
Aggregate Available	6,000,000
Brian Herb [Member]
Trading Arrangements, by Individual
Name	Brian Herb
Title	Executive Vice President, Chief Financial and Administrative Officer of the Company
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 29, 2023
Arrangement Duration	253 days
Aggregate Available	265,173
Mary Jo Prigge [Member]
Trading Arrangements, by Individual
Name	Mary Jo Prigge
Title	Executive Vice President, Chief Service Delivery Officer of the Company
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 10, 2023
Arrangement Duration	242 days
Aggregate Available	100,000
Marc Fredman [Member]
Trading Arrangements, by Individual
Name	Marc Fredman
Title	Senior Vice President, Chief Strategy Officer of the Company
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 17, 2023
Arrangement Duration	246 days
Aggregate Available	1,124,008
Rodney Christo [Member]
Trading Arrangements, by Individual
Name	Rodney Christo
Title	Senior Vice President, Finance and Chief Accounting Officer of the Company
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	November 30, 2023
Arrangement Duration	270 days
Aggregate Available	205,624

Organization and Nature of Oper

Organization and Nature of Operations	12 Months Ended
	Dec. 31, 2023
Text Block [Abstract]
Organization and Nature of Operations	1. ORGANIZATION AND NATURE OF OPERATIONS CCC Intelligent Solutions Holdings Inc., a Delaware corporation, is a leading software as a service ("SaaS") platform for the multi-trillion-dollar property and casualty ("P&C") insurance economy powering operations for insurers, repairers, automakers, parts suppliers, lenders and more. CCC's cloud technology connects businesses digitizing mission-critical workflows, commerce and customer experiences. Our cloud-based SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, artificial intelligence ("AI") enabled digital workflows. The Company is headquartered in Chicago, Illinois. The Company’s primary operations are in the United States (“US”) and it also has operations in China. The Company was originally incorporated as a Cayman Islands exempted company on July 3, 2020 as a special purpose acquisition company under the name Dragoneer Growth Opportunities Corp ("Dragoneer"). On February 2, 2021, Cypress Holdings Inc., ("CCCIS") entered into the Business Combination Agreement (the "Business Combination Agreement") with Dragoneer. In connection with the closing of the business combination ("Business Combination") (see Note 3), Dragoneer changed its jurisdiction of incorporation by deregistering as an exempted company in the Cayman Islands and continuing and domesticating as a Delaware corporation on July 30, 2021, upon which Dragoneer changed its name to CCC Intelligent Solutions Holdings Inc.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation —The consolidated balance sheets as of December 31, 2023 and 2022, the consolidated statements of operations and comprehensive (loss) income, the consolidated statements of mezzanine equity and stockholders’ equity and the consolidated statements of cash flows for the years ended December 31, 2023, 2022 and 2021, have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). The Business Combination (see Note 3) was accounted for as a reverse recapitalization in accordance with GAAP, with Dragoneer treated as the acquired company and CCCIS treated as the acquirer. The consolidated assets, liabilities, and results of operations prior to the reverse recapitalization are those of CCCIS. The shares and corresponding capital amounts and losses per share, prior to the reverse recapitalization, have been retroactively restated based on shares reflecting the exchange ratio of 1:340.5507 (the “Exchange Ratio”) established in the Business Combination. Basis of Accounting —The accompanying consolidated financial statements are prepared in accordance with GAAP and include the accounts of the Company and its wholly-owned subsidiaries and majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The consolidated financial statements include 100% of the accounts of wholly-owned and majority-owned subsidiaries. The ownership interest of the minority investor is recorded as a non-controlling interest in a subsidiary. Use of Estimates —The preparation of the consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts, and the disclosures of contingent amounts in the Company’s consolidated financial statements and the accompanying notes. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Although the Company regularly assesses its estimates, actual results could differ from management’s estimates if past experience or other assumptions are not substantially accurate. Changes in estimates are recorded in the period in which they become known. Significant estimates in these consolidated financial statements include the estimation of contract transaction prices, the determination of the amortization period for contract assets, the valuation of goodwill and intangible assets, the estimates and assumptions associated with the valuation of the warrant liabilities, and the estimates and assumptions associated with stock incentive plans, including the fair value of common stock prior to the Business Combination. Cash and Cash Equivalents —The Company considers all highly liquid investments, including money market funds, purchased with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. Cash and cash equivalents are carried at cost, which approximates fair value. The Company believes it is not exposed to any significant credit risk on cash and cash equivalents. While the Company has deposits that exceed federally insured limits at financial institutions, the Company places its cash and cash equivalents in highly rated institutions. The Company has never experienced losses related to these balances. Foreign Currency —The Company’s functional currency is the US dollar, however, for operations located in China, the functional currency is the local currency. Assets and liabilities of the foreign operations are translated to US dollars at exchange rates in effect at the consolidated balance sheet date, while statement of operations accounts are translated to US dollars at the average exchange rates for the period. Translation gains and losses are recorded and remain as a component of accumulated other comprehensive loss in stockholders’ equity until transactions are settled or the foreign entity is sold or liquidated. Gains and losses resulting from transactions that are denominated in a currency that is not the functional currency are recorded to other income–net, in the consolidated statements of operations and comprehensive (loss) income . Significant Customers and Concentration of Credit Risks —The Company is potentially subject to concentration of credit risk primarily through its accounts receivable. The Company performs ongoing credit evaluations of its customers and maintains allowances for potential credit losses which, when realized, have been within the range of management’s expectations. The Company generally does not require collateral. Credit risk on accounts receivables is minimized as a result of the large and diverse nature of the Company’s customer base. During the years ended December 31, 2023, 2022 , and 2021 no single customer represented more than 10 % of revenue. As of December 31, 2023 , no customer had an account receivable greater than 10 % of accounts receivable. As of December 31, 2022 , one customer had an account receivable of 11 % of accounts receivable. Revenue Recognition —The Company’s revenue recognition policy follows guidance from Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers. The Company generates revenue from contracts that are generally billed either on a monthly subscription or transactional basis. Other revenue primarily consists of professional services and other non-software services revenue that is generally transaction-based (where a fee per transaction is charged). Revenues are recognized as control of these services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. The Company determines revenue recognition based on the application of the following steps: • Identification of the contract, or contracts, with a customer • Identification of the performance obligation(s) in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligation(s) in the contract • Recognition of revenue when, or as a performance obligation is satisfied Software Subscription Revenues —Software services are hosted and provide customers with the right to use the hosted software over the contract period without taking possession of the software and are generally billed on either a monthly subscription or transactional basis. Revenues related to services billed on a subscription basis are recognized ratably over the contract period as this is the time period over which services are transferred to the customer, generally between three and five years. Revenues from subscription services represent a stand-ready obligation to provide access to the Company’s platform. As each day of providing services is substantially the same and the customer simultaneously receives and consumes the benefits as access is provided, subscription arrangements include a series of distinct services. The Company may provide certain of its customers with implementation activities such as basic setup, installation and initial training that the Company must undertake to fulfill the contract. These are considered fulfillment activities that do not transfer the service to the customer. For contracts with fixed and variable consideration, to the extent that customers’ usage exceeds the committed contracted amounts under their subscriptions, they are charged for their incremental usage. In addition to overage fees, consideration may vary due to discounts, incentives, and potential service level credits or contractual penalties. For such variable consideration, the Company includes an estimate of the most likely amount it expects to receive for the total transaction price if it is probable that a significant reversal of cumulative revenue recognized will not occur. When customers’ usage falls below the committed contracted amounts, the customer does not receive any credits or refunds for the shortfall. For contracts where fees are solely based on transaction volume, the amount invoiced corresponds directly with the value provided to the customer, and revenue is recognized when invoiced using the as-invoiced practical expedient. Other Revenue —Other revenues consist of professional services and other non-software services and are recognized over time as the services are performed. Other revenues are generally invoiced monthly in arrears. Revenues related to such services that are billed on a transactional basis are recognized when the transaction for the related service occurs. Transaction revenue is primarily comprised of fees for services applied to the volume of transactions. These are typically based on a per-unit rate and are invoiced for the same period in which the transactions were processed and as the performance obligation is satisfied. For contracts with transaction fees, the amount invoiced corresponds directly with the value provided to the customer, and revenue is recognized when invoiced using the as-invoiced practical expedient. Contracts with Multiple Performance Obligations —The Company’s contracts with customers can include access to different software applications such as CCC workflow, estimating, valuation and analytics, each of which is its own performance obligation. These additional services are either sold on a standalone basis or could be used on their own with readily available resources. For these contracts, the Company accounts for individual performance obligations separately, if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. The standalone selling price for distinct performance obligations is generally based on directly observable pricing. In instances where standalone selling price is not directly observable, the Company determines standalone selling price based on overall pricing objectives, which take into consideration observable data, market conditions and entity-specific factors. The Company may occasionally recognize an adjustment in revenue in the current period for performance obligations partially or fully satisfied in the previous periods resulting from changes in estimates for the transaction price, including any changes to the Company’s assessment of whether an estimate of variable consideration is constrained. For the years ended December 31, 2023, 2022 and 2021, the impact on revenue recognized in the current period, from performance obligations partially or fully satisfied in the previous period, was not significant. Contract Liabilities —Contract liabilities consist of deferred revenue and include customer billings in advance of revenues being recognized from subscription contracts and professional services. Deferred revenue that is expected to be recognized during the succeeding twelve-month period is recorded as current, and the remaining portion is recorded as noncurrent and included within other liabilities on the consolidated balance sheets. Costs to Obtain and Fulfill the Contract —The Company defers costs that are considered to be incremental and recoverable costs of obtaining a contract with a customer, including sales commissions. Costs to fulfill contracts are capitalized when such costs are direct and related to implementation activities for hosted software solutions. Capitalized costs to obtain a contract and costs to fulfill a contract are generally amortized over a period between three and five years, which represents the expected period of benefit of these costs and corresponds to the contract period. In instances where the contract term is significantly different than our general contract terms of between three and five years, costs to obtain and fulfill are amortized over the contract term which the Company believes best reflects the period of benefit of these costs. Cost of Revenues —Cost of revenues is primarily composed of personnel costs, including stock-based compensation, and costs of external resources used in the delivery of services to customers, including software configuration, integration services, customer support activities, third party costs related to hosting the Company’s software for its customers, internal support of production infrastructure, IT security costs, depreciation expense, cost of software production, and data licensing and royalty fees paid to third parties. Cost of revenues also includes amortization of internal use software, including capitalized development costs, and amortization and impairment of acquired technologies. Research and Development —Research and development expenses consist primarily of personnel-related costs, including stock-based compensation, and costs of external development resources involved in the engineering, design and development of new solutions, as well as expenses associated with significant ongoing improvements to existing solutions. Research and development expenses also include costs for certain IT expenses. Research and development costs, other than software development costs qualifying for capitalization, are expensed as incurred Selling and Marketing —Selling and marketing expenses consist primarily of personnel-related costs for our sales and marketing functions, including sales commissions and stock-based compensation. Additional expenses include advertising costs, marketing costs and event costs, including the Company’s annual industry conference. The Company expenses advertising and other promotional expenditures as incurred. Advertising expenses were $ 1.5 million, $ 1.1 million and $ 1.1 million for the years ended December 31, 2023, 2022 and 2021 , respectively. General and Administrative —General and administrative expenses consist primarily of personnel-related costs, including stock-based compensation, for our executive management and administrative employees, including finance and accounting, human resources, internal systems IT, facilities and legal functions. Additional expenses include professional service fees, insurance premiums, and other corporate expenses that are not allocated to the above expense categories. Amortization of Intangible Assets —Amortization of intangible assets consists of the capitalized costs of intangible assets. These intangible assets are amortized on a straight-line basis over their estimated useful lives (see Note 12). Goodwill and Intangible Asset Impairments —Goodwill and intangible asset impairments includes the goodwill and intangible asset impairment charges specific to the Company's China reporting unit (see Note 12). Stock-Based Compensation —The Company’s stock-based compensation plans are described in Note 21. The Company accounts for stock-based payment awards based on the grant date fair value. The incremental fair value of modifications to stock-based payment awards is estimated at the date of modification. Stock-based payment awards that are settled in cash are accounted for as liabilities. The Company recognizes stock-based compensation expense for only the portion of awards expected to vest, based on an estimated forfeiture rate. The Company recognizes stock-based compensation expense for time-based awards on a straight-line basis over the requisite service period, which is generally the vesting period of the respective awards. Stock-based compensation expense for performance-based awards with a market condition is recognized over the estimated service period, regardless of whether the market condition is satisfied. Stock-based compensation expense for performance-based awards with a market condition, when the market condition is a liquidity event or change in control, is not recognized until the performance condition is probable of occurring. The fair value of RSUs with only a time-based vesting component or a performance-based vesting component is determined using the quoted price of our common stock on the date of grant. As of each reporting period, we estimate the number of RSUs with a performance-based vesting component that are expected to vest based on our current estimate of performance compared to the target metrics and record a cumulative-effect adjustment to stock-based compensation expense when necessary. For stock-based awards that are accounted for as liabilities, we remeasure the fair value of the associated liability at each reporting date through settlement using the Black-Scholes option pricing model and recognize the adjustment as stock-based compensation expense. The fair value of the Company’s stock options with only a time-based component is estimated using the Black-Scholes option pricing model. The fair value of the Company’s performance-based awards with a market condition is estimated using a Monte Carlo simulation model. Stock-based compensation expense related to purchase rights issued under the CCC Intelligent Solutions Holdings Inc. 2021 Employee Stock Purchase Plan ("ESPP") is based on the Black-Scholes option pricing model's fair value of the estimated number of awards as of the beginning of the applicable offering period. Stock-based compensation expense is recognized using the straight-line method over the applicable offering period. The inputs and assumptions utilized under these methods require judgments and estimates. Changes in the inputs and assumptions could affect the measurement of the estimated fair value of the related compensation expense of these stock-based payment awards. Accounts Receivable—Net —Accounts receivable, as presented in the consolidated balance sheets, are net of customer sales allowances and doubtful accounts. The Company determines allowances for its sales reserves and doubtful accounts based on specific identification of customer accounts and historical experience to the remaining accounts receivable balance. The Company’s assessment of doubtful accounts includes estimating its expected credit losses based on historical information and adjusted for current conditions and forecasts for the probability of collection from customers. Doubtful accounts are charged to general and administrative expenses in the consolidated statements of operations and comprehensive (loss) income . Software, Equipment, and Property—Net —Software, equipment, and property are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed on a straight-line basis over the asset’s estimated useful lives, which are as follows: Software, equipment, and property Estimated Useful Life Software and licenses 2 - 5 years Computer equipment 3 years Furniture and other equipment 5 years Database 25 years Building 39 years Leasehold improvements Lesser of the estimated useful life or life of lease Land Indefinite Maintenance and repairs are expensed as incurred. Significant improvements and enhancements are capitalized. Internal Use Software —The Company capitalizes the direct costs incurred in developing or obtaining internal use software, including platform development, infrastructure and tools, as well as certain payroll and payroll-related costs of employees who are directly associated with internal use computer software projects. The amount of capitalized payroll costs with respect to these employees is limited to the time directly spent on such projects. The costs associated with preliminary project stage activities, training, maintenance, and all other post-implementation activities are expensed as incurred. Additionally, the Company expenses internal costs related to minor upgrades and enhancements as it is impractical to separate these costs from normal maintenance activities. Capitalized internal use software costs are recorded within software, equipment, and property on the Company’s consolidated balance sheets. Goodwill and Intangible Assets —Goodwill and intangible assets deemed to have indefinite lives are not amortized, but are subject to an annual impairment test, or more frequently if events or changes in circumstances indicate that the carrying value may not be recoverable. The Company performs its annual impairment assessment of goodwill and indefinite life intangible assets as of November 30 of each year. Under GAAP, the Company has the option to first assess qualitative factors in order to determine if it is more likely than not that the fair value of one of its reporting units or indefinite life intangible assets is greater than its carrying value ("Step 0"). If the qualitative assessment leads to a determination that the fair value is less than its carrying value, or if the Company elects to bypass the qualitative assessment, it is required to perform a quantitative impairment test ("Step 1") by calculating the fair value of the reporting unit or indefinite life intangible asset and comparing the fair value with its associated carrying value. If the carrying value exceeds the fair value, an impairment loss is recognized in an amount equal to the excess, up to the carrying value of the goodwill or indefinite life intangible asset. During the three months ended June 30, 2023, the Company performed an interim quantitative impairment test for its China reporting unit due to events which indicated that the carrying amount was in excess of its estimated fair value. As a result of the interim quantitative impairment test, the Company recorded a goodwill impairment charge of $ 77.4 million (see Note 12). The Company performed its annual impairment test for its Domestic reporting unit, its remaining reporting unit with goodwill and indefinite lived assets as of November 30, 2023 and determined no impairment existed. For the years ended December 31, 2022 and 2021 , the Company performed its annual impairment tests for its goodwill and indefinite lived intangible assets and determined no impairment existed. Long-Lived Assets —Long-lived assets, other than goodwill, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset or asset group to estimated undiscounted future cash flows expected to be generated by such assets. If the carrying amount of the assets exceeds their estimated future cash flows, an impairment charge is recognized equal to the amount by which the carrying amount of the assets exceeds their fair value. During the year ended December 31, 2023, the Company performed the recoverability test on its China reporting unit's intangible assets due to events which indicated the carrying amount may not be recoverable. As a result, the Company recorded impairment charges totaling $ 5.3 million (see Note 12). There were no events or changes in circumstances that indicated the carrying value may not be recoverable and no impairment charges were recognized during the years ended December 31, 2022 and 2021 . Equity Method Investment —The Company accounts for its 7 % investment in a limited partnership using the equity method of accounting. Under the equity method of accounting, the investee’s accounts are not reflected within the Company’s consolidated balance sheets and consolidated statements of operations and comprehensive (loss) income . The Company’s investment was initially recognized at cost and adjusted thereafter for the post acquisition changes in the Company’s share of the investee’s earnings which would be recorded in other income-net. Deferred Financing Costs —Deferred financing costs are capitalized and amortized over the life of the underlying financing agreement (see Note 16). Business Combinations —The Company allocates the purchase consideration of acquired companies to tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date, with the excess recorded to goodwill. These estimates are inherently uncertain and subject to refinement. During the measurement period, which may be up to one year from the acquisition date, adjustments may be recorded to the fair value of these tangible and intangible assets acquired and liabilities assumed, including uncertain tax positions and tax-related valuation allowances, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations and comprehensive (loss) income. The Company estimates the fair value of contingent consideration related to business combinations on the date of acquisition (see Note 4). The fair value of the contingent consideration is remeasured each reporting period, with any change in the fair value recorded within the consolidated statements of operations and comprehensive (loss) income . Fair Value of Financial Instruments and Fair Value Measurements —Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value. Level 1 —Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 —Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 —Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment. Warrant Liability —The Company assumed publicly-traded warrants (“Public Warrants”) and warrants sold in a private placement (“Private Warrants”) upon consummation of the Business Combination. The Company accounts for its Public Warrants and Private Warrants under ASC 815-40, Derivatives and Hedging-Contracts in Entity’s Own Equity , in conjunction with the SEC Division of Corporation Finance’s April 12, 2021 Public Statement, Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies ("SPACs") . The terms of the warrants provide for potential changes to the settlement amounts dependent upon the characteristics of the warrant holder, and preclude the warrants from being classified in equity and thus the warrants are classified as a liability. Accordingly, the Company recorded the warrants as long-term liabilities on its consolidated balance sheet at fair value upon the closing of the Business Combination (see Note 3), with subsequent changes in the fair value of the warrants recognized in the consolidated statements of operations and comprehensive (loss) income at each reporting date. Prior to their redemption during the year ended December 31, 2021, the Public Warrants were publicly traded and thus had an observable market price in an active market and were valued at their trading price as of each reporting date. The Private Warrants are valued using the Black-Scholes option pricing model. The assumptions utilized under the Black-Scholes option pricing model require judgments and estimates. Changes in these inputs and assumptions could affect the measurement of the estimated fair value of the related fair value of the Private Warrants. Derivative Instruments —The Company records derivative instruments as an asset or liability measured at fair value each reporting period. The Company has not designated its derivatives as hedging instruments for accounting purposes and recognizes the changes in fair value within its consolidated statement of operations and comprehensive (loss) income. Gain and losses from the change in fair value and cash payments and receipts related to the derivative instruments are recognized in other income (expense)—net, in the consolidated statements of operations and comprehensive (loss) income . The Company does not enter into derivative instrument transactions for trading or speculative purposes. Income Taxes —Deferred income tax assets and liabilities are recognized for the expected future tax effects of temporary differences between the financial and income tax reporting basis of assets and liabilities using tax rates in effect for the years in which the differences are expected to reverse. Deferred income taxes relate to the timing of recognition of certain revenue and expense items, and the timing of the deductibility of certain reserves and accruals for income tax purposes that differs from the timing for financial reporting purposes. The Company establishes a tax valuation allowance to the extent that it is more likely than not that a deferred tax asset will not be realizable against future taxable income. A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation process, based on its technical merits. Income tax positions must meet a more-likely-than-not recognition threshold to be recognized. The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. Employee Insurance Benefits —The Company maintains a self-insured group medical program. The program contains stop loss thresholds with amounts in excess of the self-insured levels fully insured by third-party insurers. Liabilities associated with this program are estimated in part by considering historical claims experience and medical cost trends. Leases —The Company’s lease policy follows guidance from ASC 842, Leases . In accordance with ASC 842, the Company, at the inception of the contract, determines whether a contract is or contains a lease. For leases with terms greater than 12 months, the Company records the related operating or finance right of use asset and lease liability at the present value of lease payments over the lease term. The Company is generally not able to readily determine the implicit rate in the lease and therefore uses the determined incremental borrowing rate at lease commencement to determine the present value of lease payments. The incremental borrowing rate represents an estimate of the market interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease. Renewal options are not included in the measurement of the right of use assets and lease liabilities unless the Company is reasonably certain to exercise the optional renewal periods. Some leases also include early termination options, which can be exercised under specific conditions. Additionally, certain leases contain incentives, such as construction allowances from landlords. These incentives reduce the right-of-use asset related to the lease. Some of the Company’s leases contain rent escalations over the lease term. The Company recognizes expense for operating leases on a straight-line basis over the lease term. The Company has elected the practical expedient to combine lease and non-lease components for all asset categories. Therefore, the lease payments used to measure the lease liability for these leases include fixed minimum rentals along with fixed non-lease component charges. Lease related costs, which are variable rather than fixed, are expensed in the period incurred. The Company does not have significant residual value guarantees or restrictive covenants in the lease portfolio. Redeemable Non-Controlling Interest —The Company presents a redeemable non-controlling interest as mezzanine equity within its consolidated balance sheets when it is redeemable at a fixed or determinable price on a fixed or determinable date at the option of the holder or upon the occurrence of an event that is not solely within the control of the Company. The redeemable non-controlling interest was initially measured at fair value on the date of issuance. When the redemption of a mezzanine-classified non-controlling interest becomes probable, the carrying amount of the redeemable non-controlling interest is increased by periodic accretions using the interest method so that the carrying amount will equal the redemption amount on the date that the shares become redeemable. These adjustmen

Business Combination

Business Combination	12 Months Ended
	Dec. 31, 2023
Business Combinations [Abstract]
Business Combination	3. BUSINESS COMBINATION On July 30, 2021 ("Closing Date"), the Company consummated the Business Combination pursuant to the terms of the Business Combination Agreement, dated as of February 2, 2021, as amended, by and among Dragoneer, Chariot Opportunity Merger Sub, Inc. (“Chariot Merger Sub”), a Delaware corporation, and CCCIS, a Delaware corporation. Immediately upon the consummation of the Business Combination and the other transactions contemplated by the Business Combination Agreement (collectively, the “Transactions”), Chariot Merger Sub, a wholly-owned direct subsidiary of Dragoneer, merged with and into CCCIS, with CCCIS surviving the Business Combination as a wholly-owned direct subsidiary of Dragoneer (the “Merger”). In connection with the Transactions, Dragoneer changed its name to “CCC Intelligent Solutions Holdings Inc.” The Merger was accounted for as a reverse recapitalization in accordance with GAAP. Under this method of accounting, Dragoneer was treated as the acquired company for accounting purposes and the Business Combination was treated as the equivalent of CCCIS issuing stock for the net assets of Dragoneer, accompanied by a recapitalization. CCCIS was determined to be the accounting acquirer based on the following predominant factors among others: • the pre-Closing CCCIS stockholders continue to control the Company following the Closing of the Business Combination; • the board of directors and management of the Company following the Business Combination are composed of individuals associated with CCCIS; • CCCIS was the larger entity based on historical operating activity, assets, revenues, and employee base at the time of the Closing of the Transactions; and • the ongoing operations of the Company following the Business Combination comprise those of CCCIS. The net assets of Dragoneer are stated at historical cost, with no goodwill or other intangible assets recorded. Reported shares and earnings per share available to holders of CCCIS’s capital stock and equity awards prior to the Business Combination have been retroactively restated reflecting the Exchange Ratio. Pursuant to the Merger, at the Effective Time of the Merger (the “Effective Time”): • each share of CCCIS common stock that was issued and outstanding immediately prior to the Effective Time was automatically canceled and converted into the right to receive shares of the Company’s common stock based on the Exchange Ratio, rounded down to the nearest whole number of shares; • each option to purchase shares of CCCIS common stock, whether vested or unvested, that was outstanding and unexercised as of immediately prior to the Effective Time was assumed by the Company and became an option (vested or unvested, as applicable) to purchase a number of shares of the Company’s common stock equal to the number of shares of CCCIS common stock subject to such option immediately prior to the Effective Time multiplied by the Exchange Ratio, rounded down to the nearest whole number of shares, at an exercise price equal to the exercise price per share of such option immediately prior to the Effective Time divided by the Exchange Ratio and rounded up to the nearest whole cent; • each of Dragoneer’s redeemable Class A ordinary shares and Class B ordinary shares that were issued and outstanding immediately prior to the Effective Time were exchanged for an equal number of shares of the Company’s common stock. Concurrently with the execution of the Business Combination Agreement, the Company entered into subscription agreements with certain institutional investors (the “PIPE Investors”), pursuant to which the PIPE Investors purchased, immediately prior to the Closing, an aggregate of 15,000,000 shares of the Company’s common stock at a purchase price of $ 10.00 per share. Prior to the Closing, the Company entered into forward purchase agreements with Dragoneer Funding LLC and Willett Advisors LLC, pursuant to which the Company issued an aggregate of 17,500,000 forward purchase units, each consisting of one common share and one-fifth of one Public Warrant to purchase one common share for $ 11.50 per share, for a purchase price of $ 10.00 per unit. The Public Warrants were redeemed in December 2021 (see Note 22). Effective upon Closing, 8,625,000 shares issued and held by Dragoneer Growth Opportunities Holdings (the “Sponsor Vesting Shares”) became non-transferable and subject to forfeiture on the tenth anniversary of Closing if neither of the following triggering events has occurred: (a) the share price of the Company’s common stock has been greater than or equal to $ 13.00 per share for any twenty trading days within any thirty consecutive trading day period beginning after Closing, or (b) a change in control as defined in the Business Combination Agreement. The Sponsor Vesting Shares do not meet the criteria to be classified as a liability and are presented within stockholders’ equity. As part of the Business Combination, 15.0 million shares of the Company’s common stock (the “Company Earnout Shares”) shall be issued to CCCIS shareholders existing as of immediately prior to Closing and holders of vested and unvested equity awards of CCCIS as of the date of the Business Combination Agreement (subject to continued employment), following a triggering event (“CCC Triggering Event”). A CCC Triggering Event is defined as the earlier of (a) the first date on which the shares of the Company’s common stock have traded for greater than or equal to $ 15.00 per share for any twenty trading days within any thirty consecutive trading day period commencing after the Closing or (b) a change in control as defined in the Business Combination Agreement. If a CCC Triggering Event does not occur within ten years after Closing, the CCC Earnout Shares will be forfeited. Of the 15.0 million Company Earnout Shares, 13.5 million shares are reserved for issuance to CCCIS shareholders. The Company Earnout Shares do not meet the criteria to be classified as a liability and the fair value of the shares reserved for shareholders of $ 98.9 million was charged to additional paid-in capital during the year ended December 31, 2021. The remaining 1.5 million Company Earnout Shares are reserved for issuance to CCCIS option holders (see Note 21). The Company Earnout Shares are not issued shares and are excluded from the table of common stock outstanding below. The total number of shares of the Company’s common stock outstanding immediately following the Closing was 603,170,380 , comprised as follows: Shares issued to Dragoneer public shareholders and Sponsor 56,615,002 Sponsor Vesting Shares 8,625,000 Shares issued to Legacy CCC shareholders 505,430,378 Shares issued to Forward Purchasers 17,500,000 Shares issued to PIPE Investors 15,000,000 Total shares of common stock outstanding immediately following the Business 603,170,380 In connection with the Business Combination, the Company incurred underwriting fees and other costs considered direct and incremental to the transaction totaling $ 11.1 million (before tax), consisting of legal, accounting, financial advisory and other professional fees. These amounts were treated as a reduction of the cash proceeds and were deducted from the Company’s additional paid-in capital. The following table reconciles the elements of the Business Combination to the consolidated statement of cash flows and the consolidated statement of mezzanine equity and stockholders’ equity for the year ended December 31, 2021 (in thousands). Cash - Dragoneer trust and cash $ 449,441 Cash - PIPE Financing 150,000 Cash - Forward Purchase Agreements 175,000 Less: transaction costs and advisory fees ( 11,141 ) Net cash contributions from Business Combination 763,300 Less: non-cash fair value of Public Warrants and Private Warrants ( 58,459 ) Net equity infusion from Business Combination $ 704,841

Business Acquisition

Business Acquisition	12 Months Ended
	Dec. 31, 2023
Business Combinations [Abstract]
Business Acquisition	4. BUSINESS ACQUISITION On February 8, 2022, the Company completed its acquisition of Safekeep, Inc. (“Safekeep”), a privately held company that leverages AI to streamline and improve subrogation management across auto, property, workers’ compensation and other insurance lines of business. Leveraging Safekeep’s AI-enabled subrogation solutions, the acquisition broadens the Company’s portfolio of cloud-based solutions available to its insurance customers. In exchange for all the outstanding shares of Safekeep, the Company paid total cash consideration of $ 32.3 million upon closing. In accordance with the acquisition agreement, the Company placed $ 6.0 million in escrow for a general indemnity holdback to be paid to the sellers within 15 months of closing, subject to reduction for certain indemnifications and other potential obligations of the selling shareholders. The remaining cash held in escrow was paid to the sellers in May 2023. As additional consideration for the shares, the acquisition agreement includes a contingent earnout for additional cash consideration. The potential amount of the earnout is calculated as a multiple of revenue, above a defined floor, during the 12-month measurement period ending December 31, 2024 and is not to exceed $ 90.0 million. The fair value of the contingent consideration as of the acquisition date of $ 0.2 million was estimated using a Monte Carlo simulation model that relies on unobservable inputs, including management estimates and assumptions. Thus, the contingent earnout is a Level 3 measurement. The acquisition date fair value of the consideration transferred was $ 32.5 million, which consisted of the following (in thousands): Cash paid through closing $ 32,300 Fair value of contingent earnout consideration 200 Total acquisition date fair value of the consideration transferred $ 32,500 The acquisition was accounted for as a business combination and reflects the application of acquisition accounting in accordance with ASC 805, Business Combinations . The total purchase consideration was allocated to the assets acquired and liabilities assumed based on their fair values as of the acquisition date with the excess purchase price assigned to goodwill. The goodwill was primarily attributable to the expected synergies from the combined service offerings and the value of the acquired workforce. The goodwill is not deductible for tax purposes. The Company’s estimates of the fair values of the assets acquired, liabilities assumed and contingent consideration are based on information that was available at the date of the acquisition. During the measurement period, which may be up to one year from the acquisition date, adjustments may be recorded to the fair value of these tangible and intangible assets acquired and liabilities assumed, including uncertain tax positions and tax-related valuation allowances, with the corresponding offset to goodwill. The Company recorded a measurement period adjustment to reflect the facts and circumstances in existence at the acquisition date in December 2022. The adjustment relates to the valuation of the deferred tax liabilities for $ 0.9 million, with a corresponding increase in goodwill. There were no other significant changes to the preliminary purchase price allocation. The purchase price allocation of estimated fair values was finalized as of December 31, 2022. The following table summarizes the final allocation of the consideration to the fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands): Assets acquired: Current assets $ 150 Intangible asset - acquired technology 4,800 Total assets acquired 4,950 Liabilities assumed: Current liabilities 147 Deferred tax liabilities 548 Total liabilities assumed 695 Net assets acquired 4,255 Goodwill 28,245 Total purchase price $ 32,500 The acquired technology intangible asset has an estimated useful life of seven years and is being amortized on a straight-line basis. The fair value of the acquired technology intangible asset was determined by a valuation model based on estimates of future operating projections as well as judgments on the discount rate and other variables. This fair value measurement is based on significant unobservable inputs, including management estimates and assumptions and thus represents a Level 3 measurement. The Company incurred transaction costs associated with the acquisition of $ 1.2 million, included in general and administrative expenses within the consolidated statements of operations and comprehensive (loss) income for the year ended December 31, 2022.

Revenue

Revenue	12 Months Ended
	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Revenue	5. REVENUE Disaggregation of Revenue —The Company provides disaggregation of revenue based on type of service as it believes these categories best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The following table summarizes revenue by type of service for the years ended December 31 (in thousands): Year Ended December 31, 2023 2022 2021 Software subscriptions $ 830,117 $ 752,505 $ 662,300 Other 36,261 29,943 25,988 Total revenues $ 866,378 $ 782,448 $ 688,288 Contract Assets and Liabilities — The balances of the Company’s receivables, contract assets and contract liabilities from contracts with customers are as follows (in thousands): December 31, December 31, December 31, 2023 2022 2021 Accounts receivables-Net of allowances $ 102,365 $ 98,353 $ 78,793 Deferred contract costs 17,900 16,556 15,069 Deferred contract costs-non-current 22,302 20,161 22,117 Other assets (accounts receivable, non-current) 15,198 16,437 8,622 Deferred revenues 43,567 35,239 31,042 Other liabilities (deferred revenues, non-current) 1,373 1,240 1,574 Deferred Contract Costs — A summary of the activity impacting the deferred contract costs during the years ended December 31, 2023, 2022 and 2021 is presented below (in thousands): Year Ended December 31, 2023 2022 2021 Balance at beginning of period $ 36,717 $ 37,186 $ 26,306 Costs amortized ( 19,197 ) ( 17,986 ) ( 15,384 ) Additional amounts deferred 22,682 17,517 26,264 Balance at end of period $ 40,202 $ 36,717 $ 37,186 Classified as: Current $ 17,900 $ 16,556 $ 15,069 Non-current 22,302 20,161 22,117 Total deferred contract costs $ 40,202 $ 36,717 $ 37,186 Deferred Revenue — A summary of the activity impacting deferred revenue balances during the years ended December 31, 2023, 2022 and 2021, is presented below (in thousands): Year Ended December 31, 2023 2022 2021 Balance at beginning of period $ 36,479 $ 32,616 $ 28,515 Revenue recognized 1 ( 434,197 ) ( 380,977 ) ( 334,524 ) Additional amounts deferred 1 442,658 384,840 338,625 Balance at end of period $ 44,940 $ 36,479 $ 32,616 Classified as: Current $ 43,567 $ 35,239 $ 31,042 Non-current 1,373 1,240 1,574 Total deferred revenue $ 44,940 $ 36,479 $ 32,616 1 Amounts include total revenue deferred and recognized during each respective period. During the years ended December 31, 2023, 2022 and 2021, $ 35.1 million, $ 31.0 million and $ 26.5 million, respectively, that was included in the deferred revenue balance at the beginning of each period was recognized as revenue. Transaction Price Allocated to the Remaining Performance Obligations —Remaining performance obligations represent contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. As of December 31, 2023 , approximately $ 1,552 million of revenue is expected to be recognized from remaining performance obligations with approximately $ 597 million impacting the next twelve months, and approximately $ 955 million thereafter. The estimated revenues do not include unexercised contract renewals. The remaining performance obligations exclude future transaction revenue where revenue is recognized as the services are rendered and in the amount to which the Company has the right to invoice.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	6. FAIR VALUE MEASUREMENTS Assets and Liabilities Measured at Fair Value on a Recurring Basis Private Warrants —As of December 31, 2023 and 2022, the Company’s Private Warrants are recognized as liabilities and measured at fair value on a recurring basis. The Private Warrants are valued using Level 1 and Level 2 inputs within the Black-Scholes option pricing model. The inputs and assumptions utilized under the Black-Scholes option pricing model require judgments and estimates. Changes in these inputs and assumptions could affect the measurement of the estimated fair value of the Private Warrants. Accordingly, the Private Warrants are classified within Level 2 of the fair value hierarchy. The valuation of the Private Warrants as of December 31, 2023 and December 31, 2022 was determined using the Black-Scholes option pricing model using the following assumptions: December 31, December 31, 2023 2022 Expected term (in years) 2.6 3.6 Expected volatility 34 % 38 % Expected dividend yield 0 % 0 % Risk-free interest rate 4.10 % 4.15 % The estimated fair value of each Private Warrant using the Company's stock price on the valuation date and the above assumptions was $ 2.89 and $ 2.05 as of December 31, 2023 and 2022, respectively. Contingent Consideration Liability —The contingent consideration liability related to the acquisition of Safekeep (see Note 4), recognized within other liabilities on the consolidated balance sheet, is adjusted each reporting period for changes in fair value, which can result from changes in anticipated payments and changes in the assumed discount rate. These inputs are unobservable in the market and therefore, the contingent consideration liability was classified within Level 3 of the fair value hierarchy as of December 31, 2023 and 2022. The estimated fair value of the contingent consideration at the date of acquisition was determined using probability-weighted discounted cash flows and a Monte Carlo simulation model. The discount rate used to estimate fair value is based on the Company's estimated cost of debt and was 10 % as of December 31, 2022. As of December 31, 2022, the contingent consideration liability had a fair value of $ 0.1 million. As of December 31, 2023, there were no significant changes to the inputs used within the Monte Carlo simulation model, and the estimated fair value of the contingent consideration liability was $ 0.1 million. The contingent consideration liability is classified within other liabilities in the accompanying consolidated balance sheets. During the year ended December 31, 2023, the Company did no t recognize any change in the estimated fair value of the contingent consideration. During the year ended December 31, 2022, the Company recognized a $ 0.1 million gain from the change in the estimated fair value of the contingent consideration liability, within general and administrative expenses on the consolidated statement of operations and comprehensive (loss) income. Interest Rate Cap —In August 2022, the Company entered into two interest rate cap agreements to reduce its exposure to increases in interest rates applicable to its floating rate long-term debt (See Note 16). The fair value of the interest rate cap agreements was estimated using inputs that were observable or that could be corroborated by observable market data and therefore, was classified within Level 2 of the fair value hierarchy as of December 31, 2023 and 2022. The Company did not designate its interest rate cap agreements as hedging instruments and records the changes in fair value within other income-net on the consolidated statement of operations and comprehensive (loss) income . The interest rate cap agreements' fair value was $ 6.2 million and $ 12.0 million as of December 31, 2023 and 2022, respectively, classified within other assets in the accompanying consolidated balance sheet. The following table presents the fair value of the assets and liabilities measured at fair value on a recurring basis at December 31, 2023 (in thousands): Fair Value Level 1 Level 2 Level 3 Assets Interest rate cap $ 6,208 $ — $ 6,208 $ — Total Assets $ 6,208 $ — $ 6,208 $ — Liabilities Contingent consideration related to business acquisition $ 100 $ — $ — $ 100 Private warrants 51,501 — 51,501 — Total Liabilities $ 51,601 $ — $ 51,501 $ 100 The following table presents the fair value of the assets and liabilities measured at fair value on a recurring basis at December 31, 2022 (in thousands): Fair Value Level 1 Level 2 Level 3 Assets Interest rate cap $ 11,951 $ — $ 11,951 $ — Total Assets $ 11,951 $ — $ 11,951 $ — Liabilities Contingent consideration related to business acquisition $ 100 $ — $ — $ 100 Private warrants 36,405 — 36,405 — Total Liabilities $ 36,505 $ — $ 36,405 $ 100 Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis —The Company has assets that under certain conditions are subject to measurement at fair value on a nonrecurring basis. These assets include those associated with acquired businesses, including goodwill and other intangible assets. For these assets, measurement at fair value in periods subsequent to their initial recognition is applicable if one or more is determined to be impaired. During the year ended December 31, 2023 the Company recognized impairment charges of goodwill and definite-lived intangible assets (See Note 12). The Company did no t recognize impairment charges related to these assets during the years ended December 31, 2022 and 2021. Fair Value of Other Financial Instruments — The following table presents the carrying amounts, net of debt discount, and estimated fair values of the Company’s financial instruments that are not recorded at fair value on the consolidated balance sheets (in thousands): December 31, 2023 December 31, 2022 Carrying Estimated Carrying Estimated Description Amount Fair Value Amount Fair Value Term B Loan, including current maturities $ 782,564 $ 784,000 $ 790,331 $ 766,260 The fair value of the Company’s long-term debt, including current maturities, was estimated based on the quoted market prices for the same or similar instruments and fluctuates with changes in applicable interest rates among other factors. The fair value of long-term debt is classified as a Level 2 measurement in the fair value hierarchy and is established based on observable inputs in less active markets.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	7. INCOME TAXES The components of pretax (loss) income attributable to domestic and foreign operations are as follows (in thousands): Year Ended December 31, 2023 2022 2021 Domestic $ ( 80,486 ) $ 54,799 $ ( 261,900 ) Foreign ( 4,061 ) ( 4,937 ) ( 13,019 ) Pretax (loss) income $ ( 84,547 ) $ 49,862 $ ( 274,919 ) The goodwill and intangible asset impairment charges (see Note 12) recognized during the year ended December 31, 2023 are included in the domestic pretax loss in the table above. The Company's income tax provision (benefit) consisted of the following (in thousands): Year Ended December 31, 2023 2022 2021 Current provision: Federal $ 41,804 $ 37,470 $ 15,263 State 10,053 8,387 5,620 Total current provision 51,857 45,857 20,883 Deferred provision (benefit): Federal ( 36,253 ) ( 26,570 ) ( 35,284 ) State ( 10,080 ) ( 7,831 ) ( 11,599 ) Foreign ( 502 ) 1,054 ( 2,080 ) Change in valuation allowance 502 ( 1,054 ) 2,080 Total deferred benefit ( 46,333 ) ( 34,401 ) ( 46,883 ) Total income tax provision (benefit) $ 5,524 $ 11,456 $ ( 26,000 ) The Company’s effective income tax rate differs from the federal statutory rate as follows (in thousands, except percentages): Year Ended December 31, 2023 2022 2021 Federal income tax benefit at statutory rate $ ( 17,755 ) 21.0 % $ 10,471 21.0 % $ ( 57,733 ) 21.0 % Goodwill impairment 16,255 ( 19.2 ) — — — — Executive compensation 12,555 ( 14.8 ) 12,508 25.0 25,362 ( 9.2 ) Fair value of warrants 3,170 ( 3.7 ) ( 5,475 ) ( 11.0 ) 13,545 ( 4.9 ) Stock-based compensation ( 3,844 ) 4.5 ( 4,074 ) ( 8.1 ) ( 3,647 ) 1.3 Research and experimentation credit ( 6,920 ) 8.2 ( 3,510 ) ( 7.0 ) ( 2,914 ) 1.1 Impact of foreign operations 1,794 ( 2.1 ) 2,807 5.6 261 ( 0.1 ) Valuation allowance 502 ( 0.6 ) ( 1,054 ) ( 2.1 ) 2,080 ( 0.8 ) State and local taxes-net of federal income tax effect ( 22 ) 0.0 439 0.9 ( 4,723 ) 1.7 Other nondeductible expenses 836 ( 1.0 ) 344 0.7 756 ( 0.3 ) Uncertain tax positions 396 ( 0.5 ) ( 303 ) ( 0.6 ) 594 ( 0.2 ) Foreign rate difference ( 164 ) 0.2 ( 182 ) ( 0.4 ) ( 493 ) 0.2 Other—net ( 1,279 ) 1.5 ( 515 ) ( 1.0 ) 912 ( 0.3 ) Income tax provision (benefit) $ 5,524 ( 6.5 )% $ 11,456 23.0 % $ ( 26,000 ) 9.5 % The Company made income tax payments of $ 43.0 million, $ 55.7 million and $ 15.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. The Company received insignificant refunds from the Internal Revenue Service and various states during the years ended December 31, 2023, 2022 and 2021, respectively. The approximate income tax effect of each type of temporary difference giving rise to deferred income tax assets and liabilities as of December 31, 2023 and 2022 was as follows (in thousands): Year Ended December 31, 2023 2022 Deferred income tax assets: Stock-based compensation $ 36,329 $ 37,156 Operating lease liabilities 13,751 14,339 Accrued compensation 10,373 10,962 Net operating losses—foreign 10,875 10,373 Capitalized R&E—net of amortization 26,082 10,221 Sales allowances and doubtful accounts 1,393 1,339 Interest expense limitation — 673 Net operating losses—domestic (state) 479 506 Research and experimental credit 373 386 Other 775 826 Total deferred income tax assets 100,430 86,781 Valuation allowance for deferred tax asset ( 10,875 ) ( 10,373 ) Net deferred income tax assets 89,555 76,408 Deferred income tax liabilities: Intangible asset amortization 255,572 282,032 Software, equipment and property depreciation and amortization 11,541 17,628 Deferred contract costs 10,044 9,235 Operating lease assets 7,078 7,604 Interest rate cap 685 1,607 Total deferred income tax liabilities 284,920 318,106 Net deferred income tax liabilities $ 195,365 $ 241,698 Valuation Allowance —The Company has accumulated net operating losses related to its foreign subsidiaries of $ 10.9 million and $ 10.4 million at December 31, 2023 and 2022 , respectively. A valuation allowance equal to 100 % of the related tax benefit has been established as of December 31, 2023 and 2022 . The valuation allowance increased $ 0.5 million during the year ended December 31, 2023, decreased $ 1.0 million during the year ended December 31, 2022 and increased $ 2.0 million during the year ended December 31, 2021. The changes in the valuation allowance during each year were due to foreign subsidiaries' net operating losses in the current year and the expiration of prior year's net operating losses. No amounts were released during the years ended December 31, 2023, 2022 and 2021 . The net operating losses are set to expire in 2024 through 2028 as China allows for a five-year carryforward. The state net operating losses at December 31, 2023 of $ 0.5 million are expected to be more likely than not fully utilized. Most states allow for a 20-year carryforward of net operating losses. All losses will expire in 2035 - 2042 if not fully utilized. The change in unrecognized tax benefits excluding interest and penalties for the years ended December 31, 2023 and 2022 was as follows (in thousands): 2023 2022 Balance at beginning of year $ 3,723 $ 3,722 Additions based on tax positions related to the current year 1,062 797 Additions based on adjustments to tax positions related to prior years 527 105 Reductions for tax positions of prior years ( 897 ) ( 901 ) Balance at end of year $ 4,415 $ 3,723 The Company believes its liability for unrecognized tax benefits, excluding interest and penalties, will not significantly change over the following twelve months. However, due to the open statute of limitations within the various jurisdictions in which the Company files tax returns, the amount of any change cannot be reasonably estimated and it is possible there could be significant changes in the amount of unrecognized tax benefits over the following twelve months. The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. As of December 31, 2023 and 2022, the amount accrued for interest and penalties was not material. The Company reflects its liability for unrecognized tax benefits within income taxes payable and other liabilities in its consolidated balance sheets. The amounts included in “reductions for tax positions of prior years” represent expirations of statutes of limitation and decreases in the unrecognized tax benefits relating to settlements reached with taxing authorities during each year shown. With few US State exceptions, the major jurisdictions subject to examination by the relevant taxing authorities and open tax years, stated as the Company’s fiscal years, are as follows: Jurisdiction Open Tax Years US Federal 2020 - 2022 US States 2020 - 2022 China 2020 - 2022 Canada 2020 - 2022

Accounts Receivable

Accounts Receivable	12 Months Ended
	Dec. 31, 2023
Financing Receivable, Allowance for Credit Loss [Line Items]
Accounts Receivable	8. ACCOUNTS RECEIVABLE Accounts receivable–Net as of December 31, 2023 and 2022, consists of the following (in thousands): December 31, 2023 2022 Accounts receivable $ 107,939 $ 103,692 Allowance for doubtful accounts and sales reserves ( 5,574 ) ( 5,339 ) Accounts receivable–Net $ 102,365 $ 98,353 Changes to the allowance for doubtful accounts and sales reserves during the years ended December 31, 2023, 2022 and 2021, consists of the following (in thousands): Year Ended December 31, 2023 2022 2021 Balance at beginning of period $ 5,339 $ 3,791 $ 4,224 Charges to bad debt and sales reserves 7,079 4,262 3,634 Write-offs, net ( 6,844 ) ( 2,714 ) ( 4,067 ) Balance at end of period $ 5,574 $ 5,339 $ 3,791

Other Current Assets

Other Current Assets	12 Months Ended
	Dec. 31, 2023
Prepaid Expense And Other Assets Current [Line Items]
Other Current Assets	9. OTHER CURRENT ASSETS Other current assets as of December 31, 2023 and 2022, consists of the following (in thousands): December 31, 2023 2022 Prepaid SaaS costs 7,833 7,423 Prepaid service fees 5,992 5,268 Prepaid software and equipment maintenance 5,547 7,638 Prepaid insurance 2,289 4,062 Non-trade receivables — 690 Other 10,703 11,277 Total $ 32,364 $ 36,358

Software, Equipment, and Proper

Software, Equipment, and Property	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Software, Equipment, and Property	10. SOFTWARE, EQUIPMENT, AND PROPERTY Software, equipment, and property as of December 31, 2023 and 2022, consists of the following (in thousands): December 31, 2023 2022 Software, licenses and database $ 220,625 $ 175,616 Computer equipment 27,467 33,043 Leasehold improvements 31,046 30,430 Building and land 4,910 4,910 Furniture and other equipment 1,370 1,478 Total software, equipment, and property 285,418 245,477 Less accumulated depreciation and amortization ( 125,002 ) ( 99,034 ) Net software, equipment, and property $ 160,416 $ 146,443 Depreciation and amortization expense related to software, equipment, and property was $ 36.9 million, $ 27.9 million and $ 24.5 million for the years ended December 31, 2023, 2022 and 2021 , respectively.

Leases

Leases	12 Months Ended
	Dec. 31, 2023
Leases [Abstract]
Leases	11. LEASES The Company leases real estate in the form of office space and data center facilities. Generally, at the inception of the contract, the term for real estate leases ranges from 1 to 17 years and the term for equipment leases is 1 to 3 years. Some real estate leases include options to renew that can extend the original term by 3 to 5 years. Operating lease costs are included within cost of revenues, exclusive of amortization and impairment of acquired technologies, research and development and general and administrative expenses on the consolidated statements of operations and comprehensive (loss) income. The Company does not have any finance leases. In December 2022, the Company terminated a corporate office lease which otherwise would have expired in March 2026. In connection with the lease termination, the Company agreed to a termination fee in the amount of $ 3.8 million, which released the Company from all future minimum lease payments and variable leases costs related to this facility. As of the termination date, the Company derecognized the operating lease asset and operating lease liability and recognized a loss on lease termination of $ 3.1 million, included within general and administrative expenses in the consolidated statement of operations and comprehensive (loss) income. The components of lease expense for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands): December 31, 2023 2022 2021 Operating lease costs $ 5,958 $ 12,390 $ 16,386 Variable lease costs 3,497 2,319 2,110 Total lease costs $ 9,455 $ 14,709 $ 18,496 The $ 3.1 million loss on lease termination is included in operating lease costs for the year ended December 31, 2022. The lease term and discount rate consisted of the following as of December 31, 2023, 2022 and 2021: December 31, 2023 2022 2021 Weighted-average remaining lease term (years) 12.9 13.6 12.9 Weighted-average discount rate 6.5 % 6.4 % 6.3 % Supplemental cash flow and other information related to leases for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands): December 31, 2023 2022 2021 Cash payments for operating leases $ 5,706 $ 11,933 $ 11,403 Operating lease assets obtained in exchange for lease liabilities — 2,825 2,876 The $ 3.8 million lease termination fee is included in the cash payments for operating leases for the year ended December 31, 2022. The table below reconciles the undiscounted future minimum lease payments (in thousands) under noncancelable operating leases with terms of more than one year to the total operating lease liabilities recognized on the consolidated balance sheet as of December 31, 2023. Years Ending December 31: 2024 7,016 2025 7,178 2026 7,205 2027 5,403 2028 6,465 Thereafter 51,027 Total lease payments 84,294 Less: Interest ( 26,710 ) Total $ 57,584

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intagible Assets	12. GOODWILL AND INTANGIBLE ASSETS Goodwill and intangible assets are primarily the result of business acquisitions. The Company performs its annual impairment assessment of goodwill and indefinite life intangible assets as of November 30 of each year. During the year ended December 31, 2023, the Company's China reporting unit experienced adverse impacts as a result of changes in market conditions and increases in interest rates which contributed to reduced forecasted revenues and reduced projected future cash flows. As a result of these adverse impacts, the Company performed an interim quantitative assessment of goodwill impairment by comparing the fair value of its China reporting unit to its carrying value, including goodwill. When performing the assessment, the Company determined the fair value of its China reporting unit based on forecasted future cash flows. Based on the Company's forecast of the future cash flows of its China reporting unit, it was determined the carrying value of goodwill for its China reporting unit was impaired and the Company recorded a goodwill impairment charge of $ 77.4 million during the three months ended June 30, 2023. The Company used a quantitative approach to measure the fair value of its China reporting unit using a discounted cash flow approach, which is a Level 3 measurement. The discounted cash flow analysis requires significant judgments, including estimates of future cash flows, which are dependent on internal forecasts and determination of the Company’s weighted average cost of capital, which is risk-adjusted to reflect the specific risk profile of the reporting unit being tested. The weighted average cost of capital used for the China reporting unit in the Company’s analysis was 12.5 %. During the year ended December 31, 2023, the Company performed a qualitative assessment for its remaining reporting unit with goodwill and its trademark indefinite life intangible assets. For the qualitative analysis performed as of November 30, 2023, the Company assessed several events and circumstances that could affect the significant inputs used to determine the fair values of the reporting unit and trademarks, including the significance of the amount of excess fair value over carrying value, consistency of operating margins and cash flows, budgeted-to-actual performance from prior year, no significant changes to projected forecasts, overall change in economic climate, changes in the industry and competitive environment, key management turnover, and earnings quality and sustainability. There were no unanticipated changes or negative indicators in the above qualitative factors that would impact the fair values as of the annual impairment date. As such, the Company determined there were no indicators of impairment and that it is more likely than not that the fair value of the reporting unit and trademarks are greater than their carrying values and therefore performing the next step of the impairment test was unnecessary. For the years ended December 31, 2022 and 2021 the Company performed a quantitative impairment test which indicated no impairment and there was no change to the carrying amount of goodwill or trademarks due to impairment. The following table presents the gross amount, accumulated impairment loss, and net carrying amount of goodwill as of December 31, 2023 and 2022 (in thousands): Accumulated Net Gross Amount Impairment Loss Carrying Amount Balance as of December 31, 2023 1,520,926 ( 103,202 ) 1,417,724 Balance as of December 31, 2022 $ 1,520,926 $ ( 25,797 ) $ 1,495,129 The accumulated impairment loss as of December 31, 2022 was recognized during the year ended December 31, 2019. Changes in the net carrying amount of goodwill were as follows during the year ended December 31, 2022 (in thousands): Net Carrying Amount Balance as of December 31, 2021 $ 1,466,884 Acquisition of Safekeep, Inc. 28,245 Balance as of December 31, 2022 $ 1,495,129 Impairment ( 77,405 ) Balance as of December 31, 2023 $ 1,417,724 The intangible assets balance as of December 31, 2023, is reflected below (in thousands): Weighted- Average Estimated Remaining Gross Net Useful Life Useful Life Carrying Accumulated Carrying (Years) (Years) Amount Amortization Amount Intangible assets: Customer relationships 16 – 18 11.3 $ 1,291,830 $ ( 479,054 ) $ 812,776 Acquired technologies 3 – 7 1.7 184,640 ( 172,840 ) 11,800 Subtotal 1,476,470 ( 651,894 ) 824,576 Trademarks—indefinite life 190,470 — 190,470 Total intangible assets $ 1,666,940 $ ( 651,894 ) $ 1,015,046 The intangible assets balance as of December 31, 2022, is reflected below (in thousands): Weighted- Average Estimated Remaining Gross Net Useful Life Useful Life Carrying Accumulated Carrying (Years) (Years) Amount Amortization Amount Intangible assets: Customer relationships 16 – 18 12.3 $ 1,299,750 $ ( 410,095 ) $ 889,655 Acquired technologies 3 – 7 1.8 187,950 ( 149,256 ) 38,694 Subtotal 1,487,700 ( 559,351 ) 928,349 Trademarks—indefinite life 190,470 — 190,470 Total intangible assets $ 1,678,170 $ ( 559,351 ) $ 1,118,819 During the year ended December 31, 2023, the Company recorded an impairment charge to its China reporting unit's customer relationships and acquired technologies intangible assets. The Company's forecast of the China reporting unit's expected cash flows indicated the carrying amounts of the intangible assets were no t recoverable and therefore the Company recorded an impairment charge of $ 5.3 million. As a result of the impairment charge, the Company recorded a write off of the gross carrying amount and accumulated amortization of the associated intangible assets during the year ended December 31, 2023. No intangible asset impairments were recorded during the years ended December 31, 2022 and 2021. During February 2022, the Company recorded $ 4.8 million of acquired technology intangible assets as a result of the acquisition of Safekeep (see Note 4). Amortization expense for intangible assets was $ 98.4 million, $ 99.2 million and $ 98.7 million for the years ended December 31, 2023, 2022 and 2021, respectively. Future amortization expense for each of the next five years and thereafter for intangible assets as of December 31, 2023, is as follows (in thousands): Years Ending December 31: 2024 $ 80,768 2025 72,454 2026 72,454 2027 72,454 2028 72,454 Thereafter 453,992 Total $ 824,576

Equity Method Investment

Equity Method Investment	12 Months Ended
	Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]
Equity Method Investment	13. EQUITY METHOD INVESTMENT The Company maintains an investment in a limited partnership (the “Investee”), which is affiliated with one of the Company’s principal equity owners. The Company invested $ 10.2 million, including related fees and expenses, for an approximate 7 % interest of the Investee. Since the Company's investment in June 2021, the Investee has not recognized any income or loss, thus there have been no changes to the carrying value of the Company's equity method investment and the investment is recorded at $ 10.2 million as of December 31, 2023 and 2022 on the consolidated balance sheets.

Accrued Expenses

Accrued Expenses	12 Months Ended
	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued Expenses	14. ACCRUED EXPENSES Accrued expenses as of December 31, 2023 and 2022, consist of the following (in thousands): December 31, 2023 2022 Compensation $ 54,593 $ 53,530 Royalties and licenses 4,381 3,832 Sales tax 2,968 2,615 Employee insurance benefits 2,572 2,749 Software license agreements 2,233 3,243 Professional services 2,183 1,877 Other 2,548 3,599 Total $ 71,478 $ 71,445

Other Liabilities

Other Liabilities	12 Months Ended
	Dec. 31, 2023
Other Liabilities Disclosure [Abstract]
Other Liabilities	15. OTHER LIABILITIES Other liabilities as of December 31, 2023 and 2022, consist of the following (in thousands): December 31, 2023 2022 Income taxes payable—non-current $ 3,937 $ — Software license agreements 1,004 1,208 Deferred revenue—non-current 1,373 1,240 Contingent consideration 100 100 Other — 110 Total $ 6,414 $ 2,658

Long-Term Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Long-Term Debt	16. LONG-TERM DEBT On September 21, 2021, CCC Intelligent Solutions Inc., an indirect wholly owned subsidiary of the Company, together with certain of the Company’s subsidiaries acting as guarantors entered into a credit agreement (the “2021 Credit Agreement”). The 2021 Credit Agreement replaced the Company’s 2017 First Lien Credit Agreement (the “First Lien Credit Agreement”), dated as of April 27, 2017, as amended as of February 14, 2020. The proceeds of the 2021 Credit Agreement and cash on hand were used to repay all outstanding borrowings under the First Lien Credit Agreement. 2021 Credit Agreement —The 2021 Credit Agreement consists of an $ 800.0 million term loan (the “Term B Loan”) and a revolving credit facility for an aggregate principal amount of $ 250.0 million (the “2021 Revolving Credit Facility” and together with the Term B Loan, the "2021 Credit Facilities"). The 2021 Revolving Credit Facility has a sublimit of $ 75.0 million for letters of credit. The Company received proceeds of $ 798.0 million, net of debt discount of $ 2.0 million, related to the Term B Loan. The Company incurred $ 9.8 million in financing costs related to the Term B Loan, recorded to a contra debt account. The Company incurred $ 3.1 million in financing costs related to the 2021 Revolving Credit Facility, recorded as deferred financing fees. The financing costs are being amortized to interest expense over the terms of the Term B Loan and 2021 Revolving Credit Facility using the effective interest method. The Term B Loan requires quarterly principal payments of $ 2.0 million until June 30, 2028 , with the remaining outstanding principal amount required to be paid on the maturity date, September 21, 2028 . Beginning with the fiscal year ended December 31, 2022, if the Company's leverage ratio, as defined in the 2021 Credit Agreement is greater than 3.5, the Term B Loan requires a prepayment of principal, subject to certain exceptions, in connection with the receipt of proceeds from certain asset sales, casualty events, and debt issuances by the Company, and up to 50 % of annual excess cash flow, as defined in and as further set forth in the 2021 Credit Agreement. When a principal prepayment is required, the prepayment offsets the future quarterly principal payments of the same amount. As of December 31, 2023 and 2022 , the Company's leverage ratio did not exceed the 3.5 threshold and the Company was not subject to the annual excess cash flow calculation, and as such, no t required to make a prepayment of principal. As of December 31, 2023 and 2022 , the amount outstanding on the Term B Loan is $ 784.0 million and $ 792.0 million, respectively, of which $ 8.0 million is classified as current in the accompanying consolidated balance sheets. Borrowings under the 2021 Credit Facilities bear interest at rates based on the ratio of CCC Intelligent Solutions Inc. and certain of its subsidiaries’ consolidated first lien net indebtedness to consolidated EBITDA for applicable periods specified in the 2021 Credit Agreement. On May 19, 2023, the Company entered into Amendment No. 1 to the 2021 Credit Agreement (the “Amendment”) to establish SOFR as the benchmark rate for determining the applicable interest rate, replacing LIBOR. No other terms, including the amount of borrowings, required payments or maturity date, were changed as a result of the Amendment. The Company did not incur any significant costs associated with the Amendment. Subsequent to the execution of the Amendment, the interest rate per annum applicable to the loans is based on a fluctuating rate of interest equal to the sum of an applicable rate and term SOFR (other than with respect to Euros, Euribor and with respect to British Pounds Sterling, SONIA) with a term as selected by the Company, of one, three or six months (subject to (x) in the case of term loans, a 0.50 % per annum floor and (y) in the case of revolving loans, a 0.00 % per annum floor. Prior to the execution of the Amendment, the interest rate per annum applicable to the loans was based on a fluctuating rate of interest equal to the sum of an applicable rate and, at the Company’s election from time to time, either: (1) a base rate determined by reference to the highest of (a) the rate last quoted by the Wall Street Journal as the “prime rate,” (b) the federal funds effective rate plus 0.50 %, (c) one-month LIBOR plus 1.00 % and (d) with respect to the Term B Loan, 1.50 % and with respect to the 2021 Revolving Credit Facility, 1.00 %, or (2) a Eurocurrency rate determined by reference to LIBOR (other than with respect to Euros, Euribor and with respect to British Pounds Sterling, SONIA) with a term as selected by the Company, of one, three or six months (subject to (x) in the case of term loans, a 0.50 % per annum floor and (y) in the case of revolving loans, a 0.00 % per annum floor). A quarterly commitment fee of up to 0.50 % is payable on the unused portion of the 2021 Revolving Credit Facility. The 2021 Revolving Credit Facility matures on September 21, 2026 . During the years ended December 31, 2023, 2022, and 2021 , the weighted-average interest rate on the outstanding borrowings under the Term B Loan was 7.5 %, 4.2 %, and 3.0 %, respectively. The Company made Term B Loan interest payments of $ 58.6 million, $ 33.5 million, and $ 6.7 million during the years ended December 31, 2023, 2022, and 2021 respectively. During the year ended December 31, 2021, the Company issued a standby letter of credit for $ 0.7 million which reduces the amount available to be borrowed under the 2021 Revolving Credit Facility and as of December 31, 2023 and 2022 , $ 249.3 million was available to be borrowed. Borrowings under the 2021 Credit Agreement are guaranteed by Cypress Holdings Intermediate Holdings II, Inc., and certain of its US subsidiaries by a perfected first priority lien on the stock of CCC Intelligent Solutions Inc., and substantially all of its assets, subject to various limitations and exceptions. The 2021 Credit Agreement contains representations and warranties, and affirmative and negative covenants, that among other things, restrict, subject to certain exceptions, our ability to: incur additional indebtedness, incur liens, engage in mergers, consolidations, liquidations or dissolutions; pay dividends and distributions on, or redeem, repurchase or retire our capital stock; and make certain investments, acquisitions, loans, or advances. The terms of the 2021 Credit Agreement include a financial covenant which requires that, at the end of each fiscal quarter, if the aggregate amount of borrowings under the 2021 Revolving Credit Facility exceeds 35 % of the aggregate commitments, the Company’s leverage ratio cannot exceed 6.25 to 1.00 . Borrowings under the 2021 Revolving Credit Facility did not exceed 35% of the aggregate commitments and the Company was not subject to the leverage test during the years ended December 31, 2023 and 2022. First Lien Credit Agreement —In April 2017, the Company entered into the First Lien Credit Agreement. The First Lien Credit Agreement initially consisted of a $ 1.0 billion term loan (“First Lien Term Loan”), a $ 65.0 million dollar revolving credit facility (“Dollar Revolver”), and a $ 35.0 million multicurrency revolving credit facility (“Multicurrency Revolver” and together with the Dollar Revolver, the “First Lien Revolvers”), with a sublimit of $ 30.0 million for letters of credit under the First Lien Revolvers. The Company received proceeds of $ 997.5 million, net of debt discount of $ 2.5 million, related to the First Lien Term Loan. In February 2020, the Company refinanced its long-term debt (“2020 Refinancing”) and entered into the First Amendment to the First Lien Credit Agreement (“First Lien Amendment”). The First Lien Amendment provided an incremental term loan in the amount of $ 375.0 million. The Company received proceeds from the incremental term loan of $ 373.1 million, net of debt discount of $ 1.9 million. The proceeds of the incremental term loan were used to repay all outstanding borrowings under the Company's previous debt agreement. The Company incurred $ 27.6 million and $ 3.4 million in financing costs related to the First Lien Credit Agreement and First Lien Amendment, respectively. These costs were recorded to a contra debt account and were being amortized to interest expense over the term of the First Lien Credit Agreement using the effective interest method. Using a portion of the proceeds from the Business Combination, the Company made a principal prepayment of $ 525.0 million on July 30, 2021. Subsequently, in September 2021, using the proceeds from the Term B Loan provided in the 2021 Credit Agreement and cash on hand, the Company fully repaid the remaining $ 804.2 million of outstanding borrowings on the First Lien Term Loan. The prepayments of outstanding borrowings under the First Lien Credit Agreement were determined to be debt extinguishments and the Company recognized a loss on early extinguishment of debt of $ 15.2 million in the consolidated statement of operations and comprehensive (loss) income during the year ended December 31, 2021. Amounts outstanding under the First Lien Credit Agreement bore interest at a variable rate of LIBOR, plus up to 3.00 % per annum based upon the Company’s leverage ratio, as defined in the First Lien Credit Agreement. A quarterly commitment fee of up to 0.50 % was payable on the unused portion of the First Lien Revolvers. During the year December 31, 2021, the weighted-average interest rate on the outstanding borrowings under the First Lien Term Loan was 4.1 %. The Company made interest payments of $ 36.1 million during the year ended December 31, 2021. Long-term debt as December 31, 2023 and 2022, consists of the following (in thousands): December 31, 2023 2022 Term B Loan $ 784,000 $ 792,000 Term B Loan—discount ( 1,436 ) ( 1,669 ) Term B Loan—deferred financing fees ( 7,060 ) ( 8,199 ) Term B Loan—net of discount and fees 775,504 782,132 Less: Current portion ( 8,000 ) ( 8,000 ) Total long-term debt—net of current portion $ 767,504 $ 774,132 The table below is a roll forward of the Company's contra debt deferred financing fees and discount and deferred financing fees asset balances (in thousands): Deferred Discount— Financing Contra Fees Debt Balance—December 31, 2021 $ 12,363 $ 1,926 Amortization of fees and discount ( 1,878 ) ( 257 ) Balance—December 31, 2022 10,485 1,669 Amortization of fees and discount ( 1,753 ) ( 233 ) Balance—December 31, 2023 $ 8,732 $ 1,436 As of December 31, 2023 and 2022, the deferred financing fees asset balance includes $ 1.7 million and $ 2.3 m illion in relation to the 2021 Revolving Credit Facility. Scheduled Payments for Debt —Principal amounts due in each of the next five years, as of December 31, 2023, are as follows (in thousands): Years Ending December 31: 2024 $ 8,000 2025 8,000 2026 8,000 2027 8,000 2028 752,000 Total $ 784,000 Interest Rate Caps —In August 2022, the Company entered into two interest rate cap agreements to reduce its exposure to increases in interest rates applicable to its floating rate long-term debt. The interest rate cap agreements have an aggregate notional amount of $ 600.0 million and a one-month SOFR cap rate of 4.00 % through their expiration in July 2025 . The fair value of the interest rate cap agreements was estimated using inputs that were observable or that could be corroborated by observable market data and therefore, was classified within Level 2 of the fair value hierarchy as of December 31, 2023 and 2022. The Company did not designate its interest rate cap agreements as hedging instruments and records the changes in fair value within earnings. During the year ended December 31, 2023, the Company transitioned the referenced interest rate within the two interest rate cap agreements from LIBOR to SOFR by terminating the original agreements and simultaneously entering into new agreements. The terms of the new agreements were unchanged except for the referenced interest rate. The Company elected the optional expedients available within ASC 848 to allow for this transition without any modification to the derivative classification of the interest rate cap agreements. As of December 31, 2023 and 2022 , the interest rate cap agreements had a fair value of $ 6.2 million and 12.0 million, respectively, classified within other assets in the accompanying consolidated balance sheets. Cash received related to the interest rate cap agreements was $ 6.5 million for the year ended December 31, 2023 recorded within other income-net on the consolidated statement of operations and comprehensive (loss) income. The Company received an insignificant amount of cash related to the interest rate cap agreements during the year ended December 31, 2022. Interest Rate Swaps —In June 2017, the Company entered into three floating to fixed interest rate swap agreements (“Swap Agreements”) to reduce its exposure to the variability from future cash flows resulting from interest rate risk related to its floating rate long-term debt. On September 21, 2021, the Company made an aggregate payment of $ 10.0 million to extinguish the Swap Agreements that were scheduled to expire in June 2022 .

Long-Term Licensing Agreement

Long-Term Licensing Agreement	12 Months Ended
	Dec. 31, 2023
Contractors [Abstract]
Long-Term Licensing Agreement	17. LONG-TERM LICENSING AGREEMENT During 2018, the Company entered into a licensing agreement with a third party to obtain a perpetual software license (“Licensing Agreement”) for a database structure, tools, and historical data used within the Company’s software. The Company has included the present value of the future payments required as a long-term licensing agreement within the accompanying consolidated balance sheets. The present value of the future payments was computed using an effective annual interest rate of 6.25 %, and the Licensing Agreement requires the Company to make quarterly principal and interest installment payments of approximately $ 1.2 million through December 2031. The present value of the future cash flows upon execution of the agreement was $ 45.6 million, which included an original discount of $ 23.2 million. At December 31, 2023, the remaining liability, net of the dis count was $ 30.8 million, with $ 3.1 million classified as current. At December 31, 2022 , the remaining liability, net of the discount was $ 33.6 million, with $ 2.9 million classified as current. The discount was recorded to a contra liability account and is being amortized to interest expense over the term of the agreement using the effective interest method. During the years ended December 31, 2023, 2022 and 2021 , the Company recognized $ 2.0 million, $ 2.2 million and $ 2.4 million, respectively, in interest expense related to the Licensing Agreement. The unamortized discount as of December 31, 2023 and 2022 was $ 8.6 million and $ 10.6 million, respectively. Principal amounts due in each of the next five years and thereafter for the Licensing Agreement as of December 31, 2023, are as follows (in thousands): Years Ending December 31: 2024 $ 3,061 2025 3,257 2026 3,466 2027 3,689 2028 3,926 Thereafter 13,354 Total $ 30,753

Redeemable Non-Controlling Inte

Redeemable Non-Controlling Interest	12 Months Ended
	Dec. 31, 2023
Noncontrolling Interest [Abstract]
Redeemable Non-Controlling Interest	18. REDEEMABLE NON-CONTROLLING INTEREST On March 12, 2020 (the “Close Date”), the Company closed a stock purchase agreement (the “Stock Purchase Agreement”) with a third-party investor (the “Investor”) for purchase by the Investor of Series A Preferred Stock in CCCIS Cayman Holdings Limited (“CCC Cayman”), the parent of the Company’s China operations. On the Close Date, CCC Cayman, a subsidiary of the Company, issued 1,818 shares of Series A Preferred Stock (the “Preferred Shares”) at $ 7,854 per share to the Investor for net proceeds of $ 14.2 million. As of December 31, 2023 and 2022, on an as-converted basis, the Preferred Shares represent an aggregate 10.0 % ownership interest of the issued and outstanding capital stock of CCC Cayman, or 8.6 % on a fully-diluted basis. The Preferred Shares are entitled to non-cumulative dividends at an annual rate of 8.0 %, when and if declared. At the option of the Investor, the Preferred Shares are convertible into ordinary shares of CCC Cayman, initially on a one-for-one basis but subject to potential adjustment, as defined by the Stock Purchase Agreement, at any time, or automatically upon the closing of an initial public offering. The Preferred Shares are redeemable upon an actual or deemed redemption event as defined in the Stock Purchase Agreement or at the option of the Investor beginning on the five-year anniversary of the Close Date, if an actual or deemed redemption event has not yet occurred. The redemption price, as defined by the Stock Purchase Agreement, is equal to the original issue price of the Preferred Shares, plus 10.0 % compound interest per annum on the Preferred Share issue price, plus any declared but unpaid dividends on the Preferred Shares. The Preferred Shares are entitled to distributions upon the occurrence of a sale or liquidation of CCC Cayman representing an amount that is equal to the original issue price of the Preferred Shares, plus 10.0% compound interest per annum on the Preferred Share issue price, plus any declared but unpaid dividends. The Preferred Shares do not participate in net income or losses. As of December 31, 2023 and 2022, the Investor’s ownership in CCC Cayman is classified in mezzanine equity as a redeemable non-controlling interest, because it is redeemable on an event that is not solely in the control of the Company. As of May 31, 2023, the Company determined it was probable the non-controlling interest would become redeemable and began to accrete the non-controlling interest to its redemption value. Changes in the carrying value of the non-controlling interest are recorded as adjustments to additional paid-in capital. The activity impacting the redeemable non-controlling interest during the years ending December 31 is presented below (in thousands): Year Ended December 31, 2023 2022 2021 Balance at beginning of period $ 14,179 $ 14,179 $ 14,179 Accretion of redeemable non-controlling interest 2,405 — — Balance at end of period $ 16,584 $ 14,179 $ 14,179

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2023
Stockholders' Equity Note [Abstract]
Capital Stock	19. CAPITAL STOCK The consolidated statements of mezzanine equity and stockholders’ equity reflect the Business Combination as of the Closing Date (see Note 3). As CCCIS was determined to be the accounting acquirer in the Business Combination, all periods prior to the Closing Date reflect the balances and activity of CCCIS. The balances, share activity and per share amounts prior to the Closing Date were retroactively adjusted, where applicable, using the Exchange Ratio of the Business Combination. Preferred Stock —The Company is authorized to issue up to 100,000,000 shares of undesignated preferred stock with a par value of $ 0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December 31, 2023 , there were no shares of preferred stock issued or outstanding. Common Stock —The Company is authorized to issue up to 5,000,000,000 shares of common stock with a par value of $ 0.0001 per share. Each holder of common stock is entitled to one (1) vote for each share of common stock held of record by such holder on all matters voted upon by the stockholders, subject to the restrictions set out in the Certificate of Incorporation. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Upon a liquidation event, subject to the rights of the holders of any Preferred Stock issued and outstanding at such time, any distribution shall be made on a pro rata basis to the common stockholders. There we re 603,128,781 and 622,072,905 shares of common stock issued and outstanding as of December 31, 2023 and 2022, respectively. Secondary Offering and Stock Repurchase —In November 2023, certain existing stockholders completed a secondary offering where the selling stockholders sold 65,000,000 shares of common stock. In addition, the underwriters exercised an option granted by the selling stockholders to purchase an additional 4,875,000 shares of the Company’s common stock at the same per share price. The Company did no t receive any of the proceeds from the sale of the shares by the selling stockholders. Concurrent with the closing of the secondary offering, 32,500,000 shares of common stock were repurchased by the Company for an aggregate price of $ 328.5 million. The shares repurchased by the Company were formally retired. The excess purchase price over par value was charged directly to accumulated deficit. In connection with the offering and repurchase, the Company incurred costs of $ 2.0 million during the year ended December 31, 2023, included within general and administrative expenses on the consolidated statement of operations and comprehensive (loss) income. Capital Stock Activity Prior to the Business Combination Dividends —In July 2021, the board of directors of CCCIS declared a cash dividend on common stock. The aggregate cash dividend of $ 134.6 million was paid on August 3, 2021. In March 2021, the board of directors of CCCIS declared a cash dividend on common stock. The aggregate cash dividend of $ 134.5 million was paid on March 17, 2021. In connection with the dividends paid in March 2021 and August 2021, certain CCCIS option holders received a strike price reduction of $ 66.40 per option to compensate for a reduction in the fair value of the underlying shares. The strike price reduction did not result in any incremental fair value and thus no additional stock-based compensation expense was recognized and the aggregate payment to the option holders of $ 9.0 million was recorded as a deemed distribution. Share Issuances —In February 2021, CCCIS issued 883,729 shares of common stock to an executive and recorded stock-based compensation expense of $ 8.0 million, equal to the fair value of the common shares at the time of issuance. In January 2021, CCCIS issued 110,679 shares of common stock to a board member for aggregate cash proceeds of $ 1.0 million, equal to the fair value of the common shares at the time of issuance.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2023
Employee Benefit Plans	20. EMPLOYEE BENEFIT PLANS The Company sponsors a tax-qualified defined contribution savings and investment plan, CCC 401(k) Retirement Savings and Investment Plan (the “Savings Plan”). Participation in the Savings Plan is voluntary with substantially all domestic employees eligible to participate. Expenses related to the Savings Plan consist primarily of the Company’s contributions that are based on percentages of employees’ contributions. The defined contribution expense for the years ended December 31, 2023, 2022 and 2021 was $ 6.5 million, $ 6.1 million and $ 5.3 million, respectively.

Stock Incentive Plans

Stock Incentive Plans	12 Months Ended
	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Stock Incentive Plans	21. STOCK INCENTIVE PLANS In connection with the Closing of the Business Combination, the CCC Intelligent Solutions Holdings Inc. 2021 Incentive Equity Plan (the "2021 Plan") was adopted and approved by the Company's board of directors and stockholders. The purpose of the 2021 Plan is to enable the Company to attract, retain, and motivate employees, consultants, and independent members of the board of directors of the Company and its subsidiaries by allowing them to become owners of common stock enabling them to benefit directly from the growth, development, and financial successes of the Company. Prior to the Business Combination, the Company maintained its 2017 Stock Option Plan (the “2017 Plan”). Upon the adoption and approval of the 2021 Plan, the 2017 Plan was terminated and each outstanding vested or unvested option, as required under the 2017 Plan, was converted to the 2021 Plan, multiplied by the Exchange Ratio, with the same key terms and vesting requirements. Additionally, the Company maintained a Phantom Stock Plan (the “Phantom Plan”), which provided for the issuance of phantom shares of CCCIS’s common stock (“Phantom Shares”) to eligible employees under the 2017 Plan. All stock-based award activity prior to the closing of the Business Combination on July 30, 2021 has been retroactively restated to reflect the Exchange Ratio. Awards granted under the 2017 Plan and the Phantom Plan either had time-based vesting or performance-based vesting with a market condition. Options expire on the tenth anniversary of the grant date. Awards granted under the Phantom Plan were settled in cash and thus accounted for as liability awards. During 2021, the board of directors of CCCIS approved a modification that resulted in vesting of the performance-based awards with a market condition and the Phantom Shares upon Closing of the Business Combination. At the time of modification, the Company estimated a new fair value of the modified awards. As such, at the time of such modification, the Company recognized $ 203.9 million of stock-based compensation based on the fair value of the performance-based awards with a market condition and $ 6.0 million of stock-based compensation based on the fair value of the Phantom Shares. The total number of shares of common stock that will be reserved and that may be issued under the 2021 Plan will automatically increase on the first day of each fiscal year, beginning with fiscal year 2022, by a number of shares equal to 5.0 % of the total number of shares of common stock outstanding on the last day of the prior fiscal year or such lesser amount as determined by the board of directors. For the year ended December 31, 2023 and 2022, the board of directors elected not to increase the number of shares of common stock reserved under the 2021 Plan. The following table summarizes the shares of common stock reserved for future issuance under the 2021 Plan as of December 31, 2023 and 2022: December 31, 2023 2022 Stock options outstanding 35,788,469 45,249,260 Restricted stock units outstanding 36,329,881 31,288,688 Restricted stock units available for future grant 49,451,502 57,946,089 Reserved for ESPP 4,981,134 5,622,825 Common stock reserved for future issuance 126,550,986 140,106,862 Restricted Stock Units —RSUs are convertible into shares of the Company’s common stock upon vesting. The grant date fair value of each RSU with time-based vesting and performance-based vesting is determined using the fair value of the underlying common stock on the date of grant. The grant date fair value of each performance-based RSU with a market condition is estimated on the date of grant using the Monte Carlo simulation model. Stock-based compensation for RSUs with time-based vesting is recognized on a straight-line basis over the requisite service period for the number of RSUs that are probable of vesting. Stock-based compensation for performance-based RSUs or performance-based RSUs with a market condition is recognized on a straight-line basis over the performance period based on the number of RSUs that are probable of vesting. During 2023, CCC's board of directors of CCCIS approved modifications to the performance-based RSUs subject to a market condition. The modifications included: (i) the extension of the performance period by one year, (ii) a change to the performance criteria, (iii) a change to the number of units to be issued depending on performance and (iv) for certain grants, imposing a maximum number of units to be issued depending on performance equal to 100 % of the target. The modification to the performance-based RSUs subject to a market condition resulted in incremental stock-based compensation expense of $ 67.0 million, which will be recognized ratably over the modified performance periods. The amount of stock-based compensation expense related to the modified awards during the year ended December 31, 2023 was not significant. The table below summarizes the RSU activity for the years ended December 31, 2023, 2022, and 2021: Weighted- Average Shares Fair Value Non-vested RSUs—December 31, 2020 — $ — Granted 18,677,411 10.74 Canceled ( 119,200 ) 11.59 Non-vested RSUs—December 31, 2021 18,558,211 $ 10.74 Granted 16,426,878 10.07 Vested ( 2,324,324 ) 11.22 Canceled ( 1,372,077 ) 10.93 Non-vested RSUs—December 31, 2022 31,288,688 10.34 Granted 12,574,115 9.01 Vested ( 5,707,373 ) 10.57 Canceled ( 1,825,549 ) 9.90 Non-vested RSUs—December 31, 2023 36,329,881 $ 10.56 During the year ended December 31, 2023 , the Company granted 12,574,115 RSUs, of which 10,946,224 have time-based vesting requirements and 1,627,891 have performance-based vesting requirements. During the year ended December 31, 2022 , the Company granted 16,426,878 RSUs, of which 14,859,033 have time-based vesting requirements, 783,949 have performance-based vesting requirements and 783,896 have performance-based with a market condition vesting requirements. During the year ended December 31, 2021 , the Company granted 18,677,411 RSUs, of which 7,730,019 have time-based vesting requirements, 5,473,701 have performance-based vesting requirements and 5,473,691 have performance-based with a market condition vesting requirements. The valuation of the performance-based RSUs with a market condition granted or modified during the years ended December 31, 2023, 2022 and 2021 was determined using a Monte Carlo Simulation model using the following assumptions: 2023 2022 2021 Expected term (in years) 1.1 - 2.1 2.8 2.2 Expected volatility 28 %- 32 % 35 % 35 % Expected dividend yield 0 % 0 % 0 % Risk-free interest rate 4.36 %- 4.87 % 2.28 % 0.51 % The key assumptions used in the Company's fair value estimates include the following: Expected Term—The expected term represents the period that the stock-based awards are expected to be outstanding. The Company uses the simplified method to determine the expected term for its option grants. The simplified method calculates the expected term as the average of the time-to-vesting and the contractual life of the stock options. The Company uses the simplified method to determine its expected term because of its limited history of stock option exercise activity. Expected Volatility—The Company has limited trading history of its common stock and the expected volatility was estimated based on the average volatility for comparable publicly traded companies over a period equal to the expected term of the stock option grants. Expected Dividend—Historically, the Company has not paid regular dividends on its common stock and has no plans to pay dividends on common stock on a regular basis. The Company does not have a dividend policy. Therefore, the Company used an expected dividend yield of zero. Risk-Free Interest Rate—The risk-free interest rate is based on the US Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of awards. The Company uses a pre-vesting forfeiture rate to estimate the number of options that are expected to vest that was based on the Company’s historical turnover rate. Stock Options — The table below summarizes the option activity for the years ended December 31, 2023, 2022 and 2021 : Weighted- Weighted-Average Average Remaining Aggregate Exercise Contractual Life Intrinsic Value Shares Price (in years) (in thousands) Options outstanding—December 31, 2020 55,570,039 3.03 6.9 $ 337,358 Granted 2,822,484 8.58 Exercised ( 1,924,063 ) 2.70 Forfeited and canceled ( 823,965 ) 3.66 Options outstanding—December 31, 2021 55,644,495 2.95 6.0 469,591 Exercised ( 10,081,164 ) 2.74 Forfeited and canceled ( 314,071 ) $ 4.46 Options outstanding—December 31, 2022 45,249,260 2.99 4.9 258,470 Exercised ( 8,923,718 ) 2.85 Forfeited and canceled ( 537,073 ) 6.88 Options outstanding—December 31, 2023 35,788,469 $ 2.96 4.0 $ 301,563 Options exercisable—December 31, 2023 33,971,974 $ 2.79 3.9 $ 292,059 Options vested and expected to vest—December 31, 2023 35,726,785 $ 2.96 4.0 $ 301,252 The weighted-average grant-date fair value for time-based options granted during the year ended December 31, 2021 was $ 3.67 . The weighted-average grant-date fair value for performance-based options with a market condition granted during the years ended December 31, 2021 was $ 0.88 . The fair value of the options that vested during the year ended December 31, 2023 was $ 2.9 million. During the year ended December 31, 2023 , the Company issued 8,923,718 shares of common stock. During the year ended December 31, 2022 , the Company issued 10,074,354 shares of common stock upon exercise of 10,081,164 stock options. As part of cashless exercises, 6,810 shares were applied to the exercise price and tax obligations of the option holders. During the year ended December 31, 2021, the Company issued 1,922,019 shares of common stock upon exercise of 1,924,063 of stock options. As part of cashless exercises, 2,044 shares were applied to the exercise price and tax obligations of the option holders. During the year ended December 31, 2021, prior to the Business Combination, the Company granted 2,822,484 stock options, of which 2,754,374 have time-based vesting and 68,110 have performance-based with a market condition vesting. The exercise price of all stock options granted during the year ended December 31, 2021 was equal to the fair value of the underlying shares at the grant date. The valuation of time-based stock options granted during the year ended December 31, 2021 was determined using the Black-Scholes option valuation model using the following assumptions: 2021 Expected term (in years) 6.5 Expected volatility 40 % Expected dividend yield 0 % Risk-free interest rate 0.62 - 0.67 % For performance-based options with a market condition, the market condition is required to be considered when calculating the grant date fair value. In order to reflect the substantive characteristics of the performance-based options with a market condition, a Monte Carlo simulation valuation model was used to calculate the grant date fair value of such stock options. Monte Carlo approaches are a class of computational algorithms that rely on repeated random sampling to compute their results. This approach allows the calculation of the fair value of such stock options based on a number of possible scenarios. Stock-based compensation expense for the performance-based options with a market condition is not recognized until the performance condition is probable of occurring. The valuation of the performance-based options with a market condition granted during the year ended December 31, 2021 was determined through the Monte Carlo simulation model using the following assumptions: 2021 Expected term (in years) 5.5 Expected volatility 33 % Expected dividend yield 0 % Risk-free interest rate 0.44 % Cayman Equity Incentive Plan —During the year ended December 31, 2022, the Company adopted the CCCIS Cayman Holdings Employees Equity Incentive Plans (“Cayman Incentive Plans”), which provide for the issuance of stock option awards in CCC Cayman (“Cayman Awards”) to eligible employees of the Company's China subsidiaries. Pursuant to the Cayman Incentive Plans, the number of Cayman Shares that may be subject to stock incentives is not to exceed 3,000,000 in the aggregate. Awards under the Cayman Incentive Plans are settled in cash and thus accounted for as liability awards. Awards granted under the Cayman Incentive Plans have time-based vesting and expire on the tenth anniversary of the grant date. The Company records stock-based compensation expense on a straight-line basis over the vesting period. Time-based awards generally vest ratably over a four-year period based on continued service. Vesting of the time-based awards can be accelerated in certain circumstances, such as an initial public offering, as defined in the Cayman Incentive Plans. During the years ended December 31, 2023 and 2022, the Company granted 539,400 and 1,303,000 stock options under the Cayman Incentive Plans, respectively. The exercise price of the optio ns granted is at least equal to the fair value of the underlying shares at the grant date. As of December 31, 2023 and 2022, 1,735,900 and 1,303,000 , respectively, are outstanding, no ne of which are exercisable. Awards under the Cayman Incentive Plans are remeasured at fair value each reporting period with the change in fair value recognized as stock-based compensation expense in that period. The fair values of the outstanding awards at December 31, 2023 and 2022 were based on the Black-Scholes option pricing model using the following assumptions: 2023 2022 Expected term (in years) 5.25 - 5.42 6.25 Expected volatility 40 % 40 % Expected dividend yield 0 % 0 % Risk-free interest rate 3.8 % 3.5 % Employee Stock Purchase Plan —In October 2021, the Company’s Board of Directors adopted the ESPP. The ESPP is intended to qualify as an employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended. Under the ESPP, employee purchases occur at the end of discrete offering periods. The first offering period began on January 1, 2022 and ended on June 30, 2022. Subsequent six-month offering periods begin on July 1 and January 1 (or such other date determined by the board of directors). Under the ESPP, eligible employees can acquire shares of the Company’s common stock by accumulating funds through payroll deductions. Employees generally are eligible to participate in the ESPP if they are a U.S. employee and are employed for at least 20 hours per week. The Company may impose additional restrictions on eligibility. Eligible employees can select a rate of payroll deduction between 1 % and 15 % of their compensation. The purchase price for shares of common stock purchased under the ESPP is 85 % of the lesser of the fair market value of the Company’s common stock on (i) the first day of the applicable offering period or (ii) the last day of the purchase period in the applicable offering period. An employee’s participation automatically ends upon termination of employment for any reason. As of December 31, 2023 and 2022, 6,031,704 shares of common stock are reserved for sale under the ESPP . The aggregate number of shares reserved for sale under the ESPP increases on January 1 by the lesser of 1 % of the total numbers of shares outstanding or a lesser amount as determined by the Board of Directors. For the year ended December 31, 2023 and 2022, the board of directors elected not to increase the number of shares of common stock reserved under the ESPP. During the years ending December 31, 2023 and 2022, 641,691 and 408,879 shares were sold under the ESPP, respectively. The fair value of ESPP purchase rights sold during the years ended December 31, 2023 and 2022 was estimated using the Black-Scholes option pricing model with the following assumptions: 2023 2022 Expected term (in years) 0.5 0.5 Expected volatility 30 %- 51 % 47 % Expected dividend yield 0 % 0 % Risk-free interest rate 2.5 %- 4.7 % 0.2 % Company Earnout Shares —Pursuant to the Business Combination Agreement, CCCIS shareholders and option holders, subject to continued employment, have the right to receive up to an additional 13.5 million shares and 1.5 million shares of common stock, respectively, if, before the tenth anniversary of the Closing, (a) the share price has been greater than or equal to $ 15.00 per share for any twenty trading days within any thirty consecutive trading day period beginning after Closing, or (b) there is a change in control, as defined in the Business Combination Agreement. The fair value of the Company Earnout Shares was estimated on the date of the grant, using the Monte Carlo simulation method. Compensation expense on the shares granted to option holders was recorded ratably over the implied service period of five months beginning on July 30, 2021. During the year ended December 31, 2021, the Company recognized $ 19.5 million of stock-based compensation expense related to the Company Earnout Shares granted to the CCCIS option holders. Phantom Stock —Phantom Shares vested under the same time-based or performance-based with a market condition as the stock options granted under the 2017 Plan. The valuation of Phantom Shares was measured based on the fair value per share of the Company’s common stock. Upon consummation of the Business Combination on July 30, 2021, all outstanding Phantom Shares vested and were subsequently settled in cash for $ 10.2 million. During the year ended December 31, 2021, the Company recognized stock-based compensation expense of $ 7.0 million related to the Phantom Shares. Stock-Based Compensation —Stock-based compensation expense has been recorded in the accompanying consolidated statements of operations and comprehensive (loss) income as follows for the years ended December 31, 2023, 2022 and 2021 (in thousands): Year Ended December 31, 2023 2022 2021 Cost of revenues $ 8,802 $ 5,812 $ 13,644 Research and development 25,467 19,536 40,681 Sales and marketing 33,204 25,309 65,045 General and administrative 77,045 58,840 142,625 Total stock-based compensation expense $ 144,518 $ 109,497 $ 261,995 As of December 31, 2023 , there was $ 171.1 million of unrecognized stock compensation expense related to non-vested time-based awards which is expected to be recognized over a weighted-average period of 2.5 years. As of December 31, 2023 , there was $ 96.6 million of unrecognized stock-based compensation expense related to non-vested performance-based awards, which is expected to be recognized over a weighted-average period of 1.4 years.

Warrants

Warrants	12 Months Ended
	Dec. 31, 2023
Warrants and Rights Note Disclosure [Abstract]
Warrants	22. WARRANTS Upon consummation of the Business Combination (see Note 3), the Company assumed the outstanding Public Warrants and Private Warrants issued by Dragoneer. Public Warrants were only able to be exercised for a whole number of shares of the Company’s common stock. All Public Warrants had an exercise price of $ 11.50 per share, subject to adjustment, beginning on August 29, 2021, and were to expire on July 30, 2026 or earlier upon redemption or liquidation. On November 29, 2021, the Company announced that it had elected to redeem all of the outstanding Public Warrants on December 29, 2021. Each Public Warrant not exercised before 5:00 p.m. Eastern Daylight Time on December 29, 2021 was redeemed by the Company for $ 0.10 and the Public Warrants subsequently ceased trading. Of the 17,299,983 Public Warrants that were outstanding as of the Closing of the Business Combination, 10,638 warrants were exercised for cash proceeds of $ 0.1 million and 15,876,341 were exercised on a cashless basis in exchange for an aggregate of 4,826,339 shares of common stock. The Company paid $ 0.1 million to redeem the remaining 1,413,004 unexercised Public Warrants. As of December 31, 2021, there were no Public Warrants outstanding. The Private Warrants are identical to the Public Warrants underlying the shares sold in Dragoneer’s initial public offering. Additionally, the Private Warrants are exercisable on a cashless basis and are non-redeemable, so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Private Warrants may only be exercised for a whole number of shares of the Company’s common stock. Each whole Private Warrant entitles the registered holder to purchase one share of the Company’s common stock. All warrants have an exercise price of $ 11.50 per share, subject to adjustment, beginning on August 29, 2021 , and will expire on July 30, 2026 or earlier upon redemption or liquidation. Since the Closing of the Business Combination, there have been no exercises or redemptions of the Private Warrants and as of December 31, 2023 and 2022 , 17,800,000 Private Warrants were outstanding. The Company recognized (expense) income of ($ 15.1 ) million, $ 26.1 million, and ($ 64.5 ) million as a change in fair value of warrant liabilities in the consolidated statements of operations and comprehensive (loss) income for years ended December 31, 2023, 2022, and 2021, respectively. As of December 31, 2023 and 2022 the Company’s warrant liability was $ 51.5 and $ 36.4 million, respectively.

Commitments

Commitments	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments	23. COMMITMENTS Purchase Obligations —The Company has long-term agreements with suppliers and other parties related to licensing data used in its solutions and services, outsourced data center, disaster recovery, and software as a service that expire at various dates through 2031 . Under the terms of these agreements with suppliers, the Company has future minimum obligations as of December 31, 2023 as follows (in thousands): Years Ending December 31: 2024 $ 18,926 2025 15,590 2026 12,483 2027 11,451 2028 9,900 Thereafter 29,700 Total $ 98,050 Guarantees —The Company’s services and solutions are typically warranted to perform in a manner consistent with general industry standards that are reasonably applicable and substantially in accordance with the Company’s services and solutions documentation under normal use and circumstances. The Company’s services and solutions are generally warranted to be performed in a professional manner and to materially conform to the specifications set forth in the related customer contract. The Company’s arrangements also include certain provisions for indemnifying customers against liabilities if its services and solutions infringe a third party’s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnifications or commitments and has not accrued any liabilities related to such obligations in the accompanying consolidated financial statements. Employment Agreements —The Company is a party to employment agreements with key employees that provide for compensation and certain other benefits. These agreements also provide for severance payments and bonus under certain circumstances.

Legal Proceedings and Contingen

Legal Proceedings and Contingencies	12 Months Ended
	Dec. 31, 2023
Legal Proceedings And Contingencies [Abstract]
Legal Proceedings and Contingencies	24. LEGAL PROCEEDINGS AND CONTINGENCIES In the ordinary course of business, the Company is from time to time, involved in various pending or threatened legal actions. The litigation process is inherently uncertain, and it is possible that the resolution of such matters might have a material adverse effect upon the Company’s consolidated financial condition and/or results of operations. The Company’s management believes, based on current information, matters currently pending or threatened are not expected to have a material adverse effect on the Company’s consolidated financial position or results of operations.

Related Parties

Related Parties	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
Related Parties	25. RELATED PARTIES The Company has engaged in transactions within the ordinary course of business with entities affiliated with its principal equity owners. The following table summarizes revenues and expenses with entities affiliated with one of its principal equity owners for the years ended December 31, 2023, 2022 and 2021 (in thousands): December 31, 2023 2022 2021 Revenues Credit card processing $ 1,051 $ 811 $ 399 Expenses Employee health insurance benefits 3,641 3,166 $ 3,228 Human resources support services 313 237 242 Board of director fees for services, including related travel and out-of-pocket reimbursements 306 131 204 IT development software 130 * * Sales tax processing and license fees for tax information ^ 561 286 * Not significant. ^ Not a related party during the year ended December 31, 2023. The following table summarizes amounts receivable and payable to entities affiliated with one of its principal equity owners as of December 31, 2023 and 2022 (in thousands): December 31, 2023 2022 Receivables Credit card processing * * Payables Employee health insurance benefits $ 480 $ 501 Human resources support services * * Sales tax processing and license fees for tax information ^ ^ Board of director fees for services, including related travel and out-of-pocket reimbursements * * IT development software * * * Not significant. ^ Not a related party as of December 31 of the year indicated. As of October 2022, the entity which provides sales tax processing and license fees for tax information is no longer affiliated with a director of the Company and is no longer a related party. During the year ended December 31, 2023, as part of the secondary offering (see Note 19), the Company entered into a share repurchase agreement with its principal equity owner, pursuant to which the Company agreed to repurchase 32.5 million shares of the Company's common stock at a price equal to the price per share paid by the underwriters, net of commissions and discounts. The aggregate price paid by the Company for the repurchased shares was $ 328.5 million. During the year ended December 31, 2021, the Company completed a strategic investment in a limited partnership (the “Investee”) in which the Company invested $ 10.0 million, plus $ 0.2 million of related fees and expenses, for an approximate 7 % interest (see Note 13). The limited partnership is affiliated with one of the Company’s principal equity owners. The limited partnership recognized no income or loss during the years ended December 31, 2023 and 2022. During the year ended December 31, 2021 the Company issued 110,679 shares of common stock to a board member for aggregate cash proceeds of $ 1.0 million, equal to the fair value of the shares at the time of issuance.

Other Income-Net

Other Income-Net	12 Months Ended
	Dec. 31, 2023
Other Income, Nonoperating [Abstract]
Other Income-Net	26. OTHER INCOME—NET Other income—net consists of the following for the years ended December 31 (in thousands): Year Ended December 31, 2023 2022 2021 (Loss) gain from change in fair value of derivative instruments $ ( 5,743 ) $ 5,663 $ — Income from derivative instruments 6,460 — — Other income–net 1,082 699 114 Total other income–net $ 1,799 $ 6,362 $ 114

Net (Loss) Income Per Share

Net (Loss) Income Per Share	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Net (Loss) Income Per Share	27. NET (LOSS) INCOME PER SHARE The Company calculates basic earnings per share by dividing the net (loss) income by the weighted average number of shares of common stock outstanding for the period. The diluted earnings per share is computed by assuming the exercise, settlement and vesting of all potential dilutive common stock equivalents outstanding for the period using the treasury stock method. We exclude common stock equivalent shares from the calculation if their effect is anti-dilutive. In a period where the Company is in a net loss position, the diluted loss per share is calculated using the basic share count. The 8,625,000 Sponsor Vesting Shares that are issued and outstanding at December 31, 2023, 2022 and 2021 are excluded from the weighted average number of shares of common stock outstanding until the vesting requirement is met and the restriction is removed. The following table sets forth a reconciliation of the numerator and denominator used to compute basic earnings per share of common stock (in thousands, except for share and per share data). Year Ended December 31, 2023 2022 2021 Numerator Net (loss) income $ ( 90,071 ) $ 38,406 $ ( 248,919 ) Accretion of redeemable non-controlling interest ( 2,405 ) — — Net (loss) income attributable to common stockholders $ ( 92,476 ) $ 38,406 $ ( 248,919 ) Denominator Weighted average shares of common stock - basic 617,889,384 607,760,886 543,558,222 Dilutive effect of stock-based awards — 35,080,710 — Weighted average shares of common stock - diluted 617,889,384 642,841,596 543,558,222 Net (loss) income per share attributable to common stockholders: Basic $ ( 0.15 ) $ 0.06 $ ( 0.46 ) Diluted $ ( 0.15 ) $ 0.06 $ ( 0.46 ) Common stock equivalent shares of 33.7 million, 8.1 million, and 32.1 million were excluded from the computation of diluted per share amounts for the years ended December 31, 2023, 2022 and 2021, respectively, because their effect was anti-dilutive.

Segment Information And Informa

Segment Information And Information About Geographic Areas	12 Months Ended
	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Segment Information And Information About Geographic Areas	28. SEGMENT INFORMATION AND INFORMATION ABOUT GEOGRAPHIC AREAS The Company operates in one operating segment. The chief operating decision maker for the Company is the chief executive officer. The chief executive officer reviews financial information presented on a consolidated basis, accompanied by information about revenue by type of service and geographic region, for purposes of allocating resources and evaluating financial performance. Revenues by geographic area presented based upon the location of the customer are as follows (in thousands): Year Ended December 31, 2023 2022 2021 United States $ 859,548 $ 774,697 $ 680,609 China 6,830 7,751 7,679 Total revenues $ 866,378 $ 782,448 $ 688,288 Software, equipment and property, net by geographic area are as follows (in thousands): December 31, 2023 2022 United States $ 160,064 $ 146,398 China 352 45 Total software, equipment and property-net $ 160,416 $ 146,443

Gain on Sale of Cost Method Inv

Gain on Sale of Cost Method Investment	12 Months Ended
	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Gain on Sale of Cost Method Investment	29. GAIN ON SALE OF COST METHOD INVESTMENT During February 2022, the Company received cash proceeds of $ 3.9 million in exchange for its equity interest in an investee as a result of the acquisition of the investee. The Company had been accounting for its investment using the cost method and recognized a gain of $ 3.6 million during the year ended December 31, 2023. The investment’s carrying value was $ 0.3 million at time of the acquisition. The Company no longer has any ownership interest in the investee.

Subsequent Event

Subsequent Event	12 Months Ended
	Dec. 31, 2023
Subsequent Events [Abstract]
Subsequent Event	30. SUBSEQUENT EVENT Secondary Offering —During January 2024, certain existing stockholders completed a secondary offering where the selling stockholders sold 22,000,000 shares of common stock. The Company did no t receive any of the proceeds from the sale of the shares by the selling stockholders. In connection with the offering, the Company did no t incur significant costs during the year ended December 31, 2023.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation —The consolidated balance sheets as of December 31, 2023 and 2022, the consolidated statements of operations and comprehensive (loss) income, the consolidated statements of mezzanine equity and stockholders’ equity and the consolidated statements of cash flows for the years ended December 31, 2023, 2022 and 2021, have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). The Business Combination (see Note 3) was accounted for as a reverse recapitalization in accordance with GAAP, with Dragoneer treated as the acquired company and CCCIS treated as the acquirer. The consolidated assets, liabilities, and results of operations prior to the reverse recapitalization are those of CCCIS. The shares and corresponding capital amounts and losses per share, prior to the reverse recapitalization, have been retroactively restated based on shares reflecting the exchange ratio of 1:340.5507 (the “Exchange Ratio”) established in the Business Combination.
Basis of Accounting	Basis of Accounting —The accompanying consolidated financial statements are prepared in accordance with GAAP and include the accounts of the Company and its wholly-owned subsidiaries and majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The consolidated financial statements include 100% of the accounts of wholly-owned and majority-owned subsidiaries. The ownership interest of the minority investor is recorded as a non-controlling interest in a subsidiary.
Use of Estimates	Use of Estimates —The preparation of the consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts, and the disclosures of contingent amounts in the Company’s consolidated financial statements and the accompanying notes. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Although the Company regularly assesses its estimates, actual results could differ from management’s estimates if past experience or other assumptions are not substantially accurate. Changes in estimates are recorded in the period in which they become known. Significant estimates in these consolidated financial statements include the estimation of contract transaction prices, the determination of the amortization period for contract assets, the valuation of goodwill and intangible assets, the estimates and assumptions associated with the valuation of the warrant liabilities, and the estimates and assumptions associated with stock incentive plans, including the fair value of common stock prior to the Business Combination.
Cash and Cash Equivalents	Cash and Cash Equivalents —The Company considers all highly liquid investments, including money market funds, purchased with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. Cash and cash equivalents are carried at cost, which approximates fair value. The Company believes it is not exposed to any significant credit risk on cash and cash equivalents. While the Company has deposits that exceed federally insured limits at financial institutions, the Company places its cash and cash equivalents in highly rated institutions. The Company has never experienced losses related to these balances.
Foreign Currency	Foreign Currency —The Company’s functional currency is the US dollar, however, for operations located in China, the functional currency is the local currency. Assets and liabilities of the foreign operations are translated to US dollars at exchange rates in effect at the consolidated balance sheet date, while statement of operations accounts are translated to US dollars at the average exchange rates for the period. Translation gains and losses are recorded and remain as a component of accumulated other comprehensive loss in stockholders’ equity until transactions are settled or the foreign entity is sold or liquidated. Gains and losses resulting from transactions that are denominated in a currency that is not the functional currency are recorded to other income–net, in the consolidated statements of operations and comprehensive (loss) income .
Significant Customers and Concentration of Credit Risks	Significant Customers and Concentration of Credit Risks —The Company is potentially subject to concentration of credit risk primarily through its accounts receivable. The Company performs ongoing credit evaluations of its customers and maintains allowances for potential credit losses which, when realized, have been within the range of management’s expectations. The Company generally does not require collateral. Credit risk on accounts receivables is minimized as a result of the large and diverse nature of the Company’s customer base. During the years ended December 31, 2023, 2022 , and 2021 no single customer represented more than 10 % of revenue. As of December 31, 2023 , no customer had an account receivable greater than 10 % of accounts receivable. As of December 31, 2022 , one customer had an account receivable of 11 % of accounts receivable.
Revenue Recognition	Revenue Recognition —The Company’s revenue recognition policy follows guidance from Accounting Standards Codification ("ASC") 606, Revenue from Contracts with Customers. The Company generates revenue from contracts that are generally billed either on a monthly subscription or transactional basis. Other revenue primarily consists of professional services and other non-software services revenue that is generally transaction-based (where a fee per transaction is charged). Revenues are recognized as control of these services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. The Company determines revenue recognition based on the application of the following steps: • Identification of the contract, or contracts, with a customer • Identification of the performance obligation(s) in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligation(s) in the contract • Recognition of revenue when, or as a performance obligation is satisfied Software Subscription Revenues —Software services are hosted and provide customers with the right to use the hosted software over the contract period without taking possession of the software and are generally billed on either a monthly subscription or transactional basis. Revenues related to services billed on a subscription basis are recognized ratably over the contract period as this is the time period over which services are transferred to the customer, generally between three and five years. Revenues from subscription services represent a stand-ready obligation to provide access to the Company’s platform. As each day of providing services is substantially the same and the customer simultaneously receives and consumes the benefits as access is provided, subscription arrangements include a series of distinct services. The Company may provide certain of its customers with implementation activities such as basic setup, installation and initial training that the Company must undertake to fulfill the contract. These are considered fulfillment activities that do not transfer the service to the customer. For contracts with fixed and variable consideration, to the extent that customers’ usage exceeds the committed contracted amounts under their subscriptions, they are charged for their incremental usage. In addition to overage fees, consideration may vary due to discounts, incentives, and potential service level credits or contractual penalties. For such variable consideration, the Company includes an estimate of the most likely amount it expects to receive for the total transaction price if it is probable that a significant reversal of cumulative revenue recognized will not occur. When customers’ usage falls below the committed contracted amounts, the customer does not receive any credits or refunds for the shortfall. For contracts where fees are solely based on transaction volume, the amount invoiced corresponds directly with the value provided to the customer, and revenue is recognized when invoiced using the as-invoiced practical expedient. Other Revenue —Other revenues consist of professional services and other non-software services and are recognized over time as the services are performed. Other revenues are generally invoiced monthly in arrears. Revenues related to such services that are billed on a transactional basis are recognized when the transaction for the related service occurs. Transaction revenue is primarily comprised of fees for services applied to the volume of transactions. These are typically based on a per-unit rate and are invoiced for the same period in which the transactions were processed and as the performance obligation is satisfied. For contracts with transaction fees, the amount invoiced corresponds directly with the value provided to the customer, and revenue is recognized when invoiced using the as-invoiced practical expedient. Contracts with Multiple Performance Obligations —The Company’s contracts with customers can include access to different software applications such as CCC workflow, estimating, valuation and analytics, each of which is its own performance obligation. These additional services are either sold on a standalone basis or could be used on their own with readily available resources. For these contracts, the Company accounts for individual performance obligations separately, if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. The standalone selling price for distinct performance obligations is generally based on directly observable pricing. In instances where standalone selling price is not directly observable, the Company determines standalone selling price based on overall pricing objectives, which take into consideration observable data, market conditions and entity-specific factors. The Company may occasionally recognize an adjustment in revenue in the current period for performance obligations partially or fully satisfied in the previous periods resulting from changes in estimates for the transaction price, including any changes to the Company’s assessment of whether an estimate of variable consideration is constrained. For the years ended December 31, 2023, 2022 and 2021, the impact on revenue recognized in the current period, from performance obligations partially or fully satisfied in the previous period, was not significant. Contract Liabilities —Contract liabilities consist of deferred revenue and include customer billings in advance of revenues being recognized from subscription contracts and professional services. Deferred revenue that is expected to be recognized during the succeeding twelve-month period is recorded as current, and the remaining portion is recorded as noncurrent and included within other liabilities on the consolidated balance sheets. Costs to Obtain and Fulfill the Contract —The Company defers costs that are considered to be incremental and recoverable costs of obtaining a contract with a customer, including sales commissions. Costs to fulfill contracts are capitalized when such costs are direct and related to implementation activities for hosted software solutions. Capitalized costs to obtain a contract and costs to fulfill a contract are generally amortized over a period between three and five years, which represents the expected period of benefit of these costs and corresponds to the contract period. In instances where the contract term is significantly different than our general contract terms of between three and five years, costs to obtain and fulfill are amortized over the contract term which the Company believes best reflects the period of benefit of these costs.
Cost of Revenues	Cost of Revenues —Cost of revenues is primarily composed of personnel costs, including stock-based compensation, and costs of external resources used in the delivery of services to customers, including software configuration, integration services, customer support activities, third party costs related to hosting the Company’s software for its customers, internal support of production infrastructure, IT security costs, depreciation expense, cost of software production, and data licensing and royalty fees paid to third parties. Cost of revenues also includes amortization of internal use software, including capitalized development costs, and amortization and impairment of acquired technologies.
Research and Development	Research and Development —Research and development expenses consist primarily of personnel-related costs, including stock-based compensation, and costs of external development resources involved in the engineering, design and development of new solutions, as well as expenses associated with significant ongoing improvements to existing solutions. Research and development expenses also include costs for certain IT expenses. Research and development costs, other than software development costs qualifying for capitalization, are expensed as incurred
Selling and Marketing	Selling and Marketing —Selling and marketing expenses consist primarily of personnel-related costs for our sales and marketing functions, including sales commissions and stock-based compensation. Additional expenses include advertising costs, marketing costs and event costs, including the Company’s annual industry conference. The Company expenses advertising and other promotional expenditures as incurred. Advertising expenses were $ 1.5 million, $ 1.1 million and $ 1.1 million for the years ended December 31, 2023, 2022 and 2021 , respectively.
General and Administrative	General and Administrative —General and administrative expenses consist primarily of personnel-related costs, including stock-based compensation, for our executive management and administrative employees, including finance and accounting, human resources, internal systems IT, facilities and legal functions. Additional expenses include professional service fees, insurance premiums, and other corporate expenses that are not allocated to the above expense categories.
Amortization of Intangible Assets	Amortization of Intangible Assets —Amortization of intangible assets consists of the capitalized costs of intangible assets. These intangible assets are amortized on a straight-line basis over their estimated useful lives (see Note 12).
Goodwill and Intangible Asset Impairments	Goodwill and Intangible Asset Impairments —Goodwill and intangible asset impairments includes the goodwill and intangible asset impairment charges specific to the Company's China reporting unit (see Note 12).
Stock-Based Compensation	Stock-Based Compensation —The Company’s stock-based compensation plans are described in Note 21. The Company accounts for stock-based payment awards based on the grant date fair value. The incremental fair value of modifications to stock-based payment awards is estimated at the date of modification. Stock-based payment awards that are settled in cash are accounted for as liabilities. The Company recognizes stock-based compensation expense for only the portion of awards expected to vest, based on an estimated forfeiture rate. The Company recognizes stock-based compensation expense for time-based awards on a straight-line basis over the requisite service period, which is generally the vesting period of the respective awards. Stock-based compensation expense for performance-based awards with a market condition is recognized over the estimated service period, regardless of whether the market condition is satisfied. Stock-based compensation expense for performance-based awards with a market condition, when the market condition is a liquidity event or change in control, is not recognized until the performance condition is probable of occurring. The fair value of RSUs with only a time-based vesting component or a performance-based vesting component is determined using the quoted price of our common stock on the date of grant. As of each reporting period, we estimate the number of RSUs with a performance-based vesting component that are expected to vest based on our current estimate of performance compared to the target metrics and record a cumulative-effect adjustment to stock-based compensation expense when necessary. For stock-based awards that are accounted for as liabilities, we remeasure the fair value of the associated liability at each reporting date through settlement using the Black-Scholes option pricing model and recognize the adjustment as stock-based compensation expense. The fair value of the Company’s stock options with only a time-based component is estimated using the Black-Scholes option pricing model. The fair value of the Company’s performance-based awards with a market condition is estimated using a Monte Carlo simulation model. Stock-based compensation expense related to purchase rights issued under the CCC Intelligent Solutions Holdings Inc. 2021 Employee Stock Purchase Plan ("ESPP") is based on the Black-Scholes option pricing model's fair value of the estimated number of awards as of the beginning of the applicable offering period. Stock-based compensation expense is recognized using the straight-line method over the applicable offering period. The inputs and assumptions utilized under these methods require judgments and estimates. Changes in the inputs and assumptions could affect the measurement of the estimated fair value of the related compensation expense of these stock-based payment awards.
Accounts Receivable—Net	Accounts Receivable—Net —Accounts receivable, as presented in the consolidated balance sheets, are net of customer sales allowances and doubtful accounts. The Company determines allowances for its sales reserves and doubtful accounts based on specific identification of customer accounts and historical experience to the remaining accounts receivable balance. The Company’s assessment of doubtful accounts includes estimating its expected credit losses based on historical information and adjusted for current conditions and forecasts for the probability of collection from customers. Doubtful accounts are charged to general and administrative expenses in the consolidated statements of operations and comprehensive (loss) income .
Software, Equipment, and Property—Net	Software, Equipment, and Property—Net —Software, equipment, and property are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed on a straight-line basis over the asset’s estimated useful lives, which are as follows: Software, equipment, and property Estimated Useful Life Software and licenses 2 - 5 years Computer equipment 3 years Furniture and other equipment 5 years Database 25 years Building 39 years Leasehold improvements Lesser of the estimated useful life or life of lease Land Indefinite Maintenance and repairs are expensed as incurred. Significant improvements and enhancements are capitalized.
Internal Use Software	Internal Use Software —The Company capitalizes the direct costs incurred in developing or obtaining internal use software, including platform development, infrastructure and tools, as well as certain payroll and payroll-related costs of employees who are directly associated with internal use computer software projects. The amount of capitalized payroll costs with respect to these employees is limited to the time directly spent on such projects. The costs associated with preliminary project stage activities, training, maintenance, and all other post-implementation activities are expensed as incurred. Additionally, the Company expenses internal costs related to minor upgrades and enhancements as it is impractical to separate these costs from normal maintenance activities. Capitalized internal use software costs are recorded within software, equipment, and property on the Company’s consolidated balance sheets.
Goodwill and Intangible Assets	Goodwill and Intangible Assets —Goodwill and intangible assets deemed to have indefinite lives are not amortized, but are subject to an annual impairment test, or more frequently if events or changes in circumstances indicate that the carrying value may not be recoverable. The Company performs its annual impairment assessment of goodwill and indefinite life intangible assets as of November 30 of each year. Under GAAP, the Company has the option to first assess qualitative factors in order to determine if it is more likely than not that the fair value of one of its reporting units or indefinite life intangible assets is greater than its carrying value ("Step 0"). If the qualitative assessment leads to a determination that the fair value is less than its carrying value, or if the Company elects to bypass the qualitative assessment, it is required to perform a quantitative impairment test ("Step 1") by calculating the fair value of the reporting unit or indefinite life intangible asset and comparing the fair value with its associated carrying value. If the carrying value exceeds the fair value, an impairment loss is recognized in an amount equal to the excess, up to the carrying value of the goodwill or indefinite life intangible asset. During the three months ended June 30, 2023, the Company performed an interim quantitative impairment test for its China reporting unit due to events which indicated that the carrying amount was in excess of its estimated fair value. As a result of the interim quantitative impairment test, the Company recorded a goodwill impairment charge of $ 77.4 million (see Note 12). The Company performed its annual impairment test for its Domestic reporting unit, its remaining reporting unit with goodwill and indefinite lived assets as of November 30, 2023 and determined no impairment existed. For the years ended December 31, 2022 and 2021 , the Company performed its annual impairment tests for its goodwill and indefinite lived intangible assets and determined no impairment existed.
Long-Lived Assets	Long-Lived Assets —Long-lived assets, other than goodwill, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset or asset group to estimated undiscounted future cash flows expected to be generated by such assets. If the carrying amount of the assets exceeds their estimated future cash flows, an impairment charge is recognized equal to the amount by which the carrying amount of the assets exceeds their fair value. During the year ended December 31, 2023, the Company performed the recoverability test on its China reporting unit's intangible assets due to events which indicated the carrying amount may not be recoverable. As a result, the Company recorded impairment charges totaling $ 5.3 million (see Note 12). There were no events or changes in circumstances that indicated the carrying value may not be recoverable and no impairment charges were recognized during the years ended December 31, 2022 and 2021 .
Equity Method Investment	Equity Method Investment —The Company accounts for its 7 % investment in a limited partnership using the equity method of accounting. Under the equity method of accounting, the investee’s accounts are not reflected within the Company’s consolidated balance sheets and consolidated statements of operations and comprehensive (loss) income . The Company’s investment was initially recognized at cost and adjusted thereafter for the post acquisition changes in the Company’s share of the investee’s earnings which would be recorded in other income-net.
Deferred Financing Costs	Deferred Financing Costs —Deferred financing costs are capitalized and amortized over the life of the underlying financing agreement (see Note 16).
Business Combinations	Business Combinations —The Company allocates the purchase consideration of acquired companies to tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date, with the excess recorded to goodwill. These estimates are inherently uncertain and subject to refinement. During the measurement period, which may be up to one year from the acquisition date, adjustments may be recorded to the fair value of these tangible and intangible assets acquired and liabilities assumed, including uncertain tax positions and tax-related valuation allowances, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations and comprehensive (loss) income. The Company estimates the fair value of contingent consideration related to business combinations on the date of acquisition (see Note 4). The fair value of the contingent consideration is remeasured each reporting period, with any change in the fair value recorded within the consolidated statements of operations and comprehensive (loss) income .
Fair Value of Financial Instruments and Fair Value Measurements	Fair Value of Financial Instruments and Fair Value Measurements —Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value. Level 1 —Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 —Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 —Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.
Warrant Liability	Warrant Liability —The Company assumed publicly-traded warrants (“Public Warrants”) and warrants sold in a private placement (“Private Warrants”) upon consummation of the Business Combination. The Company accounts for its Public Warrants and Private Warrants under ASC 815-40, Derivatives and Hedging-Contracts in Entity’s Own Equity , in conjunction with the SEC Division of Corporation Finance’s April 12, 2021 Public Statement, Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies ("SPACs") . The terms of the warrants provide for potential changes to the settlement amounts dependent upon the characteristics of the warrant holder, and preclude the warrants from being classified in equity and thus the warrants are classified as a liability. Accordingly, the Company recorded the warrants as long-term liabilities on its consolidated balance sheet at fair value upon the closing of the Business Combination (see Note 3), with subsequent changes in the fair value of the warrants recognized in the consolidated statements of operations and comprehensive (loss) income at each reporting date. Prior to their redemption during the year ended December 31, 2021, the Public Warrants were publicly traded and thus had an observable market price in an active market and were valued at their trading price as of each reporting date. The Private Warrants are valued using the Black-Scholes option pricing model. The assumptions utilized under the Black-Scholes option pricing model require judgments and estimates. Changes in these inputs and assumptions could affect the measurement of the estimated fair value of the related fair value of the Private Warrants.
Derivative Instruments	Derivative Instruments —The Company records derivative instruments as an asset or liability measured at fair value each reporting period. The Company has not designated its derivatives as hedging instruments for accounting purposes and recognizes the changes in fair value within its consolidated statement of operations and comprehensive (loss) income. Gain and losses from the change in fair value and cash payments and receipts related to the derivative instruments are recognized in other income (expense)—net, in the consolidated statements of operations and comprehensive (loss) income . The Company does not enter into derivative instrument transactions for trading or speculative purposes.
Income Taxes	Income Taxes —Deferred income tax assets and liabilities are recognized for the expected future tax effects of temporary differences between the financial and income tax reporting basis of assets and liabilities using tax rates in effect for the years in which the differences are expected to reverse. Deferred income taxes relate to the timing of recognition of certain revenue and expense items, and the timing of the deductibility of certain reserves and accruals for income tax purposes that differs from the timing for financial reporting purposes. The Company establishes a tax valuation allowance to the extent that it is more likely than not that a deferred tax asset will not be realizable against future taxable income. A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation process, based on its technical merits. Income tax positions must meet a more-likely-than-not recognition threshold to be recognized. The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense.
Employee Insurance Benefit	Employee Insurance Benefits —The Company maintains a self-insured group medical program. The program contains stop loss thresholds with amounts in excess of the self-insured levels fully insured by third-party insurers. Liabilities associated with this program are estimated in part by considering historical claims experience and medical cost trends.
Leases	Leases —The Company’s lease policy follows guidance from ASC 842, Leases . In accordance with ASC 842, the Company, at the inception of the contract, determines whether a contract is or contains a lease. For leases with terms greater than 12 months, the Company records the related operating or finance right of use asset and lease liability at the present value of lease payments over the lease term. The Company is generally not able to readily determine the implicit rate in the lease and therefore uses the determined incremental borrowing rate at lease commencement to determine the present value of lease payments. The incremental borrowing rate represents an estimate of the market interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease. Renewal options are not included in the measurement of the right of use assets and lease liabilities unless the Company is reasonably certain to exercise the optional renewal periods. Some leases also include early termination options, which can be exercised under specific conditions. Additionally, certain leases contain incentives, such as construction allowances from landlords. These incentives reduce the right-of-use asset related to the lease. Some of the Company’s leases contain rent escalations over the lease term. The Company recognizes expense for operating leases on a straight-line basis over the lease term. The Company has elected the practical expedient to combine lease and non-lease components for all asset categories. Therefore, the lease payments used to measure the lease liability for these leases include fixed minimum rentals along with fixed non-lease component charges. Lease related costs, which are variable rather than fixed, are expensed in the period incurred. The Company does not have significant residual value guarantees or restrictive covenants in the lease portfolio.
Redeemable Non-Controlling Interest	Redeemable Non-Controlling Interest —The Company presents a redeemable non-controlling interest as mezzanine equity within its consolidated balance sheets when it is redeemable at a fixed or determinable price on a fixed or determinable date at the option of the holder or upon the occurrence of an event that is not solely within the control of the Company. The redeemable non-controlling interest was initially measured at fair value on the date of issuance. When the redemption of a mezzanine-classified non-controlling interest becomes probable, the carrying amount of the redeemable non-controlling interest is increased by periodic accretions using the interest method so that the carrying amount will equal the redemption amount on the date that the shares become redeemable. These adjustments are recorded as accretion of redeemable non-controlling interest, with an offset to additional paid-in capital, on the consolidated statements of mezzanine equity and stockholders' equity (see Note 18). Any such charges to additional paid-in capital affect net (loss) income available to CCC common stockholders as part of the Company's calculation of net (loss) income per share attributable to common stockholders.
Reclassifications	Reclassifications —Certain reclassifications of prior period amounts have been made to conform to the current period presentation. For the year ended December 31, 2023, changes in the fair value of the Company's interest rate cap agreements are recognized within other income-net in the consolidated statements of operations and comprehensive (loss) income . Corresponding amounts recognized during the year ended December 31, 2022, were previously classified as a change in fair value of derivative instruments and have been reclassified to conform to the current period presentation. The amounts reclassified had no impact on net (loss) income.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements —Effective April 1, 2023, the Company adopted Accounting Standards Update ("ASU") 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, and in January 2021 subsequently issued ASU 2021-01, which refines the scope of Topic 848. These ASUs provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions, subject to meeting certain criteria, that reference the London Interbank Offered Rate ("LIBOR"), or another rate that is expected to be discontinued. ASU 2020-04 was effective upon issuance. In December 2022, the FASB issued ASU 2022-06 that defers the sunset date for applying the reference rate reform relief in Accounting Standards Codification ("ASC") 848 to December 31, 2024. The Company adopted these standards during the three months ended June 30, 2023 and transitioned the reference rate within its credit agreement and related interest rate cap agreements from LIBOR to the Secured Overnight Financing Rate ("SOFR") (see Note 16). The adoption of these standards did not have a material impact on the consolidated financial statements.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements —In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires entities to disclose disaggregated information about their effective tax rate reconciliation as well as expanded information on income taxes paid by jurisdiction. The disclosure requirements will be applied on a prospective basis, with the option to apply them retrospectively. The amendments in this update are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the disclosure requirements related to this update. In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update is intended to improve reportable segment disclosure requirements, primarily through additional disclosures about significant segment expenses. The amendments in this update are effective for fiscal years beginning after December 31, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The amendments should be applied retrospectively to all prior periods presented in the financial statements. The Company is evaluating the disclosure requirements related to this update.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2023
Accounting Policies [Abstract]
Schedule of Software,Equipment and Property	Software, equipment, and property Estimated Useful Life Software and licenses 2 - 5 years Computer equipment 3 years Furniture and other equipment 5 years Database 25 years Building 39 years Leasehold improvements Lesser of the estimated useful life or life of lease Land Indefinite

Business Combination (Tables)

Business Combination (Tables)	12 Months Ended
	Dec. 31, 2023
Business Combinations [Abstract]
Summary of Number of Shares of Common Stock Outstanding Immediately Following the Closing	The total number of shares of the Company’s common stock outstanding immediately following the Closing was 603,170,380 , comprised as follows: Shares issued to Dragoneer public shareholders and Sponsor 56,615,002 Sponsor Vesting Shares 8,625,000 Shares issued to Legacy CCC shareholders 505,430,378 Shares issued to Forward Purchasers 17,500,000 Shares issued to PIPE Investors 15,000,000 Total shares of common stock outstanding immediately following the Business 603,170,380
Scheduel of Reconciliation of Elements of Business Combination to Cash Flows and Mezzanine and Stockholders Equity	The following table reconciles the elements of the Business Combination to the consolidated statement of cash flows and the consolidated statement of mezzanine equity and stockholders’ equity for the year ended December 31, 2021 (in thousands). Cash - Dragoneer trust and cash $ 449,441 Cash - PIPE Financing 150,000 Cash - Forward Purchase Agreements 175,000 Less: transaction costs and advisory fees ( 11,141 ) Net cash contributions from Business Combination 763,300 Less: non-cash fair value of Public Warrants and Private Warrants ( 58,459 ) Net equity infusion from Business Combination $ 704,841

Business Acquisition (Tables)

Business Acquisition (Tables)	12 Months Ended
	Dec. 31, 2023
Business Combinations [Abstract]
Schedule of Business Acquisitions by Acquisition	The acquisition date fair value of the consideration transferred was $ 32.5 million, which consisted of the following (in thousands): Cash paid through closing $ 32,300 Fair value of contingent earnout consideration 200 Total acquisition date fair value of the consideration transferred $ 32,500
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the final allocation of the consideration to the fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands): Assets acquired: Current assets $ 150 Intangible asset - acquired technology 4,800 Total assets acquired 4,950 Liabilities assumed: Current liabilities 147 Deferred tax liabilities 548 Total liabilities assumed 695 Net assets acquired 4,255 Goodwill 28,245 Total purchase price $ 32,500

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2023
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]
Summarizes Revenue by Type of Service	The following table summarizes revenue by type of service for the years ended December 31 (in thousands): Year Ended December 31, 2023 2022 2021 Software subscriptions $ 830,117 $ 752,505 $ 662,300 Other 36,261 29,943 25,988 Total revenues $ 866,378 $ 782,448 $ 688,288
Summary of Receivables Contract Assets and Contract Liabilities from Contracts with Customers	The balances of the Company’s receivables, contract assets and contract liabilities from contracts with customers are as follows (in thousands): December 31, December 31, December 31, 2023 2022 2021 Accounts receivables-Net of allowances $ 102,365 $ 98,353 $ 78,793 Deferred contract costs 17,900 16,556 15,069 Deferred contract costs-non-current 22,302 20,161 22,117 Other assets (accounts receivable, non-current) 15,198 16,437 8,622 Deferred revenues 43,567 35,239 31,042 Other liabilities (deferred revenues, non-current) 1,373 1,240 1,574
Summary of Deferred Contract Costs	A summary of the activity impacting the deferred contract costs during the years ended December 31, 2023, 2022 and 2021 is presented below (in thousands): Year Ended December 31, 2023 2022 2021 Balance at beginning of period $ 36,717 $ 37,186 $ 26,306 Costs amortized ( 19,197 ) ( 17,986 ) ( 15,384 ) Additional amounts deferred 22,682 17,517 26,264 Balance at end of period $ 40,202 $ 36,717 $ 37,186 Classified as: Current $ 17,900 $ 16,556 $ 15,069 Non-current 22,302 20,161 22,117 Total deferred contract costs $ 40,202 $ 36,717 $ 37,186
Summary of Deferred Revenue	A summary of the activity impacting deferred revenue balances during the years ended December 31, 2023, 2022 and 2021, is presented below (in thousands): Year Ended December 31, 2023 2022 2021 Balance at beginning of period $ 36,479 $ 32,616 $ 28,515 Revenue recognized 1 ( 434,197 ) ( 380,977 ) ( 334,524 ) Additional amounts deferred 1 442,658 384,840 338,625 Balance at end of period $ 44,940 $ 36,479 $ 32,616 Classified as: Current $ 43,567 $ 35,239 $ 31,042 Non-current 1,373 1,240 1,574 Total deferred revenue $ 44,940 $ 36,479 $ 32,616 1 Amounts include total revenue deferred and recognized during each respective period.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Dec. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurement Inputs and Valuation Techniques	The valuation of the Private Warrants as of December 31, 2023 and December 31, 2022 was determined using the Black-Scholes option pricing model using the following assumptions: December 31, December 31, 2023 2022 Expected term (in years) 2.6 3.6 Expected volatility 34 % 38 % Expected dividend yield 0 % 0 % Risk-free interest rate 4.10 % 4.15 %
Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table presents the fair value of the assets and liabilities measured at fair value on a recurring basis at December 31, 2023 (in thousands): Fair Value Level 1 Level 2 Level 3 Assets Interest rate cap $ 6,208 $ — $ 6,208 $ — Total Assets $ 6,208 $ — $ 6,208 $ — Liabilities Contingent consideration related to business acquisition $ 100 $ — $ — $ 100 Private warrants 51,501 — 51,501 — Total Liabilities $ 51,601 $ — $ 51,501 $ 100 The following table presents the fair value of the assets and liabilities measured at fair value on a recurring basis at December 31, 2022 (in thousands): Fair Value Level 1 Level 2 Level 3 Assets Interest rate cap $ 11,951 $ — $ 11,951 $ — Total Assets $ 11,951 $ — $ 11,951 $ — Liabilities Contingent consideration related to business acquisition $ 100 $ — $ — $ 100 Private warrants 36,405 — 36,405 — Total Liabilities $ 36,505 $ — $ 36,405 $ 100
Summary of Carrying Amounts and Estimated Fair Value of the Financial Instruments	The following table presents the carrying amounts, net of debt discount, and estimated fair values of the Company’s financial instruments that are not recorded at fair value on the consolidated balance sheets (in thousands): December 31, 2023 December 31, 2022 Carrying Estimated Carrying Estimated Description Amount Fair Value Amount Fair Value Term B Loan, including current maturities $ 782,564 $ 784,000 $ 790,331 $ 766,260

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Schedule of Components of Pretax (Loss) Income Attributable to Domestic and Foreign Operations	The components of pretax (loss) income attributable to domestic and foreign operations are as follows (in thousands): Year Ended December 31, 2023 2022 2021 Domestic $ ( 80,486 ) $ 54,799 $ ( 261,900 ) Foreign ( 4,061 ) ( 4,937 ) ( 13,019 ) Pretax (loss) income $ ( 84,547 ) $ 49,862 $ ( 274,919 ) The goodwill and intangible asset impairment charges (see Note 12) recognized during the year ended December 31, 2023 are included in the domestic pretax loss in the table above.
Schedule of Components of Income Tax Benefit	The Company's income tax provision (benefit) consisted of the following (in thousands): Year Ended December 31, 2023 2022 2021 Current provision: Federal $ 41,804 $ 37,470 $ 15,263 State 10,053 8,387 5,620 Total current provision 51,857 45,857 20,883 Deferred provision (benefit): Federal ( 36,253 ) ( 26,570 ) ( 35,284 ) State ( 10,080 ) ( 7,831 ) ( 11,599 ) Foreign ( 502 ) 1,054 ( 2,080 ) Change in valuation allowance 502 ( 1,054 ) 2,080 Total deferred benefit ( 46,333 ) ( 34,401 ) ( 46,883 ) Total income tax provision (benefit) $ 5,524 $ 11,456 $ ( 26,000 )
Summary of Effective Income Tax Rate Differs from the Federal Statutory Rate	The Company’s effective income tax rate differs from the federal statutory rate as follows (in thousands, except percentages): Year Ended December 31, 2023 2022 2021 Federal income tax benefit at statutory rate $ ( 17,755 ) 21.0 % $ 10,471 21.0 % $ ( 57,733 ) 21.0 % Goodwill impairment 16,255 ( 19.2 ) — — — — Executive compensation 12,555 ( 14.8 ) 12,508 25.0 25,362 ( 9.2 ) Fair value of warrants 3,170 ( 3.7 ) ( 5,475 ) ( 11.0 ) 13,545 ( 4.9 ) Stock-based compensation ( 3,844 ) 4.5 ( 4,074 ) ( 8.1 ) ( 3,647 ) 1.3 Research and experimentation credit ( 6,920 ) 8.2 ( 3,510 ) ( 7.0 ) ( 2,914 ) 1.1 Impact of foreign operations 1,794 ( 2.1 ) 2,807 5.6 261 ( 0.1 ) Valuation allowance 502 ( 0.6 ) ( 1,054 ) ( 2.1 ) 2,080 ( 0.8 ) State and local taxes-net of federal income tax effect ( 22 ) 0.0 439 0.9 ( 4,723 ) 1.7 Other nondeductible expenses 836 ( 1.0 ) 344 0.7 756 ( 0.3 ) Uncertain tax positions 396 ( 0.5 ) ( 303 ) ( 0.6 ) 594 ( 0.2 ) Foreign rate difference ( 164 ) 0.2 ( 182 ) ( 0.4 ) ( 493 ) 0.2 Other—net ( 1,279 ) 1.5 ( 515 ) ( 1.0 ) 912 ( 0.3 ) Income tax provision (benefit) $ 5,524 ( 6.5 )% $ 11,456 23.0 % $ ( 26,000 ) 9.5 %
Schedule of Deferred Income Tax Assets and Liabilities	The approximate income tax effect of each type of temporary difference giving rise to deferred income tax assets and liabilities as of December 31, 2023 and 2022 was as follows (in thousands): Year Ended December 31, 2023 2022 Deferred income tax assets: Stock-based compensation $ 36,329 $ 37,156 Operating lease liabilities 13,751 14,339 Accrued compensation 10,373 10,962 Net operating losses—foreign 10,875 10,373 Capitalized R&E—net of amortization 26,082 10,221 Sales allowances and doubtful accounts 1,393 1,339 Interest expense limitation — 673 Net operating losses—domestic (state) 479 506 Research and experimental credit 373 386 Other 775 826 Total deferred income tax assets 100,430 86,781 Valuation allowance for deferred tax asset ( 10,875 ) ( 10,373 ) Net deferred income tax assets 89,555 76,408 Deferred income tax liabilities: Intangible asset amortization 255,572 282,032 Software, equipment and property depreciation and amortization 11,541 17,628 Deferred contract costs 10,044 9,235 Operating lease assets 7,078 7,604 Interest rate cap 685 1,607 Total deferred income tax liabilities 284,920 318,106 Net deferred income tax liabilities $ 195,365 $ 241,698
Schedule of Change in Unrecognised Tax Benefits Excluding Interest and Penalties	The change in unrecognized tax benefits excluding interest and penalties for the years ended December 31, 2023 and 2022 was as follows (in thousands): 2023 2022 Balance at beginning of year $ 3,723 $ 3,722 Additions based on tax positions related to the current year 1,062 797 Additions based on adjustments to tax positions related to prior years 527 105 Reductions for tax positions of prior years ( 897 ) ( 901 ) Balance at end of year $ 4,415 $ 3,723
Summary of Major Jurisdictions Subject to Examination by the Relevant Tax Authorities and Open Tax Years	With few US State exceptions, the major jurisdictions subject to examination by the relevant taxing authorities and open tax years, stated as the Company’s fiscal years, are as follows: Jurisdiction Open Tax Years US Federal 2020 - 2022 US States 2020 - 2022 China 2020 - 2022 Canada 2020 - 2022

Accounts Receivable (Tables)

Accounts Receivable (Tables)	12 Months Ended
	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Schedule of Accounts Receivable, Net	Accounts receivable–Net as of December 31, 2023 and 2022, consists of the following (in thousands): December 31, 2023 2022 Accounts receivable $ 107,939 $ 103,692 Allowance for doubtful accounts and sales reserves ( 5,574 ) ( 5,339 ) Accounts receivable–Net $ 102,365 $ 98,353
Schedule of Changes to the Allowance for Doubtful Accounts and Sales Reserves	Changes to the allowance for doubtful accounts and sales reserves during the years ended December 31, 2023, 2022 and 2021, consists of the following (in thousands): Year Ended December 31, 2023 2022 2021 Balance at beginning of period $ 5,339 $ 3,791 $ 4,224 Charges to bad debt and sales reserves 7,079 4,262 3,634 Write-offs, net ( 6,844 ) ( 2,714 ) ( 4,067 ) Balance at end of period $ 5,574 $ 5,339 $ 3,791

Other Current Assets (Tables)

Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2023
Prepaid Expense And Other Assets Current [Line Items]
Schedule of Other Current Assets	Other current assets as of December 31, 2023 and 2022, consists of the following (in thousands): December 31, 2023 2022 Prepaid SaaS costs 7,833 7,423 Prepaid service fees 5,992 5,268 Prepaid software and equipment maintenance 5,547 7,638 Prepaid insurance 2,289 4,062 Non-trade receivables — 690 Other 10,703 11,277 Total $ 32,364 $ 36,358

Software, Equipment, and Prop_2

Software, Equipment, and Property (Tables)	12 Months Ended
	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Schedule of Software,Equipment and Property	Software, equipment, and property as of December 31, 2023 and 2022, consists of the following (in thousands): December 31, 2023 2022 Software, licenses and database $ 220,625 $ 175,616 Computer equipment 27,467 33,043 Leasehold improvements 31,046 30,430 Building and land 4,910 4,910 Furniture and other equipment 1,370 1,478 Total software, equipment, and property 285,418 245,477 Less accumulated depreciation and amortization ( 125,002 ) ( 99,034 ) Net software, equipment, and property $ 160,416 $ 146,443

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 31, 2023
Leases [Line Items]
Summary of Lease Cost	The components of lease expense for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands): December 31, 2023 2022 2021 Operating lease costs $ 5,958 $ 12,390 $ 16,386 Variable lease costs 3,497 2,319 2,110 Total lease costs $ 9,455 $ 14,709 $ 18,496
Summary of Supplemental Cash Flow and Other Information Related to Leases	The lease term and discount rate consisted of the following as of December 31, 2023, 2022 and 2021: December 31, 2023 2022 2021 Weighted-average remaining lease term (years) 12.9 13.6 12.9 Weighted-average discount rate 6.5 % 6.4 % 6.3 % Supplemental cash flow and other information related to leases for the years ended December 31, 2023, 2022 and 2021 were as follows (in thousands): December 31, 2023 2022 2021 Cash payments for operating leases $ 5,706 $ 11,933 $ 11,403 Operating lease assets obtained in exchange for lease liabilities — 2,825 2,876
Summary of Operating Lease Liabilities	The table below reconciles the undiscounted future minimum lease payments (in thousands) under noncancelable operating leases with terms of more than one year to the total operating lease liabilities recognized on the consolidated balance sheet as of December 31, 2023. Years Ending December 31: 2024 7,016 2025 7,178 2026 7,205 2027 5,403 2028 6,465 Thereafter 51,027 Total lease payments 84,294 Less: Interest ( 26,710 ) Total $ 57,584

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2023
Goodwill [Line Items]
Schedule of Gross Amount, Accumulated Impairment Loss, and Carrying Amount of Goodwill	The following table presents the gross amount, accumulated impairment loss, and net carrying amount of goodwill as of December 31, 2023 and 2022 (in thousands): Accumulated Net Gross Amount Impairment Loss Carrying Amount Balance as of December 31, 2023 1,520,926 ( 103,202 ) 1,417,724 Balance as of December 31, 2022 $ 1,520,926 $ ( 25,797 ) $ 1,495,129
Schedule of Changes in the Carrying Amount of Goodwill	Changes in the net carrying amount of goodwill were as follows during the year ended December 31, 2022 (in thousands): Net Carrying Amount Balance as of December 31, 2021 $ 1,466,884 Acquisition of Safekeep, Inc. 28,245 Balance as of December 31, 2022 $ 1,495,129 Impairment ( 77,405 ) Balance as of December 31, 2023 $ 1,417,724
Summary of Intangible Assets Balance	The intangible assets balance as of December 31, 2023, is reflected below (in thousands): Weighted- Average Estimated Remaining Gross Net Useful Life Useful Life Carrying Accumulated Carrying (Years) (Years) Amount Amortization Amount Intangible assets: Customer relationships 16 – 18 11.3 $ 1,291,830 $ ( 479,054 ) $ 812,776 Acquired technologies 3 – 7 1.7 184,640 ( 172,840 ) 11,800 Subtotal 1,476,470 ( 651,894 ) 824,576 Trademarks—indefinite life 190,470 — 190,470 Total intangible assets $ 1,666,940 $ ( 651,894 ) $ 1,015,046 The intangible assets balance as of December 31, 2022, is reflected below (in thousands): Weighted- Average Estimated Remaining Gross Net Useful Life Useful Life Carrying Accumulated Carrying (Years) (Years) Amount Amortization Amount Intangible assets: Customer relationships 16 – 18 12.3 $ 1,299,750 $ ( 410,095 ) $ 889,655 Acquired technologies 3 – 7 1.8 187,950 ( 149,256 ) 38,694 Subtotal 1,487,700 ( 559,351 ) 928,349 Trademarks—indefinite life 190,470 — 190,470 Total intangible assets $ 1,678,170 $ ( 559,351 ) $ 1,118,819
Schedule of Future Amortization Expense for Intangible Assets	Future amortization expense for each of the next five years and thereafter for intangible assets as of December 31, 2023, is as follows (in thousands): Years Ending December 31: 2024 $ 80,768 2025 72,454 2026 72,454 2027 72,454 2028 72,454 Thereafter 453,992 Total $ 824,576

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses as of December 31, 2023 and 2022, consist of the following (in thousands): December 31, 2023 2022 Compensation $ 54,593 $ 53,530 Royalties and licenses 4,381 3,832 Sales tax 2,968 2,615 Employee insurance benefits 2,572 2,749 Software license agreements 2,233 3,243 Professional services 2,183 1,877 Other 2,548 3,599 Total $ 71,478 $ 71,445

Other Liabilities (Tables)

Other Liabilities (Tables)	12 Months Ended
	Dec. 31, 2023
Other Liabilities Disclosure [Abstract]
Summary of Other Liabilities	Other liabilities as of December 31, 2023 and 2022, consist of the following (in thousands): December 31, 2023 2022 Income taxes payable—non-current $ 3,937 $ — Software license agreements 1,004 1,208 Deferred revenue—non-current 1,373 1,240 Contingent consideration 100 100 Other — 110 Total $ 6,414 $ 2,658

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2023
Debt Disclosure [Abstract]
Summary of Long Term Debt	Long-term debt as December 31, 2023 and 2022, consists of the following (in thousands): December 31, 2023 2022 Term B Loan $ 784,000 $ 792,000 Term B Loan—discount ( 1,436 ) ( 1,669 ) Term B Loan—deferred financing fees ( 7,060 ) ( 8,199 ) Term B Loan—net of discount and fees 775,504 782,132 Less: Current portion ( 8,000 ) ( 8,000 ) Total long-term debt—net of current portion $ 767,504 $ 774,132
Summary of Debt Deferred Financing Fees and Discount	The table below is a roll forward of the Company's contra debt deferred financing fees and discount and deferred financing fees asset balances (in thousands): Deferred Discount— Financing Contra Fees Debt Balance—December 31, 2021 $ 12,363 $ 1,926 Amortization of fees and discount ( 1,878 ) ( 257 ) Balance—December 31, 2022 10,485 1,669 Amortization of fees and discount ( 1,753 ) ( 233 ) Balance—December 31, 2023 $ 8,732 $ 1,436
Summary of Aggregate Maturities of Our Long-Term Debt	Scheduled Payments for Debt —Principal amounts due in each of the next five years, as of December 31, 2023, are as follows (in thousands): Years Ending December 31: 2024 $ 8,000 2025 8,000 2026 8,000 2027 8,000 2028 752,000 Total $ 784,000

Long-Term Licensing Agreement (

Long-Term Licensing Agreement (Tables)	12 Months Ended
	Dec. 31, 2023
LongTerm Licensing Agreement [Line Items]
Summary of Principal Amounts Due in Each of the Next Five Years	Under the terms of these agreements with suppliers, the Company has future minimum obligations as of December 31, 2023 as follows (in thousands): Years Ending December 31: 2024 $ 18,926 2025 15,590 2026 12,483 2027 11,451 2028 9,900 Thereafter 29,700 Total $ 98,050
Licensing Agreement [Member]
LongTerm Licensing Agreement [Line Items]
Summary of Principal Amounts Due in Each of the Next Five Years	Principal amounts due in each of the next five years and thereafter for the Licensing Agreement as of December 31, 2023, are as follows (in thousands): Years Ending December 31: 2024 $ 3,061 2025 3,257 2026 3,466 2027 3,689 2028 3,926 Thereafter 13,354 Total $ 30,753

Redeemable Non-Controlling In_2

Redeemable Non-Controlling Interest (Tables)	12 Months Ended
	Dec. 31, 2023
Noncontrolling Interest [Abstract]
Schedule of activities impacting the redeemable non-controllable interest	The activity impacting the redeemable non-controlling interest during the years ending December 31 is presented below (in thousands): Year Ended December 31, 2023 2022 2021 Balance at beginning of period $ 14,179 $ 14,179 $ 14,179 Accretion of redeemable non-controlling interest 2,405 — — Balance at end of period $ 16,584 $ 14,179 $ 14,179

Stock Incentive Plans (Tables)

Stock Incentive Plans (Tables)	12 Months Ended
	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Shares of Common Stock Reserved for Future Issuances	The following table summarizes the shares of common stock reserved for future issuance under the 2021 Plan as of December 31, 2023 and 2022: December 31, 2023 2022 Stock options outstanding 35,788,469 45,249,260 Restricted stock units outstanding 36,329,881 31,288,688 Restricted stock units available for future grant 49,451,502 57,946,089 Reserved for ESPP 4,981,134 5,622,825 Common stock reserved for future issuance 126,550,986 140,106,862
Schedule of Non-vested Restricted Stock Units Activity	The table below summarizes the RSU activity for the years ended December 31, 2023, 2022, and 2021: Weighted- Average Shares Fair Value Non-vested RSUs—December 31, 2020 — $ — Granted 18,677,411 10.74 Canceled ( 119,200 ) 11.59 Non-vested RSUs—December 31, 2021 18,558,211 $ 10.74 Granted 16,426,878 10.07 Vested ( 2,324,324 ) 11.22 Canceled ( 1,372,077 ) 10.93 Non-vested RSUs—December 31, 2022 31,288,688 10.34 Granted 12,574,115 9.01 Vested ( 5,707,373 ) 10.57 Canceled ( 1,825,549 ) 9.90 Non-vested RSUs—December 31, 2023 36,329,881 $ 10.56
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The valuation of the performance-based RSUs with a market condition granted or modified during the years ended December 31, 2023, 2022 and 2021 was determined using a Monte Carlo Simulation model using the following assumptions: 2023 2022 2021 Expected term (in years) 1.1 - 2.1 2.8 2.2 Expected volatility 28 %- 32 % 35 % 35 % Expected dividend yield 0 % 0 % 0 % Risk-free interest rate 4.36 %- 4.87 % 2.28 % 0.51 %
Summary of Share-based Compensation Arrangements by Share-based Payment Award	The table below summarizes the option activity for the years ended December 31, 2023, 2022 and 2021 : Weighted- Weighted-Average Average Remaining Aggregate Exercise Contractual Life Intrinsic Value Shares Price (in years) (in thousands) Options outstanding—December 31, 2020 55,570,039 3.03 6.9 $ 337,358 Granted 2,822,484 8.58 Exercised ( 1,924,063 ) 2.70 Forfeited and canceled ( 823,965 ) 3.66 Options outstanding—December 31, 2021 55,644,495 2.95 6.0 469,591 Exercised ( 10,081,164 ) 2.74 Forfeited and canceled ( 314,071 ) $ 4.46 Options outstanding—December 31, 2022 45,249,260 2.99 4.9 258,470 Exercised ( 8,923,718 ) 2.85 Forfeited and canceled ( 537,073 ) 6.88 Options outstanding—December 31, 2023 35,788,469 $ 2.96 4.0 $ 301,563 Options exercisable—December 31, 2023 33,971,974 $ 2.79 3.9 $ 292,059 Options vested and expected to vest—December 31, 2023 35,726,785 $ 2.96 4.0 $ 301,252
Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount	Stock-Based Compensation —Stock-based compensation expense has been recorded in the accompanying consolidated statements of operations and comprehensive (loss) income as follows for the years ended December 31, 2023, 2022 and 2021 (in thousands): Year Ended December 31, 2023 2022 2021 Cost of revenues $ 8,802 $ 5,812 $ 13,644 Research and development 25,467 19,536 40,681 Sales and marketing 33,204 25,309 65,045 General and administrative 77,045 58,840 142,625 Total stock-based compensation expense $ 144,518 $ 109,497 $ 261,995
Time Based Vesting Conditions [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The valuation of time-based stock options granted during the year ended December 31, 2021 was determined using the Black-Scholes option valuation model using the following assumptions: 2021 Expected term (in years) 6.5 Expected volatility 40 % Expected dividend yield 0 % Risk-free interest rate 0.62 - 0.67 %
Performance And Market Based Vesting Conditions [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The valuation of the performance-based options with a market condition granted during the year ended December 31, 2021 was determined through the Monte Carlo simulation model using the following assumptions: 2021 Expected term (in years) 5.5 Expected volatility 33 % Expected dividend yield 0 % Risk-free interest rate 0.44 %
2021 Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The fair value of ESPP purchase rights sold during the years ended December 31, 2023 and 2022 was estimated using the Black-Scholes option pricing model with the following assumptions: 2023 2022 Expected term (in years) 0.5 0.5 Expected volatility 30 %- 51 % 47 % Expected dividend yield 0 % 0 % Risk-free interest rate 2.5 %- 4.7 % 0.2 %
Cayman Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The fair values of the outstanding awards at December 31, 2023 and 2022 were based on the Black-Scholes option pricing model using the following assumptions: 2023 2022 Expected term (in years) 5.25 - 5.42 6.25 Expected volatility 40 % 40 % Expected dividend yield 0 % 0 % Risk-free interest rate 3.8 % 3.5 %

Commitments (Tables)

Commitments (Tables)	12 Months Ended
	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Contractual Obligation Fiscal Year Maturity	Under the terms of these agreements with suppliers, the Company has future minimum obligations as of December 31, 2023 as follows (in thousands): Years Ending December 31: 2024 $ 18,926 2025 15,590 2026 12,483 2027 11,451 2028 9,900 Thereafter 29,700 Total $ 98,050

Related Parties (Tables)

Related Parties (Tables)	12 Months Ended
	Dec. 31, 2023
Related Party Transactions [Abstract]
Schedule of Revenues, Expenses and Amount Receivable with Entities Affiliated with Principal Owners	The following table summarizes revenues and expenses with entities affiliated with one of its principal equity owners for the years ended December 31, 2023, 2022 and 2021 (in thousands): December 31, 2023 2022 2021 Revenues Credit card processing $ 1,051 $ 811 $ 399 Expenses Employee health insurance benefits 3,641 3,166 $ 3,228 Human resources support services 313 237 242 Board of director fees for services, including related travel and out-of-pocket reimbursements 306 131 204 IT development software 130 * * Sales tax processing and license fees for tax information ^ 561 286 * Not significant. ^ Not a related party during the year ended December 31, 2023. The following table summarizes amounts receivable and payable to entities affiliated with one of its principal equity owners as of December 31, 2023 and 2022 (in thousands): December 31, 2023 2022 Receivables Credit card processing * * Payables Employee health insurance benefits $ 480 $ 501 Human resources support services * * Sales tax processing and license fees for tax information ^ ^ Board of director fees for services, including related travel and out-of-pocket reimbursements * * IT development software * * * Not significant. ^ Not a related party as of December 31 of the year indicated.

Other Income-Net (Tables)

Other Income-Net (Tables)	12 Months Ended
	Dec. 31, 2023
Other Income, Nonoperating [Abstract]
Schedule of Other Income-Net	Other income—net consists of the following for the years ended December 31 (in thousands): Year Ended December 31, 2023 2022 2021 (Loss) gain from change in fair value of derivative instruments $ ( 5,743 ) $ 5,663 $ — Income from derivative instruments 6,460 — — Other income–net 1,082 699 114 Total other income–net $ 1,799 $ 6,362 $ 114

Net (Loss) Income Per Share (Ta

Net (Loss) Income Per Share (Tables)	12 Months Ended
	Dec. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth a reconciliation of the numerator and denominator used to compute basic earnings per share of common stock (in thousands, except for share and per share data). Year Ended December 31, 2023 2022 2021 Numerator Net (loss) income $ ( 90,071 ) $ 38,406 $ ( 248,919 ) Accretion of redeemable non-controlling interest ( 2,405 ) — — Net (loss) income attributable to common stockholders $ ( 92,476 ) $ 38,406 $ ( 248,919 ) Denominator Weighted average shares of common stock - basic 617,889,384 607,760,886 543,558,222 Dilutive effect of stock-based awards — 35,080,710 — Weighted average shares of common stock - diluted 617,889,384 642,841,596 543,558,222 Net (loss) income per share attributable to common stockholders: Basic $ ( 0.15 ) $ 0.06 $ ( 0.46 ) Diluted $ ( 0.15 ) $ 0.06 $ ( 0.46 )

Segment Information And Infor_2

Segment Information And Information About Geographic Areas (Tables)	12 Months Ended
	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Schedule of Revenues by Geographic Area	Revenues by geographic area presented based upon the location of the customer are as follows (in thousands): Year Ended December 31, 2023 2022 2021 United States $ 859,548 $ 774,697 $ 680,609 China 6,830 7,751 7,679 Total revenues $ 866,378 $ 782,448 $ 688,288
Schedule of Software, Equipment and Property, Net by Geographic Area	Software, equipment and property, net by geographic area are as follows (in thousands): December 31, 2023 2022 United States $ 160,064 $ 146,398 China 352 45 Total software, equipment and property-net $ 160,416 $ 146,443

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	3 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounting Policies [Line Items]
Advertising Expense		$ 1,500,000	$ 1,100,000	$ 1,100,000
Goodwill, Impairment Loss		77,405,000	0	0
Impairment of intangible assets		4,906,000	0	0
Impairment of intangible assets, finite lived			$ 0	$ 0
China [Member]
Accounting Policies [Line Items]
Goodwill, Impairment Loss	$ 77,400,000
Impairment of intangible assets		$ 5,300,000
Retroactively restated based on shares [Member] | Prior to Reverse Recapitalization [Member]
Accounting Policies [Line Items]
Exchange Ratio Established In The Business Combination		1:340.5507
Technology Company [Member]
Accounting Policies [Line Items]
Equity Method Investment, Ownership Percentage		7%		7%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | No Single Customer [member]
Accounting Policies [Line Items]
Concentration Risk, Percentage		10%	10%	10%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage			11%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | No Single Customer [member]
Accounting Policies [Line Items]
Concentration Risk, Percentage		10%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Property Plant Equipment Estimated Useful Life (Detail)	Dec. 31, 2023
Computer Equipment [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Furniture and Fixtures [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Database [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	25 years
Building [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	39 years
Leasehold Improvements [Member]
Accounting Policies [Line Items]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	us-gaap:UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember
Land [Member]
Accounting Policies [Line Items]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	us-gaap:UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember
Maximum [Member] | Software and Licenses [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Minimum [Member] | Software and Licenses [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	2 years

Business Combination - Addition

Business Combination - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Nov. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Issuance of common stock, Shares	65,000,000
Number of trading days used to determine the share price		20 days
Number of consecutive trading days used to determine the share price		30 days
Common stock reserved for issuance		126,550,986	140,106,862
Business acquisition cost of acquired entity transaction costs				$ 1,395
Common stock shares outstanding		603,128,781	622,072,905
Dragoneer Growth Opportunities Corp [Member]
Business Acquisition [Line Items]
Business acquisition cost of acquired entity transaction costs		$ 11,100
Company Earnout Shares [Member]
Business Acquisition [Line Items]
Issuance of common stock, Shares		15,000,000
Fair value of the shares reserved charged to additional paid in capital				$ 98,900
Company Earnout Shares [Member] | CCCIS Shareholders [Member]
Business Acquisition [Line Items]
Common stock reserved for issuance		13,500,000
Company Earnout Shares [Member] | CCCIS Option Holders [Member]
Business Acquisition [Line Items]
Common stock reserved for issuance		1,500,000
Share Price Greater Than Or Equal to USD Thirteen Per Share [Member] | Company Earnout Shares [Member]
Business Acquisition [Line Items]
Share price		$ 13
Share Price Greater Than Or Equal to USD Fifteen Per Share [Member] | Company Earnout Shares [Member]
Business Acquisition [Line Items]
Share price		$ 15
Number of trading days used to determine the share price		20 days
Number of consecutive trading days used to determine the share price		30 days
Sponsor Vesting Shares [Member]
Business Acquisition [Line Items]
Number of shares non transferable and subject to forfeiture		8,625,000
Forward Purchase Agreement [Member] | Prior to the Closing [Member]
Business Acquisition [Line Items]
Share price		$ 10
Number of forward purchase units issued during period shares new issues		17,500,000
Shares issued, price per share		$ 11.5
PIPE Investors [Member] | Subscription Agreement [Member]
Business Acquisition [Line Items]
Issuance of common stock, Shares		15,000,000
Share price		$ 10

Business Combination - Summary

Business Combination - Summary of Number of Shares of Common Stock Outstanding Immediately Following the Closing (Detail) - shares	1 Months Ended	12 Months Ended
	Nov. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Issuance of common stock, Shares	65,000,000
Common stock shares outstanding		603,128,781	622,072,905
Dragoneer Public Shareholder And Sponsor [Member]
Business Acquisition [Line Items]
Issuance of common stock, Shares		56,615,002
Sponsor Vesting Shares [Member]
Business Acquisition [Line Items]
Issuance of common stock, Shares		8,625,000
Legacy CCC Shareholders [Member]
Business Acquisition [Line Items]
Issuance of common stock, Shares		505,430,378
Forward Purchases [Member]
Business Acquisition [Line Items]
Issuance of common stock, Shares		17,500,000
PIPE Investors [Member]
Business Acquisition [Line Items]
Issuance of common stock, Shares		15,000,000
After The Business Combination [Member]
Business Acquisition [Line Items]
Common stock shares outstanding		603,170,380

Business Combination - Scheduel

Business Combination - Scheduel of Reconciliation of Elements of Business Combination to Cash Flows and Mezzanine and Stockholders Equity (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Proceeds from Issuance of Common Stock	$ 0	$ 0	$ 1,007,000
Net equity infusion from the Business Combination			704,841,000
Business Combination [Member]
Business Acquisition [Line Items]
Cash - Dragoneer trust and cash			449,441,000
Less: transaction costs and advisory fees			(11,141,000)
Net cash contibutions from Business Combination			763,300,000
Less: non-cash fair value of Public Warrants and Private Warrants			(58,459,000)
Net equity infusion from the Business Combination			704,841,000
Business Combination [Member] | Forward Purchase Agreement [Member]
Business Acquisition [Line Items]
Proceeds from Issuance of Common Stock			175,000,000
Business Combination [Member] | PIPE Financing [Member]
Business Acquisition [Line Items]
Proceeds from Issuance of Common Stock			$ 150,000,000

Business Acquisition - Addition

Business Acquisition - Additional Information (Detail) - USD ($) $ in Thousands		12 Months Ended
	Feb. 08, 2022	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Deferred tax liabilities				$ 900
SafekeepInc [Member]
Business Acquisition [Line Items]
Total purchase price	$ 32,300		$ 32,500
Escrow deposit disbursements related to property acquisition	6,000
Fair value of contingent consideration	200
Fair value of consideration transferred	32,500
Deferred tax liabilities	$ 548
Transaction costs				$ 1,200
Estimated useful life			7 years
Maximum [Member]
Business Acquisition [Line Items]
Business acquisition potential earn out amount		$ 90,000

Business Acquisition - Schedule

Business Acquisition - Schedule of Business Acquisition by Acquisition (Details) - USD ($) $ in Thousands		12 Months Ended
	Feb. 08, 2022	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Fair value of contingent earnout consideration		$ 100	$ 100
SafekeepInc [Member]
Business Acquisition [Line Items]
Cash paid through closing	$ 32,300
Fair value of contingent earnout consideration	200
Total acquisition date fair value of the consideration transferred	$ 32,300	$ 32,500

Business Acquisition - Schedu_2

Business Acquisition - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands		12 Months Ended
	Feb. 08, 2022	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Deferred tax liabilities			$ 900
SafekeepInc [Member]
Business Acquisition [Line Items]
Current assets	$ 150
Intangible asset-acquired technology	4,800
Total assets acquired	4,950
Current liabilities	147
Deferred tax liabilities	548
Total liabilities assumed	695
Net assets acquired	4,255
Goodwill	28,245
Total purchase price	$ 32,300	$ 32,500

Revenue - Summarizes Revenue By

Revenue - Summarizes Revenue By Type of Services (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Contract With Customer Asset And Liability [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 866,378	$ 782,448	$ 688,288
Software Subscriptions [Member]
Contract With Customer Asset And Liability [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	830,117	752,505	662,300
Other Services [Member]
Contract With Customer Asset And Liability [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 36,261	$ 29,943	$ 25,988

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]
Revenue remaining performance obligation amount	$ 1,552
Revenue remaining performance obligation revenue to be recognized year 2021	597
Revenue remaining performance obligation revenue to be recognized thereafter	955
Deferred revenue, revenue recognized	$ 35.1	$ 31	$ 26.5

Revenue - Summary of Receivable

Revenue - Summary of Receivables Contract Assets and Contract Liabilities from Contracts with Customers (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]
Accounts receivables-Net of allowances	$ 102,365	$ 98,353	$ 78,793
Deferred contract costs	17,900	16,556	15,069
Deferred contract costs-non-current	22,302	20,161	22,117
Other assets (accounts receivable, non-current)	15,198	16,437	8,622
Deferred revenues	43,567	35,239	31,042
Other liabilities (deferred revenues, non-current)	$ 1,373	$ 1,240	$ 1,574

Revenue - Summary of Deferred C

Revenue - Summary of Deferred Contract Costs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Capitalized Contract Cost [Abstract]
Balance at beginning of period	$ 36,717	$ 37,186	$ 26,306
Costs amortized	(19,197)	(17,986)	(15,384)
Additional amounts deferred	22,682	17,517	26,264
Balance at end of period	40,202	36,717	37,186
Classified as:
Current	17,900	16,556	15,069
Non-current	22,302	20,161	22,117
Total deferred contract costs	$ 40,202	$ 36,717	$ 37,186

Revenue - Summary of Deferred R

Revenue - Summary of Deferred Revenue (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Change in Contract with Customer, Liability [Abstract]
Balance at beginning of period		$ 36,479	$ 32,616	$ 28,515
Revenue recognized	[1]	(434,197)	(380,977)	(334,524)
Additional amounts deferred	[1]	442,658	384,840	338,625
Balance at end of period		44,940	36,479	32,616
Classified as:
Current		43,567	35,239	31,042
Non-current		1,373	1,240	1,574
Total deferred revenue		$ 44,940	$ 36,479	$ 32,616
[1] 1 Amounts include total revenue deferred and recognized during each respective period.

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Discount rate		10%
Fair Value Adjustment of Warrants	$ 15,096,000	$ (26,073,000)	$ 64,501,000
Change in Contingent Consideration Liability	0	100,000
Asset Impairment Charges		0	$ 0
Fair Value, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability	51,601,000	36,505,000
Derivative Assets	6,208,000	11,951,000
Contingent Consideration Related to Business Acquisition [Member] | Fair Value, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability	100,000	100,000
Private Warrants [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value Adjustment of Warrants	2.89	2.05
Private Warrants [Member] | Fair Value, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability	51,501,000	36,405,000
Interest Rate Cap [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Assets	6,200,000	12,000,000
Interest Rate Cap [Member] | Fair Value, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Assets	$ 6,208,000	$ 11,951,000

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Measurement Inputs and Valuation Techniques (Details) - Private Warrants [Member]	Dec. 31, 2023 yr	Dec. 31, 2022 yr
Expected term (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	2.6	3.6
Expected volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0.34	0.38
Expected dividend yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0	0
Risk-free interest rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0.041	0.0415

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	$ 6,200	$ 12,000
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	6,208	11,951
Derivative Liability	$ 51,601	$ 36,505
Fair Value, Recurring [Member] | Contingent Consideration Related to Business Acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Derivative Liability	$ 100	$ 100
Fair Value, Recurring [Member] | Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	6,208	11,951
Fair Value, Recurring [Member] | Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	$ 51,501	$ 36,405
Fair Value, Recurring [Member] | Private Warrants [Member] | Contingent Consideration Related to Business Acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Fair Value, Recurring [Member] | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	$ 0	$ 0
Derivative Liability	0	0
Fair Value, Recurring [Member] | Level 1 | Contingent Consideration Related to Business Acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	0	0
Fair Value, Recurring [Member] | Level 1 | Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	0	0
Fair Value, Recurring [Member] | Level 1 | Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	0	0
Fair Value, Recurring [Member] | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	6,208	11,951
Derivative Liability	51,501	36,405
Fair Value, Recurring [Member] | Level 2 | Contingent Consideration Related to Business Acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	0	0
Fair Value, Recurring [Member] | Level 2 | Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	$ 6,208	$ 11,951
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Fair Value, Recurring [Member] | Level 2 | Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	$ 51,501	$ 36,405
Fair Value, Recurring [Member] | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	0	0
Derivative Liability	100	100
Fair Value, Recurring [Member] | Level 3 | Contingent Consideration Related to Business Acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	100	100
Fair Value, Recurring [Member] | Level 3 | Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets	0	0
Fair Value, Recurring [Member] | Level 3 | Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	$ 0	$ 0

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Carrying Amounts and Estimated Fair Value of the Financial Instruments (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Long-term debt	$ 784,000
Carrying Amount [Member]
Debt Instrument [Line Items]
Long-term debt	782,564	$ 790,331
Estimated Fair Value [Member]
Debt Instrument [Line Items]
Long-term debt	$ 784,000	$ 766,260

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Pretax (Loss) Income Attributable to Domestic and Foreign Operations (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]
Domestic	$ (80,486)	$ 54,799	$ (261,900)
Foreign	(4,061)	(4,937)	(13,019)
PRETAX (LOSS) INCOME	$ (84,547)	$ 49,862	$ (274,919)

Income Taxes - Schedule of Co_2

Income Taxes - Schedule of Components of Income Tax Benefit (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current provision :
Federal	$ 41,804	$ 37,470	$ 15,263
State	10,053	8,387	5,620
Total current provision	51,857	45,857	20,883
Deferred provision (benefit):
Federal	(36,253)	(26,570)	(35,284)
State	(10,080)	(7,831)	(11,599)
Foreign	(502)	1,054	(2,080)
Change in valuation allowance	502	(1,054)	2,080
Total deferred benefit	(46,333)	(34,401)	(46,883)
Total income tax provision (benefit)	$ 5,524	$ 11,456	$ (26,000)

Income Taxes - Summary of Effec

Income Taxes - Summary of Effective Income Tax Rate Differs From The Federal Statutory Rate (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]
Federal income tax benefit at statutory rate	$ (17,755)	$ 10,471	$ (57,733)
Goodwill impairment	16,255	0	0
Executive compensation	12,555	12,508	25,362
Fair value of warrants	3,170	(5,475)	13,545
Stock-based compensation	(3,844)	(4,074)	(3,647)
Research and experimentation credit	(6,920)	(3,510)	(2,914)
Impact of foreign operations	1,794	2,807	261
Valuation allowance	502	(1,054)	2,080
State and local taxes-net of federal income tax effect	(22)	439	(4,723)
Other nondeductible expenses	836	344	756
Uncertain tax positions	396	(303)	594
Foreign rate difference	(164)	(182)	(493)
Other—net	(1,279)	(515)	912
Total income tax provision (benefit)	$ 5,524	$ 11,456	$ (26,000)
Federal income tax benefit at statutory rate	21%	21%	21%
Goodwill impairment	(19.20%)	0%	0%
Executive compensation	(14.80%)	25%	(9.20%)
Fair value of warrants	(3.70%)	(11.00%)	(4.90%)
Stock-based compensation	4.50%	(8.10%)	1.30%
Research and experimentation credit	8.20%	(7.00%)	1.10%
Impact of foreign operations	(2.10%)	5.60%	(0.10%)
Valuation allowance	(0.60%)	(2.10%)	(0.80%)
State and local taxes-net of federal income tax effect	0%	0.90%	1.70%
Other nondeductible expenses	(1.00%)	0.70%	(0.30%)
Uncertain tax positions	(0.50%)	(0.60%)	(0.20%)
Foreign rate difference	0.20%	(0.40%)	0.20%
Other-net	1.50%	(1.00%)	(0.30%)
Income tax provision (benefit)	(6.50%)	23%	9.50%

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Deferred income tax assets:
Stock-based compensation	$ 36,329	$ 37,156
Operating lease liabilities	13,751	14,339
Accrued compensation	10,373	10,962
Net operating losses—foreign	10,875	10,373
Capitalized R&E- net of amortization	26,082	10,221
Sales allowances and doubtful accounts	1,393	1,339
Interest expense limitation	0	673
Net operating losses—domestic (state)	479	506
Research and experimental credit	373	386
Other	775	826
Total deferred income tax assets	100,430	86,781
Valuation allowance for deferred tax asset	(10,875)	(10,373)
Net deferred income tax assets	89,555	76,408
Deferred income tax liabilities:
Intangible asset amortization	255,572	282,032
Software, equipment and property depreciation and amortization	11,541	17,628
Deferred contract costs	10,044	9,235
Operating lease assets	7,078	7,604
Interest rate cap	685	1,607
Total deferred income tax liabilities	284,920	318,106
Deferred Tax Liabilities, Net, Total	$ 195,365	$ 241,698

Income Taxes - Schedule of Chan

Income Taxes - Schedule of Change in Unrecognised Tax Benefits Excluding Interest and Penalties (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance at beginning of year	$ 3,723	$ 3,722
Additions based on tax positions related to the current year	1,062	797
Additions based on adjustments to tax positions related to prior years	527	105
Reductions for tax positions of prior years	(897)	(901)
Balance at end of year	$ 4,415	$ 3,723

Income Taxes - Summary of Major

Income Taxes - Summary of Major Jurisdictions Subject to Examination by the relevant Tax Auhtorities and Open Tax Years (Detail)	12 Months Ended
	Dec. 31, 2023
Maximum [Member] | UNITED STATES | Domestic Tax Authority [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2022
Maximum [Member] | UNITED STATES | State and Local Jurisdiction [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2022
Maximum [Member] | CHINA | Foreign Tax Authority [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2022
Maximum [Member] | CANADA | Foreign Tax Authority [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2022
Minimum [Member] | UNITED STATES | Domestic Tax Authority [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2020
Minimum [Member] | UNITED STATES | State and Local Jurisdiction [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2020
Minimum [Member] | CHINA | Foreign Tax Authority [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2020
Minimum [Member] | CANADA | Foreign Tax Authority [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2020

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Tax Disclosure [Line Items]
Income tax payment	$ 43	$ 55.7	$ 15.2
Operating Loss Carryforwards	$ 0.5
Percentage of valuation allowance equal to income tax benefit	100%	100%
Operating Loss Carryforwards, Limitations on Use	20-year
Maximum [Member]
Income Tax Disclosure [Line Items]
Operating Loss Carryforwards Expiration Period	2028
Minimum [Member]
Income Tax Disclosure [Line Items]
Operating Loss Carryforwards Expiration Period	2024
Foreign Tax Authority [Member]
Income Tax Disclosure [Line Items]
Valuation allowance decreased	$ 0.5	$ (1)	$ 2
Operating Loss Carryforwards, Valuation Allowance	$ 10.9	$ 10.4
State and Local Jurisdiction [Member] | Maximum [Member]
Income Tax Disclosure [Line Items]
Operating Loss Carryforwards Expiration Period	2042
State and Local Jurisdiction [Member] | Minimum [Member]
Income Tax Disclosure [Line Items]
Operating Loss Carryforwards Expiration Period	2035

Accounts Receivable - Schedule

Accounts Receivable - Schedule of Accounts Receivable, Net (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts receivable	$ 107,939	$ 103,692
Allowance for doubtful accounts and sales reserves	(5,574)	(5,339)	$ (3,791)	$ (4,224)
Accounts receivable--Net	$ 102,365	$ 98,353

Accounts Receivable - Schedul_2

Accounts Receivable - Schedule of Changes to the Allowance for Doubtful Accounts and Sales Reserves (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Balance at beginning of period	$ 5,339	$ 3,791	$ 4,224
Charges to bad debt and sales reserves	7,079	4,262	3,634
Write-offs, net	(6,844)	(2,714)	(4,067)
Balance at end of period	$ 5,574	$ 5,339	$ 3,791

Other Current Assets - Schedule

Other Current Assets - Schedule of Other Current Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Prepaid Expense And Other Assets Current [Line Items]
Prepaid SaaS costs	$ 7,833	$ 7,423
Prepaid service fees	5,992	5,268
Prepaid software and equipment maintenance	5,547	7,638
Prepaid Insurance	2,289	4,062
Non-trade receivables	0	690
Other	10,703	11,277
Total	$ 32,364	$ 36,358

Software, Equipment, and Prop_3

Software, Equipment, and Property - Schedule of Software,Equipment and Property (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	$ 285,418	$ 245,477
Less accumulated depreciation and amortization	(125,002)	(99,034)
Net software, equipment, and property	160,416	146,443
Software, Licenses and Database [Member]
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	220,625	175,616
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	27,467	33,043
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	31,046	30,430
Building and Land [Member]
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	4,910	4,910
Furniture and Other Equipment [Member]
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	$ 1,370	$ 1,478

Software, Equipment, and Prop_4

Software, Equipment, and Property - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 36.9	$ 27.9	$ 24.5

Leases - Additional Information

Leases - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2022	Dec. 31, 2023
Leases [Line Items]
Operating Lease, Right-of-Use Asset	$ 32,874	$ 32,874	$ 30,456
Operating Lease, Liability			$ 57,584
Lease termination fee		3,800
Loss on lease termination		$ (3,100)
Lessee, Operating Lease, Description	In December 2022, the Company terminated a corporate office lease which otherwise would have expired in March 2026.
General and Administrative Expense [Member]
Leases [Line Items]
Loss on lease termination	$ (3,100)
Corporate Office [Member]
Leases [Line Items]
Lease termination fee	$ 3,800
Maximum [Member] | Office Space and Data Center Facilities [Member]
Leases [Line Items]
Operating lease term			17 years
Operating lease term extension			5 years
Maximum [Member] | Equipment Leases [Member]
Leases [Line Items]
Operating lease term			3 years
Minimum [Member] | Office Space and Data Center Facilities [Member]
Leases [Line Items]
Operating lease term			1 year
Operating lease term extension			3 years
Minimum [Member] | Equipment Leases [Member]
Leases [Line Items]
Operating lease term			1 year

Leases - Summary of Lease Cost

Leases - Summary of Lease Cost (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Line Items]
Operating lease costs	$ 5,958	$ 12,390	$ 16,386
Variable lease costs	3,497	2,319	2,110
Total lease costs	$ 9,455	$ 14,709	$ 18,496

Leases - Summary of Supplementa

Leases - Summary of Supplemental Cash Flow and Other Information Related to Leases (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Leases [Line Items]
Weighted-average remaining lease term (years)	12 years 10 months 24 days	13 years 7 months 6 days	12 years 10 months 24 days
Weighted-average discount rate	6.50%	6.40%	6.30%
Cash payments for operating leases	$ 5,706	$ 11,933	$ 11,403
Operating lease assets obtained in exchange for lease liabilities	$ 0	$ 2,825	$ 2,876

Leases - Summary of Operating L

Leases - Summary of Operating Lease Liabilities (Detail) $ in Thousands	Dec. 31, 2023 USD ($)
Leases [Line Items]
2024	$ 7,016
2025	7,178
2026	7,205
2027	5,403
2028	6,465
Thereafter	51,027
Total lease payments	84,294
Less: Interest	(26,710)
Total	$ 57,584

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Additional Information (Detail) - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
	Feb. 28, 2022	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill impairment			$ 77,405,000	$ 0	$ 0
Goodwill			1,417,724,000	1,495,129,000	1,466,884,000
Impairment charge			4,906,000	0	0
Amortization of Intangible Assets			71,972,000	72,278,000	72,358,000
Subsidiaries [Member]
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill impairment				0	0
Goodwill				0	0
Amortization of Intangible Assets			$ 98,400,000	$ 99,200,000	$ 98,700,000
China [Member]
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill impairment		$ 77,400,000
Percentage of weighted average cost of capital			12.50%
Goodwill			$ 0
Impairment charge			$ 5,300,000
Acquired Technologies [Member] | Subsidiaries [Member]
Goodwill And Intangible Assets Disclosure [Line Items]
Acquired intangible assets	$ 4,800,000

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Gross Amount, Accumulated Impairment Loss, and Carrying Amount of Goodwill (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Gross Amount	$ 1,520,926	$ 1,520,926
Accumulated Impairment Loss	(103,202)	(25,797)
Net Carrying Amount	$ 1,417,724	$ 1,495,129	$ 1,466,884

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Goodwill [Line Items]
Carrying Amount	$ 1,417,724	$ 1,495,129	$ 1,466,884
Impairment	$ (77,405)	0	$ 0
SafekeepInc [Member]
Goodwill [Line Items]
Carrying Amount		$ 28,245

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Summary of Intangible Assets Balance (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Schedule Of Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,476,470	$ 1,487,700
Accumulated Amortization	(651,894)	(559,351)
Net Carrying Amount	824,576	928,349
Intangible assets, Gross Carrying Amount	1,666,940	1,678,170
Trademarks - indefinite life, Accumulated Amortization	(651,894)	(559,351)
Intangible assets, Net Carrying Amount	1,015,046	1,118,819
Trademarks [Member]
Schedule Of Intangible Assets [Line Items]
Indefinite life intangible assets	190,470	190,470
Intangible assets, Net Carrying Amount	$ 190,470	$ 190,470
Customer Relationships [Member]
Schedule Of Intangible Assets [Line Items]
Weighted- Average Remaining Useful Life (Years)	11 years 3 months 18 days	12 years 3 months 18 days
Gross Carrying Amount	$ 1,291,830	$ 1,299,750
Accumulated Amortization	(479,054)	(410,095)
Net Carrying Amount	$ 812,776	$ 889,655
Acquired Technologies [Member]
Schedule Of Intangible Assets [Line Items]
Weighted- Average Remaining Useful Life (Years)	1 year 8 months 12 days	1 year 9 months 18 days
Gross Carrying Amount	$ 184,640	$ 187,950
Accumulated Amortization	(172,840)	(149,256)
Net Carrying Amount	$ 11,800	$ 38,694
Subsidiaries [Member] | Customer Relationships [Member] | Maximum [Member]
Schedule Of Intangible Assets [Line Items]
Estimated Useful Life (Years)	18 years	18 years
Subsidiaries [Member] | Customer Relationships [Member] | Minimum [Member]
Schedule Of Intangible Assets [Line Items]
Estimated Useful Life (Years)	16 years	16 years
Subsidiaries [Member] | Acquired Technologies [Member] | Maximum [Member]
Schedule Of Intangible Assets [Line Items]
Estimated Useful Life (Years)	7 years	7 years
Subsidiaries [Member] | Acquired Technologies [Member] | Minimum [Member]
Schedule Of Intangible Assets [Line Items]
Estimated Useful Life (Years)	3 years	3 years

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets - Schedule of Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Finite Lived Intangible Assets Future Amortization Expense [Line Items]
2024	$ 80,768
2025	72,454
2026	72,454
2027	72,454
2028	72,454
Thereafter	453,992
Total	$ 824,576	$ 928,349

Equity Method Investment - Addi

Equity Method Investment - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Schedule of Equity Method Investments [Line Items]
Purchase of equity method investment	$ 0	$ 0	$ 10,228
Equity Method Investments	$ 10,228	$ 10,228
Technology Company [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	7%		7%
Subsidiaries [Member] | Technology Company [Member]
Schedule of Equity Method Investments [Line Items]
Purchase of equity method investment	$ 10,200

Accrued Expenses - Schedule of

Accrued Expenses - Schedule of Accrued Expenses (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Accrued Liabilities, Current [Abstract]
Compensation	$ 54,593	$ 53,530
Royalties and licenses	4,381	3,832
Sales tax	2,968	2,615
Employee insurance benefits	2,572	2,749
Software license agreements	2,233	3,243
Professional services	2,183	1,877
Other	2,548	3,599
Total	$ 71,478	$ 71,445

Other Liabilities - Summary of

Other Liabilities - Summary of other Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Other Liabilities, Noncurrent [Abstract]
Income taxes payable-non-current	$ 3,937	$ 0
Software license agreements	1,004	1,208
Deferred revenue-non-current	1,373	1,240
Contingent consideration	100	100
Other	0	110
Total	$ 6,414	$ 2,658

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail)		1 Months Ended			12 Months Ended
	Sep. 21, 2021 USD ($)	Aug. 31, 2022 USD ($)	Sep. 30, 2021 USD ($)	Feb. 29, 2020 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jul. 30, 2021 USD ($)
Debt Instrument [Line Items]
Gain (Loss) on Extinguishment of Debt					$ 0	$ 0	$ (15,240,000)
Proceeds from issuance of long-term debt					0	0	789,927,000
Debt instrument, unamortized discount					1,436,000	1,669,000	1,926,000
Debt issuance costs, net					8,732,000	10,485,000	12,363,000
Debt instrument, annual principal payment								$ 525,000,000
Long-term debt					784,000,000
Long-Term Debt, Current Maturities					8,000,000	8,000,000
Repayment of long term debt					$ 8,000,000	8,000,000	1,336,153,000
Fed Funds Effective Rate Overnight Index Swap Rate [Member]
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate					0.50%
LIBOR [Member]
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate					1%
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Line of credit facility, expiration period	6 months
Payments for extinguish the interest rate swaps	$ 10,000,000
Interest Rate Cap [Member]
Debt Instrument [Line Items]
Derivative Assets					$ 6,200,000	$ 12,000,000
Cash received on interest rate cap agreement					6,500,000
Derivative, Notional Amount		$ 600,000,000
Derivative, cap interest rate		4%
Debt Instrument, Maturity Date		Jul. 31, 2025
First Lien Amendment [Member]
Debt Instrument [Line Items]
Debt issuance costs, net					3,400,000
First Lien Credit Agreement [Member]
Debt Instrument [Line Items]
Debt issuance costs, net					27,600,000
Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Proceeds from issuance of long-term debt					$ 798,000,000
Percentage of annual excess cash flow on line of credit					50%
Line of credit facility, maximum borrowing capacity					$ 75,000,000
Percentage of aggregate commitments on borrowings					35%
Leverage ratio					0.035	0.035
Term Loans [Member] | SOFR [Member]
Debt Instrument [Line Items]
Long term debt floor rate percentage					0.50%
Term Loans [Member] | LIBOR [Member]
Debt Instrument [Line Items]
Long term debt floor rate percentage					0.50%
Maximum [Member] | Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Leverage ratio					0.0625
Minimum [Member] | Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Leverage ratio					0.01
First Lien Term Loan [Member]
Debt Instrument [Line Items]
Gain (Loss) on Extinguishment of Debt							$ 15,200,000
Weighted average interest rate of debt outstanding							4.10%
Interest Expense, Debt							$ 36,100,000
Repayment of long term debt			$ 804,200,000
First Lien Term Loan [Member] | First Lien Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term line of credit					$ 1,000,000,000
Proceeds from issuance of long-term debt					997,500,000
Debt instrument, unamortized discount					$ 2,500,000
First Lien Term Loan [Member] | Minimum [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Interest Rate at Period End					3%
Dollar Revolving Credit Facility [Member] | First Lien Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term line of credit					$ 65,000,000
Multicurrency Revolving Credit Facility [Member] | First Lien Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term line of credit					$ 35,000,000
First Lien Revolvers [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Commitment Fee Percentage					0.50%
First Lien Revolvers [Member] | First Lien Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term line of credit					$ 30,000,000
Incremental Term Loan [Member] | First Lien Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term line of credit				$ 375,000,000
Proceeds from issuance of long-term debt				373,100,000
Debt instrument, unamortized discount				$ 1,900,000
Standby Letters of Credit [Member] | Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity							$ 700,000
Term B Loan [Member] | Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term line of credit					800,000,000
Debt instrument, unamortized discount					2,000,000
Debt issuance costs, net					9,800,000
Line of credit facility, periodic payment, principal					2,000,000
Debt instrument, annual principal payment					0	$ 0
Long-term debt					784,000,000	792,000,000
Long-Term Debt, Current Maturities					$ 8,000,000	$ 8,000,000
Line of Credit Facility, Commitment Fee Percentage					0.50%
Weighted average interest rate of debt outstanding					7.50%	4.20%	3%
Interest Expense, Debt					$ 58,600,000	$ 33,500,000	$ 6,700,000
Term B Loan [Member] | Maximum [Member] | Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Line of credit facility, expiration period					6 years 1 month 9 days
Term B Loan [Member] | Minimum [Member] | Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Line of credit facility, expiration period					6 years 10 months 24 days
Two Thousand and Twenty one Revolving Credit Facility [Member] | Second Lien Credit Agreement [Member]
Debt Instrument [Line Items]
Debt issuance costs, net					$ 1,700,000	2,300,000
Two Thousand and Twenty one Revolving Credit Facility [Member] | Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term line of credit					$ 250,000,000
Line of credit facility, expiration period					4 years 1 month 9 days
Debt issuance costs, net					$ 3,100,000
Line of Credit Facility, Current Borrowing Capacity					$ 249,300,000	$ 249,300,000
Revolving Credit Facility [Member] | Eurodollar [Member]
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate					1%
Revolving Credit Facility [Member] | SOFR [Member]
Debt Instrument [Line Items]
Long term debt floor rate percentage					0%
Revolving Credit Facility [Member] | LIBOR [Member]
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate					1.50%
Long term debt floor rate percentage					0%

Long-Term Debt - Summary of Lon

Long-Term Debt - Summary of Long Term Debt (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term debt—discount	$ (1,436)	$ (1,669)	$ (1,926)
Long-term debt—deferred financing fees	(8,732)	(10,485)	$ (12,363)
Long-term debt—net of discount & fees	784,000
Less: Current portion	(8,000)	(8,000)
Total long-term debt—net of current portion	767,504	774,132
Term B Loan [Member]
Debt Instrument [Line Items]
Long-term debt, gross	784,000	792,000
Long-term debt—discount	(1,436)	(1,669)
Long-term debt—deferred financing fees	(7,060)	(8,199)
Long-term debt—net of discount & fees	$ 775,504	$ 782,132

Long-Term Debt - Summary of Deb

Long-Term Debt - Summary of Debt Deferred Financing Fees and Discount (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Debt Issuance Costs, Net [Abstract]
Deferred Financing Fees, Beginning balance	$ 10,485	$ 12,363
Amortization of fees and discount	(1,753)	(1,878)	$ (3,682)
Deferred Financing Fees, Ending balance	8,732	10,485	12,363
Debt Instrument, Unamortized Discount [Abstract]
Discount (contra debt), Beginning balance	1,669	1,926
Amortization of fees and discount	(233)	(257)	(604)
Discount (contra debt), Ending balance	$ 1,436	$ 1,669	$ 1,926

Long-Term Debt - Summary of Agg

Long-Term Debt - Summary of Aggregate Maturities of Our Long-Term Debt (Detail) $ in Thousands	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
2024	$ 8,000
2025	8,000
2026	8,000
2027	8,000
2028	752,000
Total	$ 784,000

Long-Term Licensing Agreement -

Long-Term Licensing Agreement - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2018	Dec. 31, 2020
LongTerm Licensing Agreement [Line Items]
Contract with customer, liability	$ 44,940	$ 36,479	$ 32,616		$ 28,515
Debt instrument, unamortized discount	1,436	1,669	1,926
Licensing Agreement [Member]
LongTerm Licensing Agreement [Line Items]
Effective interest rate during the period				6.25%
Line of credit facility, annual principal payment				$ 1,200
Contract with customer, liability	30,800	33,600		45,600
Debt issuance costs, current	3,100	2,900		$ 23,200
Interest expense, debt	2,000	2,200	$ 2,400
Debt instrument, unamortized discount	$ 8,600	$ 10,600

Long-Term Licensing Agreement_2

Long-Term Licensing Agreement - Summary Of Principal Amounts Due In Each Of The Next Five Years (Detail) $ in Thousands	Dec. 31, 2023 USD ($)
LongTerm Licensing Agreement [Line Items]
2024	$ 18,926
2025	15,590
2026	12,483
2027	11,451
2028	9,900
Thereafter	29,700
Total	98,050
Subsidiaries [Member]
LongTerm Licensing Agreement [Line Items]
2024	3,061
2025	3,257
2026	3,466
2027	3,689
2028	3,926
Thereafter	13,354
Total	$ 30,753

Redeemable Non-Controlling In_3

Redeemable Non-Controlling Interest - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands		1 Months Ended	12 Months Ended
	Mar. 12, 2020	Nov. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Noncontrolling Interest [Line Items]
Stock issued during period, shares, new issues		65,000,000
Stock issued during period, value, new issues					$ 1,007
Percentage of compound interest per annum on the preferred share issue price	10%
Series A Preferred Stock [Member] | CCC Cayman [Member]
Noncontrolling Interest [Line Items]
Stock issued during period, shares, new issues	1,818
Shares issued, price per share	$ 7,854
Stock issued during period, value, new issues	$ 14,200
Percentage of shares reserved for issuance under employee incentive plan			8.60%	8.60%
Preferred stock, dividend rate, percentage			8%
Series A Preferred Stock [Member] | CCC Cayman [Member] | Ownership Interest [Member]
Noncontrolling Interest [Line Items]
Ownership percentage by noncontrolling owners			10%	10%

Redeemable Non-controlling In_4

Redeemable Non-controlling Interest - Schedule of activities impacting the redeemable non-controllable interest (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Noncontrolling Interest [Abstract]
Redeemable Non-Controlling Interest, Beginning balance	$ 14,179	$ 14,179	$ 14,179
Accretion of redeemable non-controlling interest	2,405	0	0
Redeemable Non-Controlling Interest, Ending balance	$ 16,584	$ 14,179	$ 14,179

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($)				1 Months Ended		12 Months Ended
	Aug. 03, 2021	Mar. 17, 2021	Feb. 28, 2021	Nov. 30, 2023	Jan. 31, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Class of Stock [Line Items]
Shares authorized total						5,000,000,000
Common stock par or stated value per share						$ 0.0001	$ 0.0001
Common stock shares issued						603,128,781	622,072,905
Issuance of common stock, Shares				65,000,000
Common stock shares outstanding						603,128,781	622,072,905
Purchase of shares				4,875,000
Stock Repurchased and Retired During Period, Value						$ 328,453,000
Payments for Repurchase of Initial Public Offering						2,000,000
Proceeds from Issuance of Common Stock						$ 0	$ 0	$ 1,007,000
Stock issued during the period shares stock options exercised						8,923,718	10,081,164	1,924,063
Payment of dividend classified as financing activities	$ 134,600,000	$ 134,500,000
Preferred stock shares issued						0	0
Preferred stock shares outstanding						0	0
Preferred stock shares authorised						100,000,000	100,000,000
Preferred stock par or stated value per share						$ 0.0001	$ 0.0001
Common stock shares description of voting rights						one
Strike price reduction per option						$ 66.4
Deemed distribution to CCCIS option holders						$ 0	$ 0	$ 9,006,000
Secondary Offering [Member]
Class of Stock [Line Items]
Repurchase and retirement of common stock, Shares						32,500,000
Purchase of shares						32,500,000
Stock Repurchased and Retired During Period, Value						$ 328,500,000
Common Stock [Member]
Class of Stock [Line Items]
Issuance of common stock, Shares								110,679
Repurchase and retirement of common stock, Shares						32,500,000
Stock Repurchased and Retired During Period, Value						$ 3,000
Executive Officer [Member] | Common Stock [Member]
Class of Stock [Line Items]
Stock issued during the period shares stock options exercised			883,729
Allocated share based compensation			$ 8,000,000
Director [Member] | Common Stock [Member]
Class of Stock [Line Items]
Stock issued during the period shares stock options exercised					110,679
Allocated share based compensation					$ 1,000,000
Common Class A [Member]
Class of Stock [Line Items]
Common stock par or stated value per share						$ 0.0001

Employee Benefit Plans - Additi

Employee Benefit Plans - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
CCC 401(k) Retirement Savings and Investment Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined contribution plan cost	$ 6.5	$ 6.1	$ 5.3

Stock Incentive Plans - Summary

Stock Incentive Plans - Summary Of Shares Of Common Stock Reserved For Future Issuance under the Plan (Detail) - shares	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	126,550,986	140,106,862
Employee Stock Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	35,788,469	45,249,260
Restricted Stock Units R S U [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	36,329,881	31,288,688
Restricted Stock Units Available For Future Grant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	49,451,502	57,946,089
Reserved For Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	4,981,134	5,622,825

Stock Incentive Plans - Schedul

Stock Incentive Plans - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)		2 years 9 months 18 days	2 years 2 months 12 days
Expected volatility		35%	35%
Expected volatility, minimum	28%
Expected volatility, maximum	32%
Expected dividend yield	0%	0%	0%
Risk-free interest rate		2.28%	0.51%
Risk-free interest rate minimum	4.36%
Risk-free interest rate maximum	4.87%
Time Based Vesting Conditions [Member] | Employee Stock Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)			6 years 6 months
Expected volatility			40%
Expected dividend yield			0%
Risk-free interest rate minimum			0.62%
Risk-free interest rate maximum			0.67%
Performance And Market Based Vesting Conditions [Member] | Employee Stock Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)			5 years 6 months
Expected volatility			33%
Expected dividend yield			0%
Risk-free interest rate			0.44%
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)	2 years 1 month 6 days
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)	1 year 1 month 6 days
2021 Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)	6 months	6 months
Expected volatility		47%
Expected volatility, minimum	30%
Expected volatility, maximum	51%
Expected dividend yield	0%	0%
Risk-free interest rate		0.20%
Risk-free interest rate minimum	2.50%
Risk-free interest rate maximum	4.70%
Cayman Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)		6 years 3 months
Expected volatility	40%	40%
Expected dividend yield	0%	0%
Risk-free interest rate	3.80%	3.50%
Cayman Equity Incentive Plan [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)	5 years 5 months 1 day
Cayman Equity Incentive Plan [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)	5 years 3 months

Stock Incentive Plans - Summa_2

Stock Incentive Plans - Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount (Detail) - Cypress Holdings Inc And Subsidiaries [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expense	$ 144,518	$ 109,497	$ 261,995
Cost of Revenues [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expense	8,802	5,812	13,644
Research and development [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expense	25,467	19,536	40,681
Sales and marketing [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expense	33,204	25,309	65,045
General and administrative [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expense	$ 77,045	$ 58,840	$ 142,625

Stock Incentive Plans - Summa_3

Stock Incentive Plans - Summary of Share-based Compensation Arrangements by Share-based Payment Award (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Shares - Beginning Balance	45,249,260	55,644,495	55,570,039
Shares - Granted			2,822,484
Shares - Exercised	(8,923,718)	(10,081,164)	(1,924,063)
Shares - Forfeited and canceled	(537,073)	(314,071)	(823,965)
Shares - Ending Balance	35,788,469	45,249,260	55,644,495	55,570,039
Shares - Exercisable	33,971,974
Shares - Vested and expected to vest	35,726,785
Weighted- Average Exercise Price - Beginning Balance	$ 2.99	$ 2.95	$ 3.03
Weighted- Average Exercise Price - Granted			8.58
Weighted- Average Exercise Price - Exercised	2.85	2.74	2.7
Weighted- Average Exercise Price - Forfeited and canceled	6.88	4.46	3.66
Weighted- Average Exercise Price - Ending Balance	2.96	$ 2.99	$ 2.95	$ 3.03
Weighted- Average Exercise Price - Exercisable	2.79
Weighted- Average Exercise Price - Vested and expected to vest	$ 2.96
Weighted-Average Remaining Contractual Life (in years)	4 years	4 years 10 months 24 days	6 years	6 years 10 months 24 days
Weighted-Average Remaining Contractual Life (in years) - Exercisable	3 years 10 months 24 days
Weighted-Average Remaining Contractual Life (in years) - Vested and expected to vest	4 years
Aggregate Intrinsic Value - Beginning Balance	$ 258,470	$ 469,591	$ 337,358
Aggregate Intrinsic Value - Ending Balance	301,563	$ 258,470	$ 469,591	$ 337,358
Aggregate Intrinsic Value - Exercisable	292,059
Aggregate Intrinsic Value - Vested and expected to vest	$ 301,252

Stock Incentive Plans - Summa_4

Stock Incentive Plans - Summary Of Restricted stock units Activity (Detail) - Restricted Stock Units (RSUs) [Member] - $ / shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Non-vested RSUs - Begining Balance	31,288,688	18,558,211	0
Granted	12,574,115	16,426,878	18,677,411
Vested	(5,707,373)	(2,324,324)
Canceled	(1,825,549)	(1,372,077)	(119,200)
Non-vested RSUs - Ending Balance	36,329,881	31,288,688	18,558,211
Non-vested RSUs - Begining Balance	$ 10.34	$ 10.74	$ 0
Granted	9.01	10.07	10.74
Vested	10.57	11.22
Canceled	9.9	10.93	11.59
Non-vested RSUs - Ending Balance	$ 10.56	$ 10.34	$ 10.74

Stock Incentive Plans - Additio

Stock Incentive Plans - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
	Oct. 31, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross				2,822,484
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number		33,971,974
Share based compensation by share based award options excercised shares issued net of tax witholding obligation		8,923,718	10,074,354	1,922,019
Share based compensation by share based arrangement options vested during the period aggregate fair value		$ 2.9
Share based compensation by share based arrangement unrecognised compensation for options unvested		$ 96.6
Share based compensation by share based arrangement unrecognised compensation for options unvested remaining period for recognition		1 year 4 months 24 days
Common stock reserved for issuance		126,550,986	140,106,862
Modifications to the performance-based RSUs		(i) the extension of the performance period by one year, (ii) a change to the performance criteria, (iii) a change to the number of units to be issued depending on performance and (iv) for certain grants, imposing a maximum number of units to be issued depending on performance equal to 100% of the target. The modification to the performance-based RSUs subject to a market condition resulted in incremental stock-based compensation expense of $67.0 million, which will be recognized ratably over the modified performance periods. The amount of stock-based compensation expense related to the modified awards during the year ended December 31, 2023 was not significant.
Percentage of number of units to be issued depending on performance		100%
Number of trading days used to determine the share price		20 days
Number of consecutive trading days used to determine the share price		30 days
Common Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross			10,081,164	1,924,063
Shares Paid For Tax Witholding For Share Based Compensation			6,810	2,044
Two Thousand and Twenty One Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock shares reserved for future issuance increase on the first day of fiscal year by number of shares percentage of total number of shares of common stock outstanding		5%
2021 Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock reserved for issuance		6,031,704	6,031,704
Number of shares sold under plan		641,691	408,879
2021 Employee Stock Purchase Plan [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Percentage Of Rate Of Payroll Deduction Of Compensation Of Eligible Employees	15%
2021 Employee Stock Purchase Plan [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Percentage Of Rate Of Payroll Deduction Of Compensation Of Eligible Employees	1%
Threshold Percentage Of Lessor Of The Fair Market Value Of Common Stock To Purchase Price Of Shares Of Common Stock Purchased Under Plan	85%
Aggregate Number Of Shares Reserved For Sale Under Plan Increases On Beginning Of Period Percentage Of Total Number Of Shares Outstanding Or Lessor Amount		1%
Cayman Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized		3,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross		539,400	1,303,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		1,735,900	1,303,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number		0	0
Employee Stock Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock reserved for issuance		35,788,469	45,249,260
Employee Stock Option | Time Based Vesting Conditions [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average grant date fair value				$ 3.67
Employee Stock Option | Performance And Market Based Vesting Conditions [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Weighted average grant date fair value				$ 0.88
Phantom Share Units (PSUs) [Member] | Two Thousand Seventeen Stock Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Vested shares settled in cash amount		$ 10.2
Phantom Share Units (PSUs) [Member] | Phantom Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Additional stock based compensation		6
Performance Based Awards [Member] | Two Thousand Seventeen Stock Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Additional stock based compensation		$ 203.9
Company Earnout Shares [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Allocated share based compensation expense				$ 19.5
Number of additional shares		13,500,000	1,500,000
Restricted Stock Units R S U [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement equity instruments other than options granted during the period		12,574,115	16,426,878	18,677,411
Share based compensation by share based award weighted average grant date fair value of options granted during the period		$ 9.01	$ 10.07	$ 10.74
Common stock reserved for issuance		36,329,881	31,288,688
Incremental stock-based compensation expense		$ 67
Restricted Stock Units R S U [Member] | Performance And Market Based Vesting Conditions [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement equity instruments other than options granted during the period			783,896	5,473,691
Restricted Stock Units R S U [Member] | Time Based Vesting Requirements [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement equity instruments other than options granted during the period		10,946,224	14,859,033	7,730,019
Restricted Stock Units R S U [Member] | Performance Based Vesting Requirements [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement equity instruments other than options granted during the period		1,627,891	783,949	5,473,701
Common Class B [Member] | Two Thousand Seventeen Stock Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross				2,822,484
Common Class B [Member] | Time Based Vesting Conditions [Member] | Two Thousand Seventeen Stock Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross				2,754,374
Common Class B [Member] | Performance And Market Based Vesting Conditions [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement unrecognised compensation for options unvested remaining period for recognition			2 years 6 months
Common Class B [Member] | Performance And Market Based Vesting Conditions [Member] | Two Thousand Seventeen Stock Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross				68,110
Common Class B [Member] | Time Based Vesting [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement unrecognised compensation for options unvested		$ 171.1
Common Class B [Member] | Phantom Share Units (PSUs) [Member] | General and administrative [Member] | Two Thousand Seventeen Stock Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Allocated share based compensation expense				$ 7
Share Price Greater Than or Equal to Usd Fifteen Per Share [Member] | Company Earnout Shares [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share price		$ 15
Number of trading days used to determine the share price		20 days
Number of consecutive trading days used to determine the share price		30 days

Commitments - Additional Inform

Commitments - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2023
Long Term Purchasing Agreement Relating To Licensing Data Used [Member]
Other Commitments [Line Items]
Long term purchase commitment month of expiry	2031

Commitments - Schedule of Contr

Commitments - Schedule of Contractual Obligation Fiscal Year Maturity (Detail) $ in Thousands	Dec. 31, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2024	$ 18,926
2025	15,590
2026	12,483
2027	11,451
2028	9,900
Thereafter	29,700
Total	$ 98,050

Warrants - Additional Informati

Warrants - Additional Information (Detail) - USD ($)		12 Months Ended
	Nov. 29, 2021	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Class of Warrant or Right [Line Items]
Exercise price		$ 11.5
Warrants expire date		Jul. 30, 2026
Change in fair value of warrant liabilities		$ 15,096,000	$ (26,073,000)	$ 64,501,000
Warrant liabilities		$ 51,501,000	$ 36,405,000
Class of Warrant or Right, Date from which Warrants or Rights Exercisable		Aug. 29, 2021
Class Of Warrant Or Rights Date From Which Warrants Or Rights Exercisable Expired		Jul. 30, 2026
Class or warrant issued price per share	$ 0.1
Public Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants outstanding	17,299,983
Class of warrant or right number of securities called by each warrant or right	10,638
Proceeds from Warrant Exercises	$ 100,000
Class Of Warrants and Rights Issued During the Period	15,876,341
Payment for Redemption of warrants	$ 100,000
Class of Warrant or Right, Unissued	1,413,004
Warrants and Rights Outstanding				$ 0
Public Warrants [Member] | Common Class A [Member]
Class of Warrant or Right [Line Items]
Number of shares issued in exchange of warrants	4,826,339
Private Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants outstanding		17,800,000	17,800,000
Change in fair value of warrant liabilities		$ 2.89	$ 2.05

Related Parties - Additional In

Related Parties - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Nov. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Shares repurchased during period	4,875,000
Purchase of equity method investment		$ 0	$ 0	$ 10,228
Revenues		$ 866,378	$ 782,448	$ 688,288
Technology Company [Member]
Equity Method Investment, Ownership Percentage		7%		7%
Investee [Member]
Purchase of equity method investment				$ 10,000
Related Party [Member] | Fees and Expenses [Member]
Revenues				$ 200
Secondary Offering [Member]
Shares repurchased during period		32,500,000
Aggregate price of shares repurchased		$ 328,500
Common Stock [Member] | Director [Member]
Stock issued during period, shares, issued for services				110,679
Stock issued during period, value, issued for services				$ 1,000

Related Parties - Schedule of R

Related Parties - Schedule of Revenues, Expenses and Amount Receivable with Entities Affiliated with Principal Owners (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
Total revenues	$ 866,378	$ 782,448	$ 688,288
Related Party [Member] | IT development software [Member]
Related Party Transaction [Line Items]
Expenses	130
Credit Card Processing [Member] | Related Party [Member]
Related Party Transaction [Line Items]
Total revenues	1,051	811	399
Employee Health Insurance Benefits [Member] | Related Party [Member]
Related Party Transaction [Line Items]
Expenses	3,641	3,166	3,228
Payables	480	501
Human Resource Support Services [Member] | Related Party [Member]
Related Party Transaction [Line Items]
Expenses	313	237	242
Board of Director Fees for Services Including Related Travel and Out-of-Pocket Reimbursements [Member] | Related Party [Member]
Related Party Transaction [Line Items]
Expenses	$ 306	131	204
Sales Tax Processing Services [Member] | Related Party [Member]
Related Party Transaction [Line Items]
Expenses		$ 561	$ 286

Other Income-Net - Schedule of

Other Income-Net - Schedule of Other Income-Net (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Other Income, Nonoperating [Abstract]
(Loss) gain from change in fair value of derivative instruments	$ (5,743)	$ 5,663	$ 0
Income from derivative instruments	6,460	0	0
Other income-net	1,082	699	114
Total other income-net	$ 1,799	$ 6,362	$ 114

Net (Loss) Income Per Share - A

Net (Loss) Income Per Share - Additional Information (Detail) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from the computation of earnings per share	33,700,000	8,100,000	32,100,000
Sponsor Vesting Shares [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted Average Number of Shares Outstanding, Diluted, Adjustment	8,625,000	8,625,000	8,625,000

Net (Loss) Income Per Share - S

Net (Loss) Income Per Share - Schedule Of Earnings Per Share, Basic and Diluted (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Numerator
Net (loss) income	$ (90,071)	$ 38,406	$ (248,919)
Accretion of redeemable non-controlling interest	(2,405)	0	0
Net (loss) income attributable to common stockholders	$ (92,476)	$ 38,406	$ (248,919)
Denominator
Weighted average shares of common stock - basic	617,889,384	607,760,886	543,558,222
Dilutive effect of stock-based awards	$ 0	$ 35,080,710	$ 0
Weighted average shares of common stock - diluted	617,889,384	642,841,596	543,558,222
Net (loss) income per share attributable to common stockholders:
Basic	$ (0.15)	$ 0.06	$ (0.46)
Diluted	$ (0.15)	$ 0.06	$ (0.46)

Segment Information And Infor_3

Segment Information And Information About Geographic Areas - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2023 Segment
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of operating segments	1

Segment Information And Infor_4

Segment Information And Information About Geographic Areas - Schedule of Revenues by Geographic Area (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues, Total	$ 866,378	$ 782,448	$ 688,288
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue from Contract with Customer By Geographic Area	859,548	774,697	680,609
China [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue from Contract with Customer By Geographic Area	$ 6,830	$ 7,751	$ 7,679

Segment Information And Infor_5

Segment Information And Information About Geographic Areas - Schedule of Software, Equipment and Property, Net by Geographic Area (Detail) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Net software, equipment, and property	$ 160,416	$ 146,443
United States [Member] | Property Plant And Equipment Net [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	160,064	146,398
China [Member] | Property Plant And Equipment Net [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	$ 352	$ 45

Divestiture - Additional Inform

Divestiture - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Gain loss on divestiture of business	$ 0	$ 0	$ 600

Gain on Sale of Cost Method I_2

Gain on Sale of Cost Method Investment - Additional Information (Detail) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Feb. 28, 2022	Dec. 31, 2023	Dec. 31, 2021
Statement of Cash Flows [Abstract]
Proceeds from sale of equity method investments	$ 3.9
Cost method investments recognized gains		$ 3.6
Cost method investments carrying value			$ 0.3

Subsequent Event - Additional I

Subsequent Event - Additional Information (Details) - USD ($)	1 Months Ended
	Jan. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Subsequent Event [Line Items]
Common stock shares issued		603,128,781	622,072,905
Subsequent Event [Member] | Secondary Offering [Member]
Subsequent Event [Line Items]
Common stock shares issued	22,000,000
Proceeds from sale of shares	$ 0
Cost incurred	$ 0